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 Preface 
The main task of the Nordic Expert Group for Criteria Documentation of Health 
Risks from Chemicals (NEG) is to produce criteria documents to be used by the 
regulatory authorities as the scientific basis for setting occupational exposure limits 
for chemical substances. For each document, NEG appoints one or several authors. 
An evaluation is made of all relevant published, peer-reviewed original literature 
found. The document aims at establishing dose-response/dose-effect relationships 
and defining a critical effect. Starting with this document, NEG will provide, when 
possible, recommendations for health-based occupational exposure limits. In the 
derivation of such limits, the ECHA Guidance on information requirements and 
chemical safety assessment1 is taken into account. Whereas NEG adopts the 
document by consensus procedures, thereby granting the quality and conclusions, 
the authors are responsible for the factual content of the document. 
The evaluation of the literature and the drafting of this document on inorganic 
chloramines were made by Drs Gunilla Wastensson at the University of Gothenburg 
and Kåre Eriksson at Umeå University, Sweden. 
The draft versions were discussed within NEG and the final version was adopted 
at the NEG meeting 8 May 2019. Editorial work and technical editing were 
performed by the NEG secretariat. The following experts participated in the 
elaboration of the document: 
NEG experts  
Gunnar Johanson (chair) Institute of Environmental Medicine, Karolinska Institutet, Sweden 
Merete Drevvatne Bugge  National Institute of Occupational Health, Norway 
Helge Johnsen National Institute of Occupational Health, Norway 
Anne Thoustrup Saber  National Research Centre for the Working Environment, Denmark 
Piia Taxell Finnish Institute of Occupational Health, Finland 
Mattias Öberg Institute of Environmental Medicine, Karolinska Institutet, Sweden 
Former NEG experts  
Nina Landvik National Institute of Occupational Health, Norway 
Vidar Skaug National Institute of Occupational Health, Norway  
Helene Stockmann-Juvala Finnish Institute of Occupational Health, Finland 
NEG secretariat  
Anna-Karin Alexandrie 
and Jill Järnberg 
Swedish Work Environment Authority, Sweden 
The NEG secretariat is financially supported by the Swedish Work Environment 
Authority and the Norwegian Ministry of Labour and Social Affairs. 
All criteria documents produced by NEG may be downloaded from 
www.nordicexpertgroup.org.  
 
Gunnar Johanson, Chairman of NEG 
                                        
1 ECHA. Guidance on information requirements and chemical safety assessment. Chapter R.8: 
Characterisation of dose [concentration]-response for human health. Version 2.1. Helsinki, 
Finland: European Chemicals Agency, 2012. 
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 Abbreviations and acronyms 
AM arithmetic mean 
BALF bronchoalveolar lavage fluid 
CC16 club cell protein 16 kDa (formerly called Clara cell protein) 
CI confidence interval 
CysLT cysteinyl leukotriene 
DENA diethylnitrosamine 
EIB exercise induced bronchoconstriction 
FENO fraction of exhaled nitric oxide 
FEV1 forced expiratory volume in the first second 
FEV% FEV1/FVC × 100 
FVC forced vital capacity 
GGT γ-glutamyltranspeptidase 
GM geometric mean 
GSH glutathione 
Ig immunoglobulin 
IL interleukin 
LC50 lethal concentration for 50% of the exposed animals at single 
inhalation exposure 
LDH lactate dehydrogenase 
L-eq litre-equivalents 
LOAEC lowest observed adverse effect concentration (at inhalation) 
LOD limit of detection 
LOQ limit of quantification 
LTB4 leukotriene B4  
NEG the Nordic Expert Group for Criteria Documentation of Health 
Risks from Chemicals 
NOAEC no observed adverse effect concentration (at inhalation)  
NOAEL no observed adverse effect level 
NTP National Toxicology Program 
OEL occupational exposure limit 
OR odds ratio 
PEF peak expiratory flow 
PR prevalence ratio 
RD50 concentration causing a 50% decrease in respiratory frequency  
S100-A8 S100 calcium binding protein A8 (also called calgranulin A) 
SD standard deviation 
STEL short-term exposure limit 
SP surfactant-associated protein 
SPIN Substances in Preparations in Nordic Countries 
US United States 
WHO World Health Organization 
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1. Introduction 
Inorganic chloramines, i.e. monochloramine (NH2Cl), dichloramine (NHCl2) and 
trichloramine (NCl3), are formed when free1 chlorine reacts with nitrogen-
containing substances present in e.g. chlorinated (disinfection) water sources. In the 
occupational setting, this may occur in swimming pool facilities (139) and in the 
food processing industry (63, 65, 76, 85). Inorganic chloramines may also be 
formed in industrial processes when liquid waste containing ammoniums ions is 
mixed with a sodium hypochlorite solution (100). Monochloramine, dichloramine 
and trichloramine are not known to be commercial products but monochloramine is 
generated in situ as needed to disinfect drinking water and waste water (68, 132). 
Monochloramine and dichloramine are water soluble of which the former is the 
dominating inorganic chloramine in the chlorinated water sources mentioned above. 
Trichloramine is immiscible with water, has a relatively high vapour pressure at 
room temperature and thus evaporates relatively fast into the air compartment (67). 
Trichloramine is therefore the dominating inorganic chloramine in the indoor air  
of swimming pools (20, 64). In the food processing industry, the fraction of 
trichloramine in air is considerably lower (63, 65, 76, 85). 
In recent years there has been an increased reporting of health problems such as 
irritation and pulmonary effects among staff in indoor chlorinated swimming pool 
facilities and in the food processing industry where chlorinated water is used. 
Chlorination of water gives rise to a number of disinfection by-products also in air, 
mainly inorganic chloramines (6, 83, 108, 138, 139). The aim of this document is 
to evaluate health effects associated with occupational exposure to inorganic 
chloramines, and if possible, to recommend health-based occupational exposure 
limits (OELs). 
2. Substance identification 
Substance identification data for the inorganic chloramines are presented in  
Table 1. 
Table 1. Substance identification data for the inorganic chloramines (97). 
Common name: Monochloramine Dichloramine Trichloramine 
CAS No.: 10599-90-3 3400-09-7 10025-85-1 
EC No.: 234-217-9 – 233-045-1 
Synonyms: Monochlorammonia, 
monochloroamine 
Dichloroamine Nitrogen trichloride, 
nitrogen(III) chloride, 
trichloroazane, agene, 
trichlorine nitride 
Molecular formula: NH2Cl NHCl2 NCl3 
Molecular weight: 51.47 g/mol 85.92 g/mol 120.36 g/mol 
–: missing data. 
                                        
1 Free chlorine: chlorine available to sanitise water, i.e. chlorine and hypochlorite/hypochlorous acid. 
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3. Physical and chemical properties 
Physical and chemical properties for the inorganic chloramines are presented in 
Table 2. Chloramines are powerful oxidants whose high redox potentials can 
oxidise many compounds including iodide ions, the latter being of interest for 
analytical purposes (Section 5.1.2) (26, 75). 
3.1 Monochloramine 
Monochloramine (NH2Cl) is a colourless to yellow liquid with a melting point of 
- 66 °C. It is soluble in ethanol and ethyl ether, and slightly soluble in benzene and 
carbon tetrachloride. Pure monochloramine liquid and monochloramine vapours are 
unstable at room temperature, but the substance is readily soluble and stable in 
aqueous solution (68, 132, 135). 
A threshold odour level of 0.65 mg/l as chlorine gas (Cl2) in aqueous solution has 
been reported, but the substance rarely causes taste and odour problems in drinking 
water below 5 mg/l as Cl2 (124). 
Monochloramine oxidises sulphhydryls and disulphides in the same manner as 
hypochlorous acid (71). 
3.2 Dichloramine 
Dichloramine (NHCl2) is a yellow gas (no boiling point data were located) at room 
temperature. The gas is unstable and reacts with many materials (66). Because of 
its instability it has been prepared only in aqueous solution (51). 
The odour threshold is 0.15 mg/l as Cl2 in aqueous solution, which is much lower 
than that of monochloramine. Most people perceive the unpleasant chlorinous smell 
when the concentration is above 0.5 mg/l (124). 
Table 2. Physical and chemical properties of the inorganic chloramines (18, 51, 66, 67, 
124, 132). 
Parameter Monochloramine Dichloramine 
(unstable) 
Trichloramine 
Boiling point at 101.3 kPa: - 50 °C, dec.  – 71 °C 
Melting point at 101.3 kPa: - 66 °C – - 40 °C 
Vapour pressure at 25 °C:  – – 150 mmHg 
(20.0 kPa) 
Density, gas at 20 °C and 101.3 kPa: – – 1.72 g/ml  
Density, liquid: – – 1.65 g/ml 
Auto ignition temperature: – – 93 °C 
Solubility in water: Miscible Soluble Immiscible 
Stability in water: Stable Dec. Dec. slowly  
Partition coefficient (air:water) at 20 °C: 0.45  1.52  435 
Odour threshold in water as chlorine gas: 0.65 mg/l 0.15 mg/l 0.02 mg/l 
Conversion factors at 20 °C: 1 mg/m3 = 
       1 ppm = 
0.469 ppm  
2.13 mg/m3  
0.280 ppm  
3.57 mg/m3  
0.200 ppm  
4.99 mg/m3  
–: missing data, dec.: decomposes. 
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3.3 Trichloramine 
Trichloramine (NCl3) is an oily yellowish liquid at room temperature. It is 
immiscible with water and is soluble in benzene, chloroform, carbon tetrachloride, 
carbon disulphide and phosphorus trichloride. Trichloramine has a relatively high 
vapour pressure at ambient temperature and explodes when heated above 93 °C or 
when the liquid is exposed to sunlight (18). It evaporates approximately 300 times 
faster than monochloramine and 100 times faster than dichloramine from water into 
the air compartment (67). 
Trichloramine has been said to produce a geranium-like and chlorinous odour. 
The odour threshold is low compared to the other inorganic chloramines, 0.02 mg/l 
in water as Cl2 (124). 
4. Occurrence, production and use  
4.1 Occurrence 
4.1.1 General  
Inorganic chloramines are formed when free chlorine reacts with nitrogen 
containing substances such as urea and ammonia (139) present in chlorinated water 
sources such as drinking water and waste water, swimming pools and in the food 
processing industry where disinfecting or cleaning water is used (63-65, 76, 85, 
132, 139). Inorganic chloramines may also be formed in industrial processes when 
liquid waste containing ammonium ions (NH4+) is mixed with a sodium 
hypochlorite solution (100). 
The formation of inorganic chloramines is illustrated below exemplified with 
ammonia (NH3) as a nitrogen-containing substance and hypochlorous acid (HClO) 
as a chlorinated disinfectant (64). 
 
NH3 + HClO                NH2Cl + H2O  
 
NH2Cl + HClO            NHCl2 + H2O  
 
NHCl2 + HClO            NCl3 + H2O  
 
The formation of inorganic chloramines in water is dependent on the chlorine-to-
nitrogen ratio and pH. In general, the optimal pH for the formation of mono-
chloramine lies in the range 7.5–9.0. Under the conditions of water and waste water 
chlorination, monochloramine is the principle inorganic chloramine encountered. 
Dichloramine has a maximum of formation at pH 4–6, and a pH < 4.4 favours the 
formation of trichloramine (26, 75, 132). 
National recommendations for pH values in chlorinated swimming pools vary 
slightly. All Nordic countries have a recommended upper pH limit of 7.6, with 
Norway and Sweden having the narrowest recommended range of 7.2–7.6 (37, 57, 
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94, 134). At a chlorine-to-nitrogen ratio of < 5:1 and a pH > 7, almost exclusively 
monochloramine is formed. At a chlorine-to-nitrogen ratio of > 5:1 and a pH < 7, 
dichloramine is formed. At pH < 7.2 an increased formation of trichloramine has 
been shown. When the chlorine-to-nitrogen molar ratio decreases, the formation of 
trichloramine decreases (52, 115, 132). 
An increased number of swimmers in a swimming pool increases the air 
concentration of trichloramine (4, 16, 25, 36, 73, 136). 
4.1.2 Monochloramine and dichloramine 
Monochloramine and dichloramine are water soluble and thus present in chlorine 
disinfected drinking water, chlorine disinfected swimming pool water and 
chlorinated water used for cleaning or disinfection purposes in the food processing 
industry. In the latter, mono- and dichloramine may account for a substantial part 
of the inorganic chloramines in air (63, 65, 76). 
4.1.3 Trichloramine 
Trichloramine is immiscible with water and has a relatively high vapour pressure at 
room temperature and evaporates relatively fast from water. Trichloramine is the 
dominating inorganic chloramine in the air of indoor swimming pool facilities (20). 
In the food processing industry, trichloramine constitutes approximately 30–70% 
of the chlorine species in air (63, 64, 76, 85). 
4.2 Production 
4.2.1 Monochloramine 
Monochloramine is not known to be a commercial product but is generated in situ 
as needed by the action of hypochlorous acid or chlorine gas on ammonia (68). 
4.2.2 Dichloramine and trichloramine 
No data were located.  
4.3 Use 
4.3.1 Monochloramine 
Monochloramine is used as an alternative to chlorine as waste water and drinking 
water disinfectant and is formed in situ when free chlorine and ammonia is added 
to the water. This disinfection method results in less formation of trihalomethanes. 
Monochloramine is less effective as disinfectant than free chlorine, but is persistent 
and is therefore primarily used as secondary disinfectant to maintain a stable 
residual in water distribution systems (68, 132). Monochloramine has also been 
used in the synthesis of a wide range of chemicals including vicinal organic chlor-
amines, N-chlorimines and hydrazine. In 1990, it was estimated that 55 000 tons of 
monochloramine was consumed worldwide in the production of hydrazine (141). 
There has been no registered use of monochloramine in the SPIN (Substances in 
Preparations in Nordic Countries) database (123). 
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4.3.2 Dichloramine 
No data were located. 
4.3.3 Trichloramine 
The agene process was formerly used for bleaching flour with trichloramine. The 
practice was discontinued in 1950 once it became known that agene-treated flour 
may cause severe neurological symptoms in dogs (canine hysteria) and other 
species. The denaturated protein (methionine sulphoximime) in the treated flour 
used for production of dog biscuits was identified as the toxic compound, and there 
were also concerns for potential adverse effects on human health (119). 
There has been no registered use of trichloramine in the SPIN database (123). 
5. Measurements and analysis of workplace exposure 
5.1 Air monitoring 
The method most often used today to determine inorganic chloramines in air was 
developed by Héry and coworkers (63, 64). It is an indirect method as chloride ions 
are determined. 
5.1.1 Monochloramine and dichloramine (soluble chlorine) 
To determine soluble chlorine 2 by the method of Héry et al. (63, 64), air is sampled 
through a tube with silica gel coated with sulphamic acid. Following sampling the 
tube is desorbed in a sulphamic acid solution and the concentration of soluble 
chlorine is determined by potentiometry with a chlorine electrode and a pH/mV 
meter (63, 70) or by colorimetry (25). 
5.1.2 Trichloramine 
When determining the trichloramine concentration in air according to Héry et al., 
interference from soluble chlorine is avoided by the tube with silica gel impregnated 
with sulphamic acid (Section 5.1.1) in the front of a filter cassette which traps these 
substances. A Teflon filter prevents any chlorides contained in airborne water 
droplets from being included in the analysis of trichloramine and is discarded  
after sampling. For sampling of trichloramine, a quartz filter in the cassette is 
impregnated with a solution of sodium carbonate and diarsenic(III) trichloride. On 
the filter, trichloramine is reduced to chloride ions. Following desorption of the 
filter with deionised water, chloride is determined by ion chromatography with 
conductivity or capillary electrophoresis detection to estimate the air concentration 
of trichloramine (63, 64, 70). 
The limit of detection (LOD) for trichloramine using the method developed by 
Héry et al. (63, 64) depends on the air volume sampled and the ion chromatographic 
                                        
2 Soluble chlorine: in occupational settings covered in this document, this means hypochlorite, 
hypochlorous acid, chlorine, monochloramine and dichloramine. 
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method used but is generally in the range of 0.0017–0.01 mg/m3 (4, 16, 24, 25, 64, 
98, 101). 
Predieri et al. developed an impinger method for determination of trichloramine 
in the workplace atmosphere. In the impinger flask, trichloramine reacts with 
potassium iodide in water solution. The released iodine reacts with diethyl-p-
phenylenediamine and produces a pink coloration. The coloration is proportional  
to the amount of trichloramine in sampled air and is determined by spectroscopy. 
The LOD was 0.0036 mg/m3 at an air sampling volume of 100 litres (105). Other 
chlorinated inorganic or organic compounds such as dichloroacetonitrile, cyanogen 
chloride, dichloroacetic acid, trichloroacetic acid or dichloromethylamine present 
in the air (4, 22, 136) are suspected to interfere with the analysis leading to an 
overestimation of the trichloramine exposure. The percentage of interference was 
however not determined. 
There is also a portable analysis tool that allows regular monitoring of trichlor-
amine in air. The analyte is retained on quartz fibre filters, released in deionised 
water and subsequently analysed by colorimetry. The minimum required sampling 
time is 45 min (69, 126). 
Air monitoring has mostly been performed as stationary sampling. The results 
may deviate from those obtained by personal sampling. Linear regression analysis 
based on data from 12 parallel 8-hour samplings of trichloramine in pool air 
suggested a relation between personal and stationary sampling of 1:1.6 (138). In a 
similar study by the same group, a linear regression based on 8 personal and 14 
stationary 8-hour samplings showed a corresponding relation of 1:2.2 between 
personal and stationary sampling (137). Only data from personnel who spent > 50% 
of their workday in the pool area were included in the analyses. 
5.2 Biological monitoring 
For saliva and gastric fluid samples, membrane introduction mass spectrometry and 
tandem mass spectrometry has been used (132).  
Monochloramine, dichloramine and monobromamine were determined in real-
time in single human breaths by selected ion flow tube mass spectrometry. Pre-
liminary measurements showed concentrations of 10–150 ppb of these substances 
in the breath of volunteers (healthy or with chronic obstructive pulmonary disease). 
Limits of detection approached 10 ppb (117). For trichloramine, 10 ppb corresponds 
to 0.05 mg/m3.  
6. Occupational exposure data 
Trichloramine is the dominating inorganic chloramine in the indoor air of 
swimming pools. The remaining fraction as sampled by the method of Héry et al. 
(63, 64) is soluble chlorine (monochloramine, dichloramine, hypochlorite/hypo-
chlorous acid and chlorine). Carbonelle et al. reported that trichloramine accounted 
for about 90% of the chlorine species in swimming pool air (20). In the food 
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processing industry, the corresponding figure is 30–70%. These lower percentages 
are due to intense stirring and spray washing of the chlorinated water, which may 
cause transfer of mono- and dichloramine into the atmosphere as vapours and 
aerosols (63, 64, 76, 85). Massin et al. carried out personal exposure measurements 
during different work tasks such as foaming and rinsing in the food industry. The 
exposure to the sum of soluble chlorine and trichloramine was 0.01–5.46 mg/m3 
(unclear if expressed as trichloramine, or chlorine, equivalents) (85).  
6.1 Monochloramine and dichloramine (soluble chlorine)  
Héry et al. performed air sampling of soluble chlorine in a green salad production 
plant. Personal air sampling was done during a half work shift and showed 
concentrations of < 0.1–3.7 mg/m3. Stationary sampling for 1–8 hours showed air 
concentrations of 0.1–10.9 mg/m3 (63). 
Personal exposures to soluble chlorine were 0.02–0.16 mg/m3 during fish curing, 
0.03–0.85 mg/m3 in slaughter houses, 0.04–1.33 mg/m3 in poultry processing,  
0.03–0.17 mg/m3 in pet food production and < 0.01–0.30 mg/m3 in delicatessen 
trade (65). 
King et al. performed personal sampling of soluble chlorine among poultry 
processing workers with exposures of 0.010–0.13 mg/m3 (76). 
Chu et al. reported mean (± standard deviation; SD) air concentrations of soluble 
chlorine (stationary sampling) of 0.072 ± 0.052 mg/m3 in 10 indoor swimming pools 
and 0.085 ± 0.056 mg/m3 in 6 spa pools (25). 
Air concentrations of soluble chlorine in an indoor waterpark resort ranged from 
non-detectable to 0.25 mg/m3 (27). 
6.2 Trichloramine 
Air measurements of trichloramine have predominantly been performed in indoor 
swimming pool facilities (during pool work and swimming) and in the food pro-
cessing industry (during cleaning and disinfection) (Table 3). The air measurement 
data presented in this section are retrieved from studies in which health effects of 
trichloramine were also studied. 
Most stationary air measurements during pool work were made at spots where 
the personnel are likely to be located during a work day. The sampling times were 
typically 1.5–3 hours. The exposure levels (arithmetic mean; AM) were usually 
0.15–0.65 mg/m3 for public and school baths and 0.2–1.25 mg/m3 for adventure 
baths (4, 16, 24, 25, 27, 36, 42, 64, 73, 79, 84, 98, 101, 129, 133, 136, 138). In two 
studies in indoor swimming pool facilities, personal sampling was used in parallel 
with stationary sampling. Overall, the personal exposure was approximately 50% 
of the levels obtained by stationary sampling (Section 5.1.2) (137, 138). 
Air measurements of trichloramine during competitive and recreational 
swimming have been performed as stationary sampling at spots close to the 
swimming pool. Exposure levels during swimming were similar to those measured 
during pool work, i.e. 0.2–1.30 mg/m3 (9-11, 15, 20, 21, 39, 47, 72, 78, 80, 118). 
 8 
In a green salad processing plant, the personal exposure was < 0.1–2.3 mg/m3  
of trichloramine during a half work shift. Stationary sampling showed air 
concentrations of 0.1–5.9 mg/m3. Sampling times were 1–8 hours (63). 
In another study, personal exposures were < 0.05–1.31 mg/m3 in slaughter houses, 
< 0.05–0.24 mg/m3 during fish curing, 0.01–2.0 mg/m3 in poultry production, 
< 0.01–0.11 mg/m3 in pet food production and 0.03–0.59 mg/m3 in delicatessen 
trade (65). Sampling times were 10–160 min and may thus not represent full-shift 
exposures. Short-time sampling is however useful to evaluate the exposure during 
specific work tasks. 
King et al. performed full-shift personal sampling of trichloramine in the poultry 
industry. The geometric mean (GM) ranged from non-detectable to 0.16 mg/m3 
(76). 
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7. Toxicokinetics 
7.1 Human data  
No human data were located, but inhalation is the dominating route of exposure to 
inorganic chloramines in the occupational setting. Exposure to monochloramine 
may also occur orally, via drinking water and via aspiration of water in swimming 
pools. 
7.2 Animal data 
7.2.1 Monochloramine 
No inhalation or dermal data were located.  
In the only study located, Abdel-Rahman et al. administered a single oral total 
dose of 1.1 mg (~ 5 mg/kg bw) radiolabelled monochloramine (NH236Cl) to each of 
4 male Sprague Dawley rats. Blood samples were collected at 15, 30 and 60 min 
and 2, 4, 8, 16, 24, 48, 72, 96 and 120 hours following administration. In a parallel 
experiment, a similar amount of radiolabelled monochloramine was administered 
to another 4 rats. Expired air samples and faecal and urine samples were collected 
at 8, 16, 24, 48, 72, 96 and 120 hours. 
A peak 36Cl plasma level was reached 8 hours after administration and the 
absorption rate constant was 0.278 mg/hour with an absorption half-time of 2.5 
hours. The 36Cl plasma level remained at a plateau 8–48 hours after administration. 
At 24 hours following administration, the 36Cl plasma level was 0.87% of the 
administered dose. At 120 hours, the highest 36Cl activity was measured in plasma 
and whole blood and the lowest in the liver, ileum and adipose tissue. After 48 
hours, the radiolabel was eliminated from the plasma with a half-time of 38.8 hours. 
Most of the total 36Cl was identified as 36Cl- which according to the authors 
indicated that the chlorine moiety was eliminated primarily in this form. Of the 
administered dose, 25% was excreted in urine and 1.98% in faeces within 120 
hours. 36Cl was not detected in expired air throughout the experiment (3). 
There is a lack of information on the rate of chloramine-chloride exchange 
(NH236Cl + Cl- ֎ NH2Cl + 36Cl) in solutions of high chloride concentrations. If the 
exchange rate is significant, the toxicokinetics of NH236Cl could appear to resemble 
that of chloride, when, in fact, the compound has lost its radiolabel through 
chloramine-chloride exchange. 
7.2.2 Dichloramine and trichloramine  
No data were located. 
7.3 In vitro data 
The persistence of monochloramine in saliva and gastric fluid was examined. 
Pooled samples of human saliva or gastric fluid samples were exposed to 1.0–20 
mg/l of monochloramine. The samples were continuously monitored using 
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membrane introduction mass spectrometry and tandem mass spectrometry in a 
multiple monitoring procedure. Monochloramine in saliva was completely depleted 
in approximately 5 min at the 1-mg/l level. The 5-mg/l solution was incompletely 
depleted in 2 hours and the higher concentration solutions (not specified) were 
unaffected. Monochloramine in gastric fluid disappeared completely in < 30 
seconds at all concentrations. Dichloramine, trichloramine and molecular chlorine 
were not observed in saliva or gastric fluid during depletion (132). 
8. Biological monitoring 
As there are no human toxicokinetic data for inorganic chloramines, there is no 
basis for biological exposure monitoring of the substances at present.  
Several effect markers have been suggested, none of which are specific for the 
inorganic chloramines. 
Pneumoproteins, serum proteins especially produced in the respiratory tract, such 
as club cell protein 16 kDa (CC16) and surfactant-associated proteins (SP-A, SP-B 
and SP-D), have been suggested as biomarkers of the hyperpermeability that occurs 
in the deep lung (12). CC16 is an anti-inflammatory protein secreted by club  
cells (formerly called Clara cells) in the airways and predominantly in terminal 
bronchioles from where it leaks into serum (13). SP-A is the major surfactant-
associated protein mainly secreted by alveolar type II cells and is considered to 
collaborate with SP-B and SP-C to spread and stabilise the phospholipid layer at 
the alveolar layer and thus reduce the surface tension (59). CC16 and SP-A are 
largely, and SP-B exclusively, confined to the lungs, whereas SP-D is expressed by 
a number of tissues (60). Small amounts of CC16, SP-A, SP-B and SP-D occur in 
blood, and these pneumoproteins have been validated as blood markers of lung 
hyperpermeability in a variety of lung disorders caused by different lung toxicants 
(58). CC16 can also be used as a peripheral marker of the integrity of club cells 
(61). 
Elevated levels of exhaled nitric oxide are associated with increased release from 
epithelial cells of the bronchial wall and reflect chronic eosinophilic airway 
inflammation (74). Measurement of the fraction of exhaled nitric oxide (FENO) is 
a non-invasive and standardised test used in clinical practice for diagnosis and 
management of asthma (114). FENO has been suggested as a possible marker of 
airway inflammation due to exposure to irritant agents and has been associated with 
airway responsiveness in lifeguards (30). 
Analysis of protein changes in nasal lavage fluid was applied in a study on pool 
workers by Fornander et al. Nasal lavage fluid was collected from 9 pool workers 
and 4 control subjects. Protein profiling of nasal lavage fluid showed altered 
distribution of three innate immunity proteins; the levels of α-1-antitrypsin and 
lactoferrin were significantly higher and that of S100 calcium binding protein A8 
(S100-A8, also called calgranulin A) was significantly lower in the pool workers 
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than in the control subjects. These effects were most pronounced in subjects with 
airway irritation (42). 
Evaluation of the predominating cell types within the nasal mucosa can indicate 
inflammation (rhinitis) due to occupational irritants. Nasal smear is collected for 
cytology and assessed using light microscopy. Erkul et al. used nasal cytology and 
found that pool workers had significantly more eosinophils in nasal smear than non-
exposed workers, indicating allergic inflammation in the nasal mucosa (34).  
9. Mechanisms of toxicity 
Inorganic chloramines are potent sensory irritants that cause eye and upper 
respiratory tract irritation by interaction with neuronal sensors located in the 
mucous membranes of the respiratory tract and the eyes (shown for mono- and 
trichloramine) (33, 43). 
Chloramines are membrane penetrating oxidants and react rapidly with 
sulphhydryl groups of proteins in the cytoskeleton and the extracellular matrix 
causing disruption of tight junctions and an almost immediate increase in epithelial 
permeability, as shown in in vitro studies [(91, 93, 128), as cited by (21)].  
9.1 Monochloramine  
Adverse health effects (methaemoglobinaemia resulting in haemolytic anaemia) 
have been shown in long-term haemodialysed patients exposed to monochloramine 
through chloraminated dialysis water (31, 77, 131). Monochloramine induces these 
effects through oxidation of haemoglobin and inhibition of the hexose mono-
phosphate shunt which protect the red blood cells from oxidant damage through 
generation of reduced nicotinamide adenine dinucleotide phosphate (31, 77). 
However, these effects were reported following a specific route of exposure 
(dialysis) and are not considered relevant for workplace exposure. 
Piva et al. investigated the effect of monochloramine on the glutamine and 
glucose transport systems in HeLa cells (human cervical cancer cell line) and rat 
mesenteric lymphocytes. Slight inhibition of both glutamine and glucose transport 
systems was initially observed in both the HeLa cells and lymphocytes. When the 
HeLa cells were pre-exposed to monochloramine, its inhibitory action increased. 
Similar results were obtained in the lymphocytes, suggesting that the effects of 
monochloramine are not cell specific. Only the sodium ion-independent (system L) 
component of the glutamine transport activity in HeLa cells was inhibited by 
monochloramine, and neither inhibition of cell metabolism nor enhanced cell lysis 
was observed suggesting that monochloramine inhibits cellular transport activity by 
binding to thiols (sulphhydryl groups) on the membrane (103). 
9.2 Dichloramine 
No data were located. 
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9.3 Trichloramine 
Besides the established irritant potency of trichloramine, it has been hypothesised 
that exposure to chlorination products in indoor pools may promote the 
development of asthma in children and swimmers (11). A basic mechanism 
underlying the associations could be a repeated or chronic disruption of the lung 
epithelial barrier facilitating the penetration of allergens in the lung, and resulting 
in a loss of pneumoproteins (Chapter 8). In contrast to mono- and dichloramine, 
trichloramine is almost completely immiscible with water and cannot easily 
penetrate the ciliated surface and epithelial lining fluid of airways. Thus, 
trichloramine may exert its toxic action in the deep lung where the cells are non-
ciliated and the tight junctions more accessible. This hypothesis is supported by the 
observation that allergic sensitisation is facilitated in the case of allergens having 
proteolytic activity, a characteristic which allows them to degrade extracellular 
matrix proteins and cross the airway epithelium more readily (11). The low water 
solubility of trichloramine also explains why it mainly increases the serum levels 
of pneumoproteins associated with the deep lung (SP-A, SP-B, SP-D), and much 
less that of CC16 predominantly produced in the terminal bronchioles (12). 
10. Effects in animals and in vitro studies 
Important studies are summarised in Tables 4–6. 
10.1 Irritation and sensitisation 
10.1.1 Monochloramine 
Clear conjunctival irritation was observed when the eyes of rabbits (5–6 animals/ 
group) were constantly wetted with a monochloramine solution corresponding to 
4 mg/l of Cl2 for 1 hour, whereas a 2-mg/l solution did not produce eye irritation. 
Monochloramine was considerably more irritating than free chlorine (33). Female 
SENCAR mice submerged (except head) in monochloramine solutions in 
concentrations up to 1 000 mg/l for 10 min for 4 consecutive days did not display 
epidermal hyperplasia like mice exposed to e.g. hypochlorous acid did (110). 
10.1.2 Dichloramine 
No data were located. 
10.1.3 Trichloramine 
Bradypnoea (slow breathing), indicative of upper airway irritation in mice, was 
evaluated during a 60-min oronasal exposure to increasing concentrations of 
chlorine (5.1–44 mg/m3) or trichloramine (4.5–25 mg/m3). The airborne con-
centration causing a 50% decrease in respiratory frequency (RD50) in mice was 
calculated for each chemical. Chlorine and trichloramine showed different time-
courses in their responses. While the maximal response of trichloramine was 
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reached in 10 min, the maximal response of chlorine was reached after 45–60 min 
of exposure. The RD50 values of chlorine and trichloramine were 17.5 and 12.5 
mg/m3, respectively. The authors concluded that trichloramine appeared to be a 
strong sensory irritant (43). 
10.2 Effects of single exposure 
10.2.1 Monochloramine 
No inhalation data were found. 
Male Sprague Dawley rats (4/group) were given a single dose of 3 ml of water 
with a monochloramine concentration of 0, 10, 20 or 40 mg/l by gavage (cor-
responding to ~ 0.19, 0.38 and 0.75 mg/kg bw). Blood was sampled 15, 30, 60 and 
120 min after the administration for analysis of glutathione (GSH) and osmotic 
fragility. The GSH level was significantly increased 15 min after administration of 
20 or 40 mg/l and after 30 and 60 min in all dose groups. After 2 hours, the GSH 
level returned to normal. The authors suggested that the increase of GSH is 
explained by an increase in the activity of glutathione reductase to compensate for 
the oxidative stress of monochloramine during the first hour after exposure. 
Osmotic fragility was without any change in all dose groups (2). 
10.2.2 Dichloramine 
No data were located. 
10.2.3 Trichloramine 
Sprague Dawley rats (5/sex/group) were exposed to clean air or average air 
concentrations of 290, 560, 570, 620 or 785 mg/m3 of trichloramine in a glass 
exposure chamber during 1 hour. Of the animals exposed to 785 mg/m3, 8 out of 10 
died during the exposure and the remaining 2 within 23 min after termination of 
exposure. In the groups exposed to 560–620 mg/m3, the mortality rate was 40–80%. 
All animals survived exposure at 290 mg/m3. During the 4-hour post-exposure 
period, laboured breathing and yellowish stains of the anogenital region were 
frequently noted. Additional observations were grasping, rapid breathing, mucoid 
or red nasal discharge, excessive salivation and lacrimation, shedding of red tears, 
reduced activity and convulsive movements. The surviving animals were observed 
during 14 days after exposure, and dry rales, red or mucoid nasal discharge, rapid 
or laboured breathing and soft stool were noted. All animals that died exhibited red 
mottling of the lung and clear fluid in the trachea or the lungs. Many showed 
distension of the gastrointestinal tract at and below the level of the stomach. 
According to the authors the respiratory tract appears to be a primary site of damage 
in rats exposed to trichloramine. All animals that died showed pulmonary oedema. 
The lethal concentration for 50% of the exposed animals at single inhalation 
exposure (LC50) was estimated to be 560 mg/m3, 95% confidence interval (CI)  
535–585 mg/m3 (7). 
In an experiment performed by Carbonelle et al., 2-month-old female C57Bl/6 
mice were exposed to trichloramine in an inhalation exposure chamber. In a first 
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experiment, groups of 9 mice were exposed to clean air or to 11.9 mg/m3 of 
trichloramine during 1, 2, 4 or 8 hours and sacrificed immediately after exposure. 
Blood was collected by cardiac puncture and bronchoalveolar lavage (BAL) was 
performed. Latex immunoassay techniques were used to determine albumin levels 
in BAL fluid (BALF) and CC16 levels in both serum and BALF. Total protein and 
lactate dehydrogenase (LDH) levels were determined in BALF. Serum CC16 levels 
increased significantly during exposure, peaking after 4 hours at levels on average 
2.5 times the pre-exposure level. CC16 levels in BALF decreased with a maximal 
reduction of about 80% after 8 hours of exposure. Statistically significant elevations 
of both albumin and total protein levels in BALF after 8 hours were observed. 
According to the authors, the lung epithelium hyperpermeability caused by 
trichloramine was not associated with cell cytotoxicity, since the LDH levels in 
BALF remained normal throughout the experiment. No evidence of lung toxicity 
was seen at light microscopy. In a parallel experiment, groups of 10 mice were 
exposed for 4 hours either to filtered air or to 0.53, 0.8, 3.45 and 13.1 mg/m3 of 
trichloramine. The observations in the previous experiment were reproduced when 
mice were exposed to 13.1 mg/m3 but were not found at 0.53–3.45 mg/m3 (21). 
To determine the in vitro toxicity of trichloramine, human alveolar cancer cells 
(A-549) were exposed to 0.1–40 mg/m3 of the substance by passing test atmos-
pheres over the cells in a continuous-flow-module during 1 hour. Nitrogen dioxide 
and synthetic or clean air were used as positive and negative control, respectively. 
Cell viability and inflammatory response manifested as interleukin (IL)-6 or IL-8 
release were investigated 2, 24 and 48 hours post-exposure. A decreasing cell 
viability with increasing trichloramine concentration was observed. Increased  
IL-8 and IL-6 levels were demonstrated > 10 mg/m3 and at 20–30 mg/m3, 
respectively. Exposure > 30 mg/m3 inhibited the release of both IL-6 and IL-8 due 
to cytotoxicity. Corresponding investigations with indoor swimming pool air 
showed similar inflammatory effects in the lung cells at doses < 0.2 mg/m3 trichlor-
amine. The authors concluded that there are additional substances present in the 
indoor pool air that contribute to the inflammatory response (116).  
10.3 Effects of short-term exposure (up to 90 days) 
10.3.1 Monochloramine 
No inhalation data were found. 
Adult African Green monkeys (5 males and 7 females) were administered 
drinking water containing 100 mg/l of monochloramine daily during 6 weeks giving 
a total dose of 10 mg/kg bw/day. Blood samples were analysed for different haema-
tological and clinicochemical parameters (red cell count, cell indices, reticulocytes, 
methaemoglobin and haemoglobin, white cell and differential counts, red cell GSH 
content, creatinine and blood urea nitrogen (BUN), total bilirubin, total protein, 
albumin, alkaline phosphatase, LDH and aspartate and alanine aminotransferases) 
and serum thyroxine (T4). No effects were seen in any of these parameters or on 
body weight. Each animal served as its own control (8). 
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Monochloramine was given in drinking water at 2.5–200 mg/l (~ 0.44–35 
mg/kg bw/day) to A/J mice (12 males/group) for 30 days. With the exception of 
body weight loss and increased haematocrit at doses ≥ 50 mg/l, all indicators of 
prehaemolytic or haemolytic stress (i.e. 10 haematological parameters including 
osmotic fragility and GSH levels) failed to show any significant exposure-related 
changes. In the case of haematocrit, which indicates anaemia if it is lowered, 
values actually increased (89). 
Body weight gain and haematological parameters in rats exposed 45 days to 
drinking water containing 10, 50 or 100 mg/ml (~ 1.2, 6.0, 12 mg/kg bw/day) of 
monochloramine did not differ from those in control animals. The only 
significant finding was a decrease in methaemoglobin in blood, the opposite of 
what was expected (19). 
Young male Sprague Dawley rats (12/group) were daily given drinking 
water containing 0, 9, 19 or 38 mg/l (~ 0.8, 1.7, 3.4 mg/kg bw/day) of 
monochloramine ad libitum during 9 weeks. The water consumption and 
estimated daily doses were not given. Parameters of immunity measured were 
spleen and thymus weights, antibody production, delayed-type hypersensitivity 
reactions, natural killer cell cytotoxicity, oxidative metabolism response and 
phagocytosis by macrophages, and production of two immunoregulatory 
cytokines (IL-2 and prostaglandin E2). Rats had reduced relative spleen weight 
(38 mg/l), decreased serum immuno-globulin G (IgG) antibody production (9 
and 19 mg/l) and augmented prostaglandin E2 production by adherent resident 
peritoneal cells (19 and 38 mg/l). The authors concluded that monochloramine is 
not a particularly strong immunodepressant as the effects were observed at 
relatively high doses (35). 
Immunotoxic effects were examined in groups of 8 female B6C3F1 
mice administered monochloramine via drinking water at 2–200 mg/l (~ 0.38–38 
mg/kg bw/day) for 28 days. No significant differences in drinking water 
consumption, body weight, body weight gain, organ weights or haematological 
parameters were noted and some minimal immunological effects (mixed-
leukocyte response and activity of natural killer cells) were judged to be 
biologically insignificant (50). 
Miller et al. studied drinking water collected at a pilot-scale drinking water 
plant using monochloramine for disinfection. The residual monochloramine level 
was 2.1 mg/l. The samples were concentrated by reverse osmosis (100 and 
400 times) before administered to CD-1 mice (10/sex) as drinking water for 30 
days. There were some significant differences in relative organ weights but no 
consistent pattern was observed (87). 
10.3.2 Dichloramine and trichloramine 
No data were found. 
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10.4 Genotoxicity  
10.4.1 Monochloramine 
10.4.1.1 In vitro studies 
Monochloramine mutagenesis was tested using different strains of Bacillus subtilis. 
Prepared early stationary phase cells were diluted 10 times into monochloramine 
solutions (0, 18, 37, 56, 74 and 92 μM) and treated for 30 min at 37 °C. The reaction 
was stopped by adding one volume of 0.02 M sodium thiosulphate. Viable cell 
counts were scored by averaging the colonies at two plates (amino acid media) after 
incubation at 37 °C for 2 days. The minimum number of colonies per plate was 
161 ± 8%. The authors concluded that monochloramine is a weak mutagen in the 
trpC locus, when reversion of trpC to trp+ in B. subtilis is used as an assay (121). 
Thomas et al. tested the mutagenic activity of monochloramine in Salmonella 
typhimurium TA100. Bacteria was incubated with 40 μM monochloramine for 
1 hour at 37 °C. Duplicate samples were added to top-agar with histidine and biotin. 
Negative control (no mutagen) values were 140 ± 40 colonies and positive control 
values with sodium azide was 2 800 ± 700 colonies. Monochloramine showed a low 
or no mutagenic activity. The authors concluded that monochloramine is highly 
reactive thus unlikely to penetrate deeply into body tissues when in contact with 
skin and mucous membranes (130). 
A study was designed to examine whether monochloramine could damage the 
DNA of gastric cells. Rabbit gastric mucosal cells (RGMC) or human gastric 
carcinoma cells (KATO III) were cultured and suspended. Cell suspensions were 
exposed to 0.1 mM hypochlorite, ammonia or monochloramine for 15 min, 
respectively. Monochloramine significantly induced DNA double strand breaks as 
well as chromatin condensation evoked by DNA fragmentation in the RGMC and 
KATO III cells (P < 0.05). Ammonia or hypochlorite had no such effects on these 
cell types. Monochloramine, but not ammonia or hypochlorite enhanced the levels 
of DNA injury, suggesting the possible involvement in the carcinogenesis of the 
gastric mucosa (125). 
Shibata et al. treated plasmid pUC18 DNA with 3 mM monochloramine, which 
induced double strand DNA breaks (120). 
10.4.1.2 In vivo studies 
Meier et al. performed a series of assays evaluating the induction of chromosomal 
aberrations (4/sex/group) and micronuclei (5/sex/group) in the bone marrow of 
Swiss CD-1 mice. The animals were dosed with 1 ml of a test solution containing 
0, 40, 100 or 200 mg/l (1.6, 4 or 8 mg/kg bw) of monochloramine by oral gavage 
for 5 consecutive days and were sacrificed after the final exposure. An acute 
exposure test administration was also done for the bone marrow aberration test by 
giving the animals 1 ml of each test solution. The animals were killed 6, 24 and 48 
hours after dosing. The authors concluded that there was no evidence of any effect 
caused by exposure to monochloramine in any of the test performed (86). 
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Monochloramine was also negative in the sperm-head abnormality assay (described 
further in Section 10.6.1). 
Gauthier and coworkers evaluated the clastogenicity of water treated with sodium 
hypochlorite or monochloramine (0.05, 0.1 or 0.15 μg/ml) using a micronucleus 
test in newt larvae (Pleurodeles waltl) reared for 12 days. Frequencies of micro-
nucleated red blood cells were evaluated per 1 000 cells. The level of micronuclei 
increased with increasing concentration of monochloramine. Only the 0.15-μg/ml 
concentration gave a statistically significant response. The authors concluded that 
monochloramine is responsible for the clastogenic effect in newt larvae (45). 
10.4.1.3 Conclusion on monochloramine 
Monochloramine was a weak mutagen in B. subtilis and S. typhimurium, and 
induced double-strand breaks in plasmid DNA, as well as DNA fragmentation, 
double strand DNA breakage and chromatin condensation in gastric mucosa cells. 
Monochloramine did not induce chromosomal aberrations, micronuclei or sperm 
abnormality in mice but induced micronuclei in newt larvae. Thus, limited data 
indicate that monochloramine is weakly mutagenic in vitro but not genotoxic in 
vivo. 
10.4.2 Dichloramine and trichloramine 
No data were located. 
10.4.3 Drinking water and swimming pool water 
More than 600 disinfection by-products have been identified in drinking water, 
many of which are genotoxic and carcinogenic (e.g. several trihalomethanes and 
haloacetic acids). A large number of studies have examined the mutagenicity of 
drinking water extracts or concentrates disinfected by chlorination. The few studies 
available on drinking water prepared by alternative disinfection methods (including 
chloramination) all showed that such drinking water was considerably less 
mutagenic than chlorinated drinking water. Although the chloramination reduce the 
formation of trihalomethanes and haloacetic acids, it may cause increased levels of 
other disinfection by-products, e.g. nitrosamines, several of which are carcinogenic 
(109).  
Swimming pools constitute environments with high levels of disinfectant by-
products in water and air due to continuous disinfection and constant organic load 
from bathers. Only a few studies have investigated the mutagenicity of swimming 
pool water (108). In a recent comprehensive study, water and air samples were 
collected from a public chlorinated swimming pool and the concentrations of free 
chlorine, inorganic chloramines and trihalomethanes were determined. Mono-
chloramine and dichloramine, but not trichloramine, could be detected in the pool 
water. However, a mean air level of 0.29 mg/m3 indicated that trichloramine had 
evaporated from the pool water. In addition, approximately one hundred other 
disinfection by-products were identified in the pool water. Two water samples 
extracted using a XAD resin process were subjected to a standard plate in-
corporation Ames Salmonella mutagenicity assay (without metabolic activation) in 
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the base-substitution strain TA100 or in the strain RSJ100, which expresses the rat 
glutathione S-transferase theta 1 (GSTT1) gene, and its control strain TPT100. 
Extracts were tested up to 100 μl/plate over a dose range of 0.01–0.3 litre-
equivalents (L-eq) based on doses used for mutagenicity tests for drinking water. 
One sample was mutagenic in TA100, whereas the other sample showed cyto-
toxicity based on a reduction of revertants/plate in TA100 at the highest doses. It 
was suggested that the 30% higher concentration of chloroform in the latter sample 
may have masked the mutagenic activity due to cytotoxicity. The limited data 
indicated that the dose range over which the pool waters were mutagenic 
was approximately 0.1–0.3 L-eq/plate. In comparison, the typical dose range for 
drinking water mutagenicity is 0.3–1.5 L-eq/plate (108). 
The large number of identified disinfection by-products demonstrate the 
chemical complexity of the chlorinated/chloraminated water and the difficulty to 
identify individual mutagenic substances in the water. 
10.5 Effects of long-term exposure and carcinogenicity 
No inhalation studies were located. 
10.5.1 Monochloramine 
Male Sprague Dawley rats (4/group) were exposed via drinking water containing 
0, 1, 10 or 100 mg/l (~ 0.05, 0.5, 5.2 mg/kg bw/day) of monochloramine daily 
for 12 months. Blood samples were collected for analysis of blood GSH and 
osmotic fragility every 2nd month and for haematological parameters every month. 
[3H]Thymidine incorporation (a measure of cell proliferation) into the nuclei of 
the liver, kidney, testes, small-intestinal mucosa and spleen was determined after 
3 months only. The GSH content in blood was significantly decreased at some time-
points during exposure in all dose groups, which according to the authors could be 
related to the oxidative stress of monochloramine and the protective role of GSH 
against damage caused by oxidants. Increased osmotic fragility was observed in the 
10- and 100-mg/l groups, and significantly at a few time-points during exposure.
Significant changes in a few haematological parameters were observed at 10- and
100 mg/l at 3 and 10 months, but were not observed at any other time-points.
Monochloramine administered for 3 months increased [3H]thymidine incorporation
in the kidney, spleen, liver and testes in all dose groups, but without a clear dose-
response pattern. The authors concluded that this indicates that exposure to
monochloramine increases the DNA synthesis in these organs. The body weight
decrease in the 100-mg/l group at 3 months persisted throughout the dosing period
(2).
In a subchronic study, monochloramine was administered in drinking water at 
concentrations of 0, 25, 50, 100 and 200 mg/l for 90 days to groups of Sprague 
Dawley rats (10/sex). Reductions in final body weight (at 200 mg/l both sexes) and 
body weight gain (≥ 50 mg/l in males; 200 mg/l in females) along with a dose-
related decrease in water consumption (in both sexes at all concentrations) were 
noted. At 200 mg/ml, reduction in organ weights (absolute, relative or both) was 
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observed in both males and females, liver and spleen weights decreased in both 
sexes. In addition, decreased liver and lung weights were noted in males at 100 and 
50 mg/ml, respectively. Subsequent histopathological examination did not reveal 
any exposure-related changes. A few alterations in parameters of haematology and 
clinical chemistry were noted but were considered not biologically significant,  
not dosage-related, or within the normal range for rats of this age and strain. 
The 100-mg/ml concentration (5.8–7.7 mg/kg bw/day) was considered to be a no 
observed adverse effect level (NOAEL) (28). 
In a similar study by the same team, B6C3F1 mice (10/sex/group) were given  
0, 12.5, 25, 50, 100 and 200 mg/l of monochloramine in drinking water for 90 days. 
Final body weight was significantly decreased at doses ≥ 100 mg/l in both sexes and 
body weight gain at doses ≥ 50 mg/l in males and ≥ 100 mg/l in females. In parallel, 
dose-related decreases in water and food consumption were observed in both sexes. 
A variety of changes in parameters of haematology and clinical chemistry were 
noted with no consistent exposure-related pattern. Numerous significant reductions 
in absolute and/or relative organ weights were evident at doses ≥ 100 mg/l but no 
exposure-related histopathology was observed. Decreased liver, heart and lung 
weights (males) and liver, heart and spleen weights (females) were seen at 100 mg/l, 
along with decreased body weight gain, reduced water and food consumption. The  
50 mg/l concentration (8.6–9.2 mg/kg bw/day) was considered to be the NOAEL 
(29). 
Sprague Dawley rats (10 males) were exposed to 200 mg/l (21.6 mg/kg/day) of 
monochloramine in drinking water for 13 weeks to resolve whether such exposure 
could cause reduced body weight gain and other changes observed in earlier studies. 
Two control groups were included; one group was given water ad libitum and the 
other was given the same volume of water as that consumed by the exposed animals. 
The authors concluded that reduced body weight gain and the minor biochemical, 
haematological, immunological and histopathological changes in exposed rats were 
largely related to reduced water and food consumption and not a direct effect of 
monochloramine (104). 
In a carcinogenicity study by the National Toxicology Program (NTP), drinking 
water containing 0, 50, 100 or 200 mg/l of monochloramine was provided to male 
and female F344/N rats or B6C3F1 mice (70 animals in each group) daily for up to 
2 years. Doses were calculated to be 0, 5.0, 8.9 and 15.9 mg/kg bw/day for male 
mice and 0, 4.8, 9.0 and 17.2 mg/kg bw/day for female mice. The corresponding 
figures for male rats were 0, 2.1, 4.8 and 8.7 mg/kg bw/day and 0, 2.8, 5.3 and 9.5 
mg/kg bw/day for female rats. The animals were evaluated at 14, 66 or 155 weeks. 
Mean body weights of high-dosed rats and dosed mice were lower than those of 
their respective controls. Decreases in absolute and/or relative organ weights were 
observed in the high-dose groups of rats and mice at some time-points. There was 
a dose-related decrease in water consumption in both species. Mononuclear cell 
leukaemia occurred with marginally increased incidence in the mid- and high-dose 
female rats receiving chloraminated water (control 8/50, low dose 11/50, mid-dose 
15/50 and high dose 16/50). The marginal increase in leukaemia incidence in female 
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rats was considered equivocal evidence of carcinogenic activity. There were no 
neoplasms or non-neoplastic lesions in male rats or in male and female mice that 
were associated with the consumption of chloraminated water (99). 
In a study carried out by Herren-Freund et al., 9 male rats (strain not given) were 
administered 14.75 mg/kg bw of monochloramine 24 hours after 2/3 partial 
hepatectomy. Seven days after the initiation, promotion by 500 mg/l of pheno-
barbital in the drinking water was begun. After 10 weeks, the exposure to the 
promoter was ceased and 1 week later the rats were killed. Samples of the liver 
tissue were stained for the incidence of γ-glutamyltranspeptidase-positive foci 
(GGT foci) as an indicator of carcinogenicity. Diethylnitrosamine (DENA) was 
used as a positive initiator control. Exposure to monochloramine did not initiate 
GGT foci and the authors concluded that monochloramine is not capable of 
initiating carcinogenesis (62). 
In a rat liver foci study, the carcinogenic activity of drinking water treated with 
monochloramine and concentrated up to 4 000 times by the XAD resin procedure 
was evaluated. Around 10 rats per group were used for the test samples, vehicle 
control (2% Emulphor) and positive control (50 mg/kg bw of DENA). All rats were 
hepatectomised on day 0 and dosed orally 24 hours later with the test solutions or 
the control solutions. A week later, the rats including controls received 500 mg/l of 
sodium phenobarbital in drinking water for 56 days. Liver samples were tested for 
histochemical detection and quantification of GGT foci. No statistical significant 
differences between monochloramine exposed rats and vehicle control animals 
were detected. The authors concluded that there was no effect on the rat liver assay 
following exposure to monochloramine (87). 
10.5.2 Dichloramine  
Male and female Sprague Dawley rats were each randomly divided into 6 groups 
each containing 10 animals. The dichloramine solution was prepared in 0.1 M acetate 
buffer and 2 control groups were used (reagent-grade water and 0.1 M acetate 
buffer). The rats were exposed to dichloramine in drinking water for 13 weeks at 
doses of 0.025, 0.26, 2.5 or 24 mg/kg bw/day for females and 0.019, 0.19, 1.9 or  
18 mg/kg bw/day for males. No significant changes were detected in xenobiotic 
metabolising enzyme activities or in haematological and biochemical parameters. 
Dichloramine induced minimal to mild adaptive histopathological changes in 
thyroid and kidneys in both sexes (no statistical analysis for individual dose levels). 
Dichloramine was associated with minimal histological changes in the gastric 
cardia (epithelial hyperplasia) at concentrations ≥ 0.19 mg/kg bw/day in males and 
≥ 2.5 mg/kg bw/day in females. Body weight gains were not significantly different 
from controls (92). 
No carcinogenicity studies were located. 
10.5.3 Trichloramine 
In an experiment parallel to the one described above for dichloramine, Sprague 
Dawley rats were exposed to trichloramine in drinking water for 13 weeks at doses 
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of 0.020, 0.23, 1.1 or 9.6 mg/kg bw/day for males and 0.028, 0.29, 1.3 or 13 mg/kg 
bw/day for females. The trichloramine solution was prepared in 0.1 M phosphate 
buffer and contained an average of 20 mg/l residual free chlorine, therefore the 
following control groups were used: reagent-grade water and 0.1 M phosphate 
buffer containing 19 mg/l chlorine. Increases in hepatic glutathione S-transferase 
and uridine diphosphate glucuronosyltransferase activities were detected in  
females receiving 13 mg/kg bw/day. No significant changes were detected in other 
xenobiotic metabolising enzyme activities or haematological and biochemical 
parameters. Trichloramine induced minimal to mild adaptive histopathological 
changes in thyroid and kidneys in both sexes. Relative kidney weights were 
increased in both sexes at the highest dose. Males in the high-dose group had 
minimal changes in kidneys consisting of glomerular adhesions and protein casts in 
the tubules of the inner cortex. Females in all dose groups displayed minimal tubular 
mineralisation in the outer cortex of the kidneys but with no clear dose-response 
over the range examined. The authors concluded that trichloramine produced mild 
histological effects at doses > 0.23 mg/kg bw/day in males and > 0.29 mg/kg bw/day 
in females (92). It is unclear how these effect levels were derived from the results 
presented in the paper. 
No carcinogenicity studies were found. 
10.6 Reproductive and developmental effects  
10.6.1 Monochloramine 
No inhalation data were found. 
Reproductive effects were studied in female (24/group) and male (12/group) 
Long-Evans rats administered 0, 2.5, 5.0 or 10.0 mg/kg bw of monochloramine by 
oral gavage. Males were dosed 56 days prior to breeding and throughout the 10-day 
breeding period. Following breeding, the males were necropsied and evaluated for 
sperm parameters and reproductive tract histopathology. Females were dosed 14 
days prior to breeding and throughout the 10-day breeding period, during gestation 
and lactation until the pups were weaned at day 21 after birth. Adult females and 
some pups were necropsied at weaning on postnatal day 21. Other pups were dosed 
post-weaning until 28 or 40 days of age. These pups were evaluated for the day of 
vaginal patency and thyroid hormone levels. No differences were observed between 
control rats and rats exposed up to 10 mg/kg/day of monochloramine when fertility, 
viability, litter size, day of eye opening or day of vaginal patency were evaluated. 
No alterations in sperm count, sperm direct progressive movement, percent motility 
or sperm morphology were observed among adult males. In addition, male and 
female reproductive organ weights were comparable to their respective control 
groups, and no significant histopathological changes were observed in the repro-
ductive tract of exposed males and females (23). 
Meier et al. administered B6C3F1 mice (10 males/group) 1.6, 4 or 8 mg/kg bw 
of monochloramine by oral gavage for 5 consecutive days and evaluated sperm-
 25 
head abnormality at 1, 3 and 5 weeks after the last dose. Monochloramine was 
judged to be negative in the assay (86). 
In a developmental study, mature virgin Sprague Dawley rats (6 females/group) 
were given 0, 1, 10 or 100 mg/l (~ 0.09, 0.9, 9.3 mg/kg bw/day) of monochloramine 
in drinking water ad libitum daily for 2.5 months prior to and throughout gestation. 
On day 20 of gestation, the rats were killed and the foetuses (34 controls, 26–28 
exposed) were examined. Monochloramine did not produce any significant changes 
regarding foetal weight, type of skeletal anomaly, skeletal or soft-tissue defects at 
any dose level. The authors concluded that monochloramine in drinking water at 
the concentration noted is relatively harmless when fed to pregnant rats (1). 
To conclude, limited data indicate that monochloramine does not induce 
reproductive or developmental effects. 
10.6.2 Dichloramine and trichloramine 
No data were located.
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os
es
  
≥ 
50
 m
g/
l w
he
re
as
 o
th
er
 h
ae
m
at
ol
og
ic
al
 p
ar
am
et
er
s 
(i
nc
lu
di
ng
 
os
m
ot
ic
 f
ra
gi
lit
y 
an
d 
G
SH
) 
w
er
e 
un
af
fe
ct
ed
.  
(8
9)
 
0,
 1
0,
 5
0,
 1
00
 m
g/
m
l 
(1
.2
, 6
.0
, 1
2 
m
g/
kg
 b
w
/d
ay
) b
 
O
ra
l (
dr
in
ki
ng
 w
at
er
),
 
45
 d
 
R
at
 (
st
ra
in
, n
o.
 a
nd
 
se
x 
no
t g
iv
en
)  
N
o 
ef
fe
ct
 o
n 
bo
dy
 w
ei
gh
t g
ai
n.
 T
he
 o
nl
y 
si
gn
if
ic
an
t h
ae
m
at
ol
og
ic
al
 
fi
nd
in
g 
w
as
 a
 d
ec
re
as
e 
in
 m
et
ha
em
og
lo
bi
n 
in
 b
lo
od
 a
t 1
00
 m
g/
l, 
th
e 
op
po
si
te
 o
f 
w
ha
t w
as
 e
xp
ec
te
d .
 
(1
9)
 
0,
 9
, 1
9,
 3
8 
m
g/
l 
(0
.8
, 1
.7
, 3
.4
 m
g/
kg
 b
w
/d
ay
) b
 
O
ra
l (
dr
in
ki
ng
 w
at
er
),
 
9 
w
k  
R
at
, S
pr
ag
ue
 D
aw
le
y 
12
 m
al
es
/g
ro
up
  
A
lte
re
d 
im
m
un
e 
fu
nc
tio
n:
 d
ec
re
as
ed
 s
er
um
 I
gG
 a
nt
ib
od
y 
pr
od
uc
tio
n 
at
 9
 a
nd
 1
9 
m
g/
l, 
i n
cr
ea
se
d 
pr
os
ta
gl
an
di
n 
E
2 
pr
od
uc
tio
n 
at
 1
9 
an
d 
38
 
m
g/
l, 
an
d 
re
du
ce
d 
re
la
tiv
e 
sp
le
en
 w
ei
gh
t a
t 3
8 
m
g/
l. 
N
o 
ef
fe
ct
s 
on
 
ot
he
r 
pa
ra
m
et
er
s 
of
 im
m
un
ity
.  
(3
5)
 
0,
 2
, 1
0,
 2
0,
 1
00
, 2
00
 m
g/
l 
(0
.3
8,
 1
.9
, 3
.8
, 1
9,
 3
8 
m
g/
kg
 
bw
/d
ay
) b
 
O
ra
l (
dr
in
ki
ng
 w
at
er
),
 
28
 d
 
M
ou
se
, B
6C
3F
1 
8 
fe
m
al
es
/g
ro
up
 
N
o 
si
gn
if
ic
an
t d
if
fe
re
nc
es
 in
 w
at
er
 c
on
su
m
pt
io
n,
 b
od
y 
w
ei
gh
t, 
bo
dy
 w
ei
gh
t g
ai
n,
 o
rg
an
 w
ei
gh
ts
, h
ae
m
at
ol
og
ic
al
 p
ar
am
et
er
s 
bu
t 
so
m
e 
m
in
im
al
 im
m
un
ol
og
ic
al
 e
ff
ec
ts
 th
at
 w
er
e 
ju
dg
ed
 to
 b
e 
bi
ol
og
ic
al
ly
 in
si
gn
if
ic
an
t.  
(5
0)
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T
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. E
ff
ec
ts
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 a
ni
m
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r 
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re
 to
 m
on
oc
hl
or
am
in
e.
 
E
xp
os
ur
e 
le
ve
l 
E
xp
os
ur
e 
ro
ut
e 
an
d 
du
ra
tio
n 
Sp
ec
ie
s,
 n
o.
 a
nd
 s
ex
 
E
ff
ec
t 
R
ef
er
en
ce
 
Lo
ng
-te
rm
 a
nd
 c
ar
ci
no
ge
ni
ci
ty
 st
ud
ie
s 
 
 
 
0,
 1
, 1
0,
 1
00
 m
g/
l 
(0
.0
5,
 0
.5
, 5
.2
 m
g/
kg
 b
w
/d
ay
) b
 
O
ra
l (
dr
in
ki
ng
 w
at
er
),
 
up
 to
 1
2 
m
o  
R
at
, S
pr
ag
ue
 D
aw
le
y 
 
4 
m
al
es
/g
ro
up
 
G
SH
 c
on
te
nt
 in
 b
lo
od
 s
ig
ni
fi
ca
nt
ly
 d
ec
re
as
ed
 a
t s
om
e 
tim
e-
po
in
ts
 
in
 a
ll 
do
se
 g
ro
up
s.
 I
nc
re
as
ed
 o
sm
ot
ic
 f
ra
gi
lit
y 
in
 th
e 
10
- 
an
d 
10
0-
m
g/
l g
ro
up
s,
 s
ig
ni
fi
ca
nt
ly
 a
t a
 f
ew
 ti
m
e -
po
in
ts
.  
Si
gn
if
ic
an
t c
ha
ng
es
 in
 a
 f
ew
 h
ae
m
at
ol
og
ic
al
 p
ar
am
et
er
s 
at
 1
0-
 a
nd
 
10
0 
m
g/
l  a
t 3
 a
nd
 1
0 
m
o,
 b
ut
 n
ot
 a
t a
ny
 o
th
er
 ti
m
e-
po
in
ts
.  
In
cr
ea
se
d 
[3
H
]t
hy
m
id
in
e 
in
co
rp
or
at
io
n 
in
 th
e 
ki
dn
ey
, s
pl
ee
n,
 li
ve
r 
an
d 
te
st
es
 in
 a
ll 
do
se
 g
ro
up
s 
af
te
r 
3 
m
o,
 b
ut
 w
ith
ou
t a
 c
le
ar
 d
os
e-
re
sp
on
se
 p
at
te
rn
.  
D
ec
re
as
ed
 b
od
y 
w
ei
gh
t i
n 
th
e 
10
0-
m
g/
l g
ro
up
 a
t 3
–1
2 
m
o.
 
(2
) 
0,
 2
.1
, 4
.8
, 8
.7
 m
g/
kg
 b
w
/d
ay
 
(m
al
es
)  
0,
 2
.8
, 5
.3
, 9
.5
 m
g/
kg
 b
w
/d
ay
 
(f
em
al
es
)  
O
ra
l (
dr
in
ki
ng
 w
at
er
),
 
2 
y  
R
at
, F
34
4/
N
 
70
/s
ex
/g
ro
up
 
N
o 
ca
rc
in
og
en
ic
 e
ff
ec
t i
n 
m
al
es
. A
 m
ar
gi
na
l i
nc
re
as
e 
in
 
m
on
on
uc
le
ar
 c
el
l l
eu
ka
em
ia
 in
ci
de
nc
e 
in
 f
em
al
es
 w
as
 c
on
si
de
re
d 
eq
ui
vo
ca
l e
vi
de
nc
e 
of
 c
ar
ci
no
ge
ni
c 
ac
tiv
it
y 
(c
on
tr
ol
 8
/5
0,
 lo
w
 
11
/5
0,
 m
id
 1
5/
50
 a
nd
 h
ig
h 
do
se
 1
6/
50
).
 
D
ec
re
as
ed
 m
ea
n 
bo
dy
 w
ei
gh
ts
 in
 e
xp
os
ed
. D
ec
re
as
es
 in
 a
bs
ol
ut
e 
an
d/
or
 r
el
at
iv
e 
or
ga
n 
w
ei
gh
ts
 in
 th
e 
hi
gh
-d
os
e 
gr
ou
ps
 a
t s
om
e 
tim
e-
po
in
ts
. D
os
e -
re
la
te
d 
de
cr
ea
se
 in
 w
at
er
 c
on
su
m
pt
io
n.
 
(9
9)
 
0,
 5
.0
, 8
.9
, 1
5.
9 
m
g/
kg
 b
w
/d
ay
 
(m
al
es
)  
0,
 4
.8
, 9
.0
, 1
7.
2 
m
g/
kg
 b
w
/d
ay
 
(f
em
al
es
)  
O
ra
l (
dr
in
ki
ng
 w
at
er
),
 
2 
y  
M
ou
se
, B
6C
3F
1 
70
/s
ex
/g
ro
up
 
N
o 
ca
rc
in
og
en
ic
 e
ff
ec
t. 
D
ec
re
as
ed
 m
ea
n 
bo
dy
 w
ei
gh
ts
 in
 th
e 
hi
gh
-d
os
e 
gr
ou
ps
. D
ec
re
as
es
  
in
 a
bs
ol
ut
e 
an
d/
or
 r
el
at
iv
e 
or
ga
n 
w
ei
gh
ts
 in
 th
e 
hi
gh
-d
os
e 
gr
ou
ps
 a
t 
so
m
e 
tim
e -
po
in
ts
. D
os
e-
re
la
te
d 
de
cr
ea
se
 in
 w
at
er
 c
on
su
m
pt
io
n.
 
(9
9)
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T
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le
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. E
ff
ec
ts
 in
 a
ni
m
al
s 
af
te
r 
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po
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re
 to
 m
on
oc
hl
or
am
in
e.
 
E
xp
os
ur
e 
le
ve
l 
E
xp
os
ur
e 
ro
ut
e 
an
d 
du
ra
tio
n 
Sp
ec
ie
s,
 n
o.
 a
nd
 s
ex
 
E
ff
ec
t 
R
ef
er
en
ce
 
0,
 2
5,
 5
0,
 1
00
, 2
00
 m
g/
l 
(1
.8
, 3
.4
, 5
.8
, 9
.0
 m
g/
kg
 b
w
/d
ay
, 
m
al
es
)  
(2
.6
, 4
.3
, 7
.7
, 1
2.
1 
m
g/
kg
 b
w
/d
ay
, 
fe
m
al
es
)  
O
ra
l (
dr
in
ki
ng
 w
at
er
),
 
90
 d
 
R
at
, C
rl
:C
D
B
R
 
Sp
ra
gu
e 
D
aw
le
y  
10
/s
ex
/g
ro
up
 
R
ed
uc
ed
 f
in
al
 b
od
y 
w
ei
gh
ts
 a
t 2
00
 m
g/
m
l i
n 
bo
th
 s
ex
es
 a
nd
 in
 b
od
y 
w
ei
gh
t g
ai
n 
at
 d
os
es
 ≥
 5
0 
m
g/
m
l i
n 
m
al
es
 a
nd
 a
t 2
00
 m
g/
m
l i
n 
fe
m
al
es
. D
os
e-
re
la
te
d 
de
cr
ea
se
 in
 w
at
er
 c
on
su
m
pt
io
n 
in
 b
ot
h 
se
xe
s.
 
So
m
e 
or
ga
n 
w
ei
gh
ts
 (
ab
so
lu
te
, r
el
at
iv
e 
or
 b
ot
h)
 w
er
e 
de
cr
ea
se
d 
 
in
 m
al
es
 a
t  d
os
es
 ≥
 5
0 
m
g/
m
l a
nd
 in
 f
em
al
es
 a
t 2
00
 m
g/
l, 
bu
t s
ub
-
se
qu
en
t h
is
to
pa
th
ol
og
ic
al
 e
xa
m
in
at
io
n 
di
d 
no
t r
ev
ea
l a
ny
 e
xp
os
ur
e-
re
la
te
d 
ch
an
ge
s.
 
A
lte
ra
ti
on
s 
in
 p
ar
am
et
er
s 
of
 h
ae
m
at
ol
og
y 
an
d 
cl
in
ic
al
 c
he
m
is
tr
y 
w
er
e 
co
ns
id
er
ed
 n
ot
 b
io
lo
gi
ca
ll
y  
si
gn
if
ic
an
t, 
no
t d
os
e-
re
la
te
d 
or
 
w
ith
in
 th
e 
no
rm
al
 r
an
ge
 f
or
 r
at
s 
of
 th
is
 a
ge
 a
nd
 s
tr
ai
n.
 
T
he
 1
00
-m
g/
l c
on
ce
nt
ra
tio
n 
w
as
 c
on
si
de
re
d 
a 
N
O
A
E
L
. 
(2
8)
 
0,
 1
2.
5,
 2
5,
 5
0,
 1
00
, 2
00
 m
g/
l 
(2
.5
, 5
.0
, 8
.6
, 1
1.
1,
 1
5.
6 
m
g/
kg
 
bw
/d
ay
, m
al
es
)  
(2
.8
, 4
.3
, 5
.3
, 9
.2
, 1
2.
9,
 1
5.
8 
m
g/
kg
 b
w
/d
ay
, f
em
al
es
)  
O
ra
l (
dr
in
ki
ng
 w
at
er
),
 
90
 d
 
M
ou
se
, B
6C
3F
1 
10
/s
ex
/g
ro
up
  
R
ed
uc
ed
 b
od
y 
w
ei
gh
t a
t d
os
es
 ≥
 1
00
 m
g/
l i
n 
bo
th
 s
ex
es
 a
nd
 b
od
y 
w
ei
gh
t g
ai
n 
at
 ≥
 5
0 
m
g/
l i
n 
m
al
es
 a
nd
 a
t ≥
 1
00
 m
g/
l i
n 
fe
m
al
es
. 
D
os
e-
re
la
te
d 
de
cr
ea
se
s 
in
 w
at
er
 a
nd
 f
oo
d 
co
ns
um
pt
io
n 
in
 b
ot
h 
se
xe
s.
 
R
ed
uc
tio
ns
 in
 a
bs
ol
ut
e 
an
d/
or
 r
el
at
iv
e 
or
ga
n 
w
ei
gh
ts
 a
t d
os
es
 
≥ 
10
0 
m
g/
l b
ut
 n
o 
ex
po
su
re
-r
el
at
ed
 h
is
to
pa
th
ol
og
y.
 
A
 v
ar
ie
ty
 o
f 
ch
an
ge
s 
in
 p
ar
am
et
er
s 
of
 h
ae
m
at
ol
og
y 
an
d 
cl
in
ic
al
 
ch
em
is
tr
y 
w
er
e 
no
te
d 
w
ith
 n
o 
co
ns
is
te
nt
 e
xp
os
ur
e-
re
la
te
d 
pa
tte
rn
. 
T
he
 5
0 -
m
g/
l c
on
ce
nt
ra
tio
n 
w
as
 c
on
si
de
re
d 
to
 b
e 
a 
N
O
A
E
L
. 
(2
9)
 
0,
 0
, 2
00
 m
g/
l 
(2
1.
6 
m
g/
kg
 b
w
/d
ay
) 
2 
co
nt
ro
l g
ro
up
s 
(s
ee
 te
xt
) 
O
ra
l (
dr
in
ki
ng
 w
at
er
),
 
13
 w
k  
R
at
, S
pr
ag
ue
 D
aw
le
y 
10
 m
al
es
/g
ro
up
 
R
ed
uc
ed
 b
od
y 
w
ei
gh
t g
ai
n 
an
d 
m
in
or
 b
io
ch
em
ic
al
, h
ae
m
at
ol
og
ic
al
, 
im
m
un
ol
og
ic
al
 a
nd
 h
is
to
pa
th
ol
og
ic
al
 c
ha
ng
es
 w
er
e 
la
rg
el
y 
re
la
te
d 
to
 r
ed
uc
ed
 w
at
er
 a
nd
 f
oo
d 
co
ns
um
pt
io
n 
an
d 
no
t d
ir
ec
tly
 c
au
se
d 
by
 
m
on
oc
hl
or
am
in
e.
 
(1
04
) 
 
29
 
T
ab
le
 4
. E
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m
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 m
on
oc
hl
or
am
in
e.
 
E
xp
os
ur
e 
le
ve
l 
E
xp
os
ur
e 
ro
ut
e 
an
d 
du
ra
tio
n 
Sp
ec
ie
s,
 n
o.
 a
nd
 s
ex
 
E
ff
ec
t 
R
ef
er
en
ce
 
14
.7
5 
m
g/
kg
 b
w
 
Si
ng
le
 d
os
e 
 
(r
ou
te
 n
ot
 g
iv
en
) 
R
at
 (
st
ra
in
 n
ot
 g
iv
en
) 
9 
m
al
es
 
M
on
oc
hl
or
am
in
e 
di
d 
no
t i
ni
tia
te
 G
G
T
 f
oc
i a
nd
 th
e 
au
th
or
s 
co
nc
lu
de
d 
th
at
 m
on
oc
hl
or
am
in
e 
is
 n
ot
 c
ap
ab
le
 o
f 
in
iti
at
in
g 
ca
rc
in
og
en
es
is
. 
(6
2)
 
Re
pr
od
uc
tiv
e 
an
d 
de
ve
lo
pm
en
ta
l s
tu
di
es
 
 
 
 
0,
 1
.6
, 4
, 8
 m
g/
kg
 b
w
/d
ay
 
O
ra
l g
av
ag
e,
  
5 
co
ns
ec
ut
iv
e 
d 
M
ou
se
, B
6C
3F
1 
10
 m
al
es
/g
ro
up
 
N
o 
sp
er
m
-h
ea
d 
ab
no
rm
al
iti
es
 1
, 3
 o
r 
5 
w
k 
af
te
r 
th
e 
la
st
 d
os
e 
at
 a
ny
 
ex
po
su
re
 le
ve
l.  
(8
6)
 
0,
 2
.5
, 5
, 1
0 
m
g/
kg
 b
w
/d
ay
 
O
ra
l g
av
ag
e,
  
M
al
es
: 5
6 
d 
pr
io
r 
to
 
br
ee
di
ng
 +
 1
0 
d 
br
ee
di
ng
 c
yc
le
 (
66
 d
).
 
Fe
m
al
es
: 1
4 
d 
pr
io
r 
to
 
br
ee
di
ng
 u
nt
il 
w
ea
ni
ng
 
d  
21
 (
up
 to
 7
3 
d)
. 
So
m
e 
pu
ps
 d
os
ed
  
po
st
-w
ea
ni
ng
 u
nt
il 
28
 
or
 4
0 
d 
of
 a
ge
.  
R
at
, L
on
g-
E
va
ns
 
12
 m
al
es
/g
ro
up
 
24
 f
em
al
es
/g
ro
up
 
N
o 
ef
fe
ct
 o
n 
sp
er
m
 c
ou
nt
, s
pe
rm
 m
ov
em
en
t o
r 
sp
er
m
 m
or
ph
ol
og
y.
 
N
o 
ef
fe
ct
 o
n 
fe
rt
ili
ty
, v
ia
bi
lit
y,
 li
tte
r 
si
ze
, d
ay
 o
f 
ey
e 
op
en
in
g 
or
 d
ay
 
of
 v
ag
in
al
 p
at
en
cy
 o
r 
fo
et
al
 w
ei
gh
t. 
 
N
o 
hi
st
op
at
ho
lo
gi
ca
l c
ha
ng
es
 o
n 
re
pr
od
uc
tiv
e 
or
ga
ns
 in
 e
ith
er
 s
ex
. 
(2
3)
 
0,
 1
, 1
0,
 1
00
 m
g/
l 
(0
.0
9,
 0
.9
, 9
.3
 m
g/
kg
 b
w
/d
ay
) b
 
O
ra
l (
dr
in
ki
ng
 w
at
er
, 
ad
 li
bi
tu
m
),
  
2.
5 
m
o 
pr
io
r 
to
 a
nd
 
th
ro
ug
ho
ut
 g
es
ta
tio
n.
  
R
at
, V
ir
gi
n 
Sp
ra
gu
e 
D
aw
le
y  
6 
fe
m
al
es
/g
ro
up
 
N
o 
ef
fe
ct
s 
on
 f
oe
tu
se
s 
(i
.e
. n
o 
sk
el
et
al
 o
r 
so
ft
-t
is
su
e 
de
fe
ct
s,
 n
o 
ef
fe
ct
s 
on
 f
oe
ta
l w
ei
gh
t)
. 
(1
) 
a 
C
al
cu
la
te
d 
by
 N
E
G
 a
ss
um
in
g 
a 
bo
dy
 w
ei
gh
t o
f 
16
0 
g 
(i
n 
th
e 
pa
pe
r,
 th
e 
bo
dy
 w
ei
gh
t i
s 
gi
ve
n 
as
 1
50
–1
70
 g
).
 
b 
C
al
cu
la
te
d 
by
 N
E
G
 a
cc
or
di
ng
 to
 th
e 
re
co
m
m
en
da
tio
ns
 b
y 
th
e 
E
ur
op
ea
n 
Fo
od
 S
af
et
y 
A
ut
ho
ri
ty
 (
E
FS
A
) 
(3
2)
. 
G
G
T
: γ
-g
lu
ta
m
yl
tr
an
sp
ep
tid
as
e,
 G
SH
: g
lu
ta
th
io
ne
, I
gG
: i
m
m
un
og
lo
bu
lin
 G
, N
O
A
E
L
: n
o 
ob
se
rv
ed
 a
dv
er
se
 e
ff
ec
t l
ev
el
. 
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T
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ts
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m
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po
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re
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 d
ic
hl
or
am
in
e.
 
E
xp
os
ur
e 
le
ve
l 
E
xp
os
ur
e 
ro
ut
e 
an
d 
du
ra
tio
n 
Sp
ec
ie
s,
 n
o.
 a
nd
 s
ex
 
E
ff
ec
t 
R
ef
er
en
ce
 
0,
 0
, 0
.0
19
, 0
.1
9,
 1
.9
, 1
8 
m
g/
kg
 b
w
/d
ay
 (
m
al
es
)  
0,
 0
, 0
.0
25
, 0
.2
6,
 2
.5
, 2
4 
m
g/
kg
 b
w
/d
ay
 (
fe
m
al
es
)  
(2
 c
on
tr
ol
 g
ro
up
s,
 s
ee
 te
xt
) 
O
ra
l (
dr
in
ki
ng
 w
at
er
),
 
13
 w
k  
R
at
, S
pr
ag
ue
 D
aw
le
y 
10
/s
ex
/g
ro
up
 
M
in
im
al
 h
is
to
pa
th
ol
og
ic
al
 c
ha
ng
es
 in
 th
e 
ga
st
ri
c 
ca
rd
ia
 (
ep
ith
el
ia
l 
hy
pe
rp
la
si
a)
 a
t  d
os
es
 ≥
 0
.1
9 
m
g/
kg
 b
w
 a
nd
 ≥
 2
.5
 m
g/
kg
 b
w
 in
 m
al
es
 
an
d 
fe
m
al
es
, r
es
pe
ct
iv
el
y,
 a
nd
 m
in
im
al
 to
 m
ild
 a
da
pt
iv
e 
ch
an
ge
s 
in
 
th
yr
oi
d 
an
d 
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11. Observations in man 
11.1 Irritation and sensitisation  
Several studies have investigated eye and respiratory tract irritation among workers 
occupationally exposed to inorganic chloramines in indoor swimming pool facilities 
and in cleaning and disinfection in the food processing industry as well as among 
competitive and recreational swimmers, as described below and summarised in 
Table 7 (effects predominantly evaluated against measurements of trichloramine 
levels). 
Data on irritation from accidental exposure and on asthma-related symptoms and 
effects are presented in Sections 11.2.1 and 11.3.1, respectively. No studies on 
dermal sensitisation were found. 
11.1.1 Swimming pool workers  
Chu et al. investigated the prevalence of work-related irritation in eyes and airways 
among pool workers in 10 indoor swimming pools in Taiwan of which 6 had spa 
pools located in the same buildings. The exposed group consisted of 61 lifeguards 
and swimming instructors (36 men, 25 women). The reference group consisted of 
43 employees (15 men, 28 women) working at the same swimming facilities, but 
their exposure was considered negligible. Exposure classification on an individual 
basis was not performed. Airborne levels of trichloramine were determined using 
stationary sampling, performed from April through October 2010. The overall 
average concentration of trichloramine was 0.035 (0.017–0.15) mg/m3 in 
swimming pools and 0.059 ± 0.042 (SD) mg/m3 in spa pools. Corresponding soluble 
chlorine concentrations were 0.072 (0.005–0.21) mg/m3 and 0.085 ± 0.056 mg/m3. 
Questionnaires were given to the pool workers during the same time as the air 
samplings were performed and comprised questions about ocular and respiratory 
symptoms. Symptoms were considered work-related if present during or after a 
work shift. The prevalence of various symptoms was compared on a group level; in 
general, exposed workers reported more symptoms from eyes and airways than non-
exposed subjects did. Exposed workers had significantly more [odds ratio (OR), 
95% CI] throat irritation (11.3, 1.4–88] and phlegm (4.2, 1.2–15) than non-exposed 
subjects, but there were no significant differences for ocular and nose irritation (25). 
Dang et al. investigated work-related symptoms via questionnaire among 143 
exposed and unexposed pool workers at an indoor waterpark in the United States 
(US). Stationary measurements of airborne trichloramine were performed during 
two high-occupancy days and one low-occupancy day. The average concentration 
for the first high-occupancy day was 0.44 mg/m3. Only 20% of all samples collected 
during the second high-occupancy day were quantifiable, but the highest 
concentration (1.06 mg/m3) was found this day. Lifeguards (37 men, 32 women) 
reported significantly more work-related irritation [prevalence ratio (PR), 95% CI] 
in throat (12, 2.9–48), nose (3.5, 1.9–6.6) and eyes (9.0, 4.1–20) than unexposed 
employees working outside the pool area (24 men, 50 women). In addition, the 
lifeguards completed a daily symptom questionnaire during the high-occupancy 
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days (n = 43) and low-occupancy day (n = 27). Work-related symptoms were 
significantly more common during the high-occupancy days than the low-
occupancy day (PR, 95% CI), such as eye irritation (2.0, 1.2–3.2) and cough (2.2, 
1.1–4.5) (adjusted for smoking habits, subjects with asthma not included) (27). 
The prevalence of ocular and respiratory symptoms was assessed via question-
naire in 128 pool workers in an Italian study. Lifeguards and swimming instructors 
(40 men, 41 women) comprised the exposed group and the other employees were 
considered non-exposed (21 men, 26 women). Measurements of airborne trichlor-
amine using stationary sampling showed an average concentration of 0.65 mg/m3. 
Exposed pool workers reported ocular and upper respiratory symptoms (sometimes 
or often) more frequently than the unexposed. Five levels of exposure to airborne 
trichloramine were defined: ≤ 0.5, > 0.5, > 0.6, > 0.7 and > 0.8 mg/m3. A strong 
dose-response relationship between trichloramine air levels and self-reported 
irritation in eyes and upper airways was demonstrated. Pool workers exposed to 
airborne trichloramine levels > 0.5 mg/m3 had significantly higher risk (OR, 95% 
CI) for experiencing runny nose (2.9, 1.2–6.9), voice loss (3.6, 1.6–7.9), red eyes 
(3.2, 1.5–6.8) and itchy eyes (2.2, 1.04–4.8) than non-exposed subjects (36). 
Work-related respiratory symptoms were investigated via interview of 146 pool 
workers (58 men, 88 women) employed at 46 swimming pool facilities in Sweden. 
In total, 17% of the pool workers reported work-related respiratory symptoms; there 
were no significant gender differences. The prevalence was relatively high among 
workers employed 1–3 year (31%) and lower among those employed 4–7 years 
(6%), indicating a possible healthy worker effect (in this case a selection bias 
meaning that employees who experience health problems at work tend to quit, and 
that those who continue to work have better health). However, the prevalence of 
symptoms was 22% in those employed > 7 years. Most pool workers with airway 
symptoms (64%) came from 6/46 swimming pool facilities. Five indoor swimming 
pools with high prevalence of reported airway irritation and four swimming pools 
without reported airway irritation among the employees were selected for 
measurements of airborne trichloramine via stationary sampling. The average 
concentration of airborne trichloramine was 0.20 mg/m3. The 39 pool workers were 
evaluated by questionnaire. No association between self-reported work-related 
airway symptoms and levels of airborne trichloramine was found. Protein profiling 
of nasal lavage fluid in 9 pool workers and 4 control subjects showed altered 
distribution of three innate immunity proteins (α-1-antitrypsin, lactoferrin and 
S100-A8) in pool workers, and more pronounced in subjects with airway irritation 
(42). 
Héry et al. measured indoor airborne levels of trichloramine in 7 standard 
swimming pools and 5 recreational swimming pools in France using stationary 
sampling. The aim was to assess the exposure of swimming instructors who had 
complained of irritative symptoms during work. The sampling devices were placed 
at different spots that were chosen to be as representative as possible of the 
swimming instructors’ exposure. Trichloramine concentrations as ranges of AMs 
were 0.15–0.39 mg/m3 at the swimming pools and 0.23–1.25 mg/m3 at the 
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recreational centres. Swimming instructors were requested to report at the onset of 
irritative symptoms during sampling. The onset of irritation in eyes and upper 
respiratory tract began at concentrations around 0.5 mg/m3 and all questioned 
complained of irritation when the concentration reached 0.7 mg/m3 (64). 
Information regarding number, age and gender of participating subjects, and how 
they were selected for the study was lacking. 
A questionnaire was sent to 1 066 pool workers from 38 swimming pool facilities 
in the Netherlands. The response rate was 59% and thus questionnaires from 624 
exposed and unexposed pool workers (240 men, 384 women) remained for analysis. 
Work-related and general respiratory symptoms as well as symptoms indicative of 
allergy were asked for. Measurements of airborne trichloramine were performed 
using stationary sampling in 6 different swimming facilities; the overall mean was 
0.56 mg/m3. Swimming instructors (n = 121) reported more work-related symptoms 
(OR, 95% CI), mainly from upper airways such as sinusitis (2.4, 1.2–4.9), chronic 
cold (3.4, 1.2–10.1), sore throat (2.4, 1.2–4.5), blocked nose (2.0, > 1.0–3.8) and 
sneezing (2.0, 1.1–3.6) than 282 reception, catering and management employees. 
ORs (95% CIs) for runny nose and irritation in eyes were 1.2 (0.8–2) and 1.5  
(0.8–2.6), respectively. The 142 employees who combined the jobs of pool 
attendant and swimming instructor also reported more work-related symptoms in 
the upper airways (OR, 95% CI) such as chronic cold (3.5, 1.2–10), sore throat 
(3.2, 1.7–5.9), blocked nose (3.7, 1.9–7.3), runny nose (2.2, 1.3–3.5), sneezing  
(2.3, 1.2–4.4) and irritation in the eyes (3.0, 1.7–5.3). The OR for sinusitis was 2.3 
(1.0–5.6). No association between estimated long-term levels of airborne trichlor-
amine (AM 0.66 mg/m3) and symptoms was found, but 1-week cumulative 
exposures (trichloramine levels of each pool multiplied by the quantity of working 
hours per week for each individual) were significantly associated with upper 
respiratory symptoms (73). 
Löfstedt et al. investigated the prevalence of ocular and respiratory symptoms 
among 52 pool workers (16 men, 36 women) from 8 indoor swimming pool 
facilities in Sweden. The reference group consisted of 50 office workers (15 men, 
35 women). The prevalence of ocular and respiratory symptoms during the last 
week, as well as during the last 3 months was assessed via questionnaire. The 
concentration of airborne trichloramine was measured by personal sampling,  
and the AM was 0.071 mg/m3. Stationary sampling was performed in parallel to 
personal sampling and showed an AM of 0.18 mg/m3 (138). Exposed workers 
reported more often itchy eyes (36% vs 14%), at least one ocular symptom (62% vs 
37%) and blocked nose (55% vs 32%) than referents during the last week. After 
adjusting for smoking, asthma and sensitisation to inhaled allergens, exposed 
workers reported more often (OR, 95% CI) at least one ocular symptom such as 
itchy, smarting, dry, running and red eyes, gravel sensation or swollen eyelids (2.4, 
1.0–5.7) and one nasal symptom such as blocked, dripping or itchy nose, and 
sneezing (2.3, 1.0–5.6) during the last week compared with the referents. The OR 
(95% CI) for respiratory (tracheobronchial) symptoms was 1.6 (0.7–3.9). Exposed 
workers reported more often ocular, nasal and/or respiratory symptoms during the 
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last 3 months than referents (data not shown in paper). No associations were shown 
between exposure levels and studied health effects (82). 
Massin et al. assessed irritant eye and upper airway symptoms at work by 
questionnaire in 334 lifeguards (256 men, 78 women) recruited from 46 public 
swimming pools and 17 adventure swimming pools in France. There was no 
reference group. Stationary measurements showed that the average airborne 
concentrations of trichloramine were 0.24 mg/m3 in the swimming pools and 
0.67 mg/m3 in the adventure swimming pools. The lifeguards were divided in four 
subgroups due to measured trichloramine concentrations in air: < 0.14, 0.14–0.22, 
0.22–0.50 and > 0.50 mg/m3. The prevalence rates of eye irritation in the groups 
were 50%, 56%, 63% and 86%, respectively. Corresponding numbers for nose 
irritation were 12%, 20%, 28% and 61%. For sore throat and dry cough, the rates 
were 16%, 15%, 27% and 29%, and 9%, 12%, 21% and 42%, respectively. These 
concentration-response relationships were all significant. In addition, a cumulative 
exposure index was calculated for each lifeguard by multiplying the average 
trichloramine level by the number of working years (mg/m3-years). The lifeguards 
were divided in four subgroups: < 0.58, 0.58–1.6, 1.6–3.12 and > 3.12 mg/m3-years. 
The prevalence rates of eye irritation in the groups were 51%, 67%, 64% and 75%, 
respectively. The corresponding numbers for nose irritation were 22%, 27%, 35% 
and 39%. For sore throat and dry cough, the rates were 15%, 24%, 23% and 25%, 
and 15%, 26%, 24% and 22%, respectively. Significant concentration-response 
relationships were found between cumulative exposure index and irritant eye and 
nose symptoms. No such relations were shown between cumulative exposure and 
sore throat and dry cough. ORs were not reported (84). 
Parrat et al. investigated the occurrence of ocular and respiratory symptoms in 
178 swimming pool workers (117 men, 61 women) in a Swiss study. Self-reported 
symptoms that had been present during and before the last 12 months, respectively, 
were collected by questionnaire. The reference group consisted of 71 office workers 
(38 men, 33 women). Stationary sampling was used to determine airborne trichlor-
amine levels; the average concentration was 0.11 mg/m3. Irritative symptoms (sum 
of symptoms that appeared before, and during the last 12 months, hereafter referred 
to as “ever”) in eyes (53% vs 22%), throat (79% vs 7%), nose (38% vs 7%) and 
skin (61% vs 8%) due to the working conditions were significantly more common 
among pool workers than among referents. Pool workers exposed to airborne 
trichloramine levels > 0.29 mg/m3 (AM 0.36 mg/m3, range 0.30–0.52 mg/m3) had 
significantly higher prevalences of irritation (OR, 95% CI) in eyes (5.6, 1.3–23.7) 
and nose (4.2, 1.4–13) during the last 12 months, and “ever” in nose (4.3, 1.5–13) 
than referents. No increased symptom prevalences were found in pool workers 
exposed to 0.1–0.29 (AM 0.15) mg/m3. Employees were divided in five groups 
according to a 1-week cumulative exposure index (combining the ratio of 
professional activity, the time spent working in potentially trichloramine-
contaminated areas and the measured trichloramine concentration). The group with 
highest exposure index had increased prevalences of eye and nose irritation, and the 
second highest index group had increased eye irritation (101). 
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Westerlund et al. investigated irritant symptoms among 23 pool workers (3 men, 
20 women) from 10 habilitation and rehabilitation swimming pool facilities in 
Sweden. The reference group consisted of 50 office workers (15 men, 35 women). 
Concentrations of airborne trichloramine measured by personal and stationary 
sampling were 0.001–0.076 (AM 0.019) mg/m3 and 0.001–0.140 (AM 0.023) 
mg/m3, respectively. Data concerning ocular, nasal and respiratory symptoms 
during the last week, as well as during the last 3 and 12 months were collected via 
questionnaire. There was no significant difference in prevalences of irritation 
between exposed and referents at any time-point. The only significant finding was 
a higher prevalence of having at least 1 out of 6 ocular symptoms (itchy, smarting, 
dry, running and red eyes, and swollen eyelids) during the last week among those 
exposed to trichloramine above the median of 0.020 mg/m3 than in those exposed 
below the median (relative risk 1.2, 95% CI 1.1–1.4) (adjustment for age and 
smoking) (137). The finding of eye irritation from exposure to trichloramine levels 
as low as 0.020–0.076 mg/m3, seems unlikely, in view of the lack of significant 
differences between exposed and referents and the results from other studies 
(described above) suggesting effects only at higher levels.  
Demange and coworkers investigated 39 French lifeguards (29 men, 10 women) 
and reported a high prevalence of work-related symptoms, such as irritation in eyes 
(72% in men, 70% in women), nose (52%, 50%) and throat (48%, 30%) (30). There 
was no reference group for comparison and no measurements of airborne trichlor-
amine were performed. 
The occurrence of allergic rhinitis was evaluated in 27 pool workers (13 men, 14 
women) in Turkey by clinical examination, a skin prick test and a nasal smear. The 
prevalence of positive skin prick test was 30% compared to 18% in the reference 
group consisting of 49 office workers (22 men, 27 women); the difference was not 
statistically significant. Pool workers had significantly more eosinophils in nasal 
smear than non-exposed workers, indicating allergic inflammation, likely due to 
exposure to chlorine derivatives in the indoor air, according to the authors (34). No 
measurements of airborne trichloramine were performed. 
A questionnaire was sent to 1 741 individuals who indicated in the Swedish 
Census of Population and Housing 1990 that they worked at indoor swimming 
pools. Ocular and respiratory symptoms related to work were asked for, as well as 
number of years hired as a pool worker and time spent in the pool area. The response 
rate was 63% and 1 102 respondents (513 men, 589 women) remained for analysis. 
Measurements of airborne trichloramine were not performed, but exposure was 
classified in 3 different categories based on the average time during a workday each 
participant spent in the pool area. Exposure category 0 consisted of those who did 
not spend any time in the pool area, category 1 occasionally spent some time and 
category 2 spent most of the workday in the pool area. Irritative symptoms were 
common among all pool workers, i.e. irritation in eyes (37%), nose (29%), throat 
(24%) and coughing (23%). A statistically significant association was found 
between the average number of hours per day spent in the pool environment and the 
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percentage of workers reporting acute work-related irritant symptoms (P < 0.01 
logistic regression) (98). 
11.1.2 Competitive and recreational swimmers 
Gomà et al. evaluated health complaints in 320 recreational swimmers (63% men, 
mean age 36 years) and 53 competitive swimmers including 34 water polo 
swimmers (84% men, mean age 22 years) before and 8 weeks after introducing a 
new disinfection method (details in Table 3) in a swimming pool in Spain. Self-
reported symptoms related to swimming, such as irritation of the eyes, respiratory 
tract and skin, were collected by questionnaire. Symptoms were graded from 1 (no 
symptoms) to 4 (severe). In addition, leukotriene B4 (LTB4) and cysteinyl 
leukotrienes (CysLTs) (surrogate markers of neutrophilic and eosinophilic 
inflammation, respectively) were measured in exhaled breath condensate collected 
from the competitive swimmers 30 min before and 30 min after swimming. 
Stationary measurements were performed at a sampling point determined as the 
“worst” point based on levels of total oxidants and subjective information from the 
pool workers. The sampling point was situated 5 cm over the water surface level 
and 20 cm from the lateral edge, just over the perimeter drain. The new disinfection 
method resulted in a 75% reduction of total oxidants and a 39% reduction of 
trichloramine. Thus, the average airborne concentration of trichloramine fell from 
0.62 mg/m3 using conventional chlorination to 0.38 mg/m3 using the new 
disinfection method. The symptom prevalences were higher in competitive 
swimmers than in recreational swimmers, the most common symptoms in both 
groups being eye and nose irritation. Competitive swimmers experienced decreased 
irritation in eyes (48% vs 19%; significant), nose (42% vs 28%; non-significant) 
and skin (30% vs 24%; non-significant) after shifting from the old to the new 
disinfection method. Also recreational swimmers had significantly lower 
prevalences regarding irritation in eyes (17% vs 6.7%), nose (12% vs 2.2%) and 
skin (11% vs 4.5%), and cough (5.8% vs 0%) after shifting methods. Participants 
with asthma did not differ from non-asthmatics in symptom prevalences. The 
baseline level of CysLTs in exhaled breath condensate was significantly reduced 
when the new method was used, whereas the LTB4 baseline level was not affected 
(47). 
Lévesque et al. compared the prevalence of respiratory symptoms in 305 
competitive swimmers (101 boys, 204 girls) with that of 499 indoor soccer players 
(297 boys, 202 girls) in the Québec City region of Canada via questionnaire, and 
evaluated the relationship between trichloramine concentrations and the athletes’ 
respiratory symptoms. The competitive swimmers reported significantly more 
symptoms (OR, 95% CI) from upper airways (3.7, 2.4–5.8), irritation in nose  
(7.2, 4–13), throat (2.1, 1.3–3.5) and eyes (11.9, 6.7–21) (ORs adjusted for gender, 
age and number of training sessions per week). No significant difference between 
the groups was observed for skin problems. Respiratory symptoms were also 
assessed during five training sessions in 72 competitive swimmers, 8–22 years of 
age and 73 soccer players, 11–17 years of age. The concentration of trichloramine 
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in air was measured in 7 swimming pool facilities and the AM was 0.34 mg/m3 
(median 0.37 mg/m3) with a range of 0.26–0.41 mg/m3. The swimmers experienced 
more symptoms (OR, 95% CI) from upper airways (3.1, 1.8–5.4) and irritation in 
eyes (5.7, 1.1–28) during the five training sessions than the soccer players. 
Swimmers with high exposure to airborne levels of trichloramine (> 0.37 mg/m3) 
had significantly more symptoms (OR, 95% CI) from upper airways (2.2, 1.0–4.8) 
and irritation in eyes (4.9, 1.9–12) compared to swimmers with an exposure < 0.37 
mg/m3 (78). 
Seys et al. initiated a study after complaints of respiratory symptoms among 
members of a swimming club when attending a municipal indoor swimming pool 
in Belgium. Competitive swimmers (n = 39) and coaches (n = 10) were invited to a 
medical evaluation. Of them, 22 swimmers aged 9–17 years (10 boys, 12 girls) and 
6 coaches aged 18–60 years (3 men, 3 women) were evaluated by interview. 
Repeated measurements of airborne trichloramine were performed by stationary 
sampling and the concentration ranged from 0.20 to 1.30 mg/m3. Most commonly 
reported symptoms were cough (57%), dyspnoea (46%), red tearing eyes (37%) and 
blocked or runny nose (21%). A glue containing polyamines used to repair a 
pipework was suspected to contribute to an excessive production of trichloramine. 
After removal of the glue, the concentration of airborne trichloramine decreased to 
a concentration below 0.5 mg/m3. At follow up one year later, including 13/28 
subjects from the first evaluation, most subjects reported improvement but some 
symptoms remained. Some swimmers reported a recent recurrence of symptoms; 
the intake of outside air to the swimming pool had presently been reduced because 
of low outside temperature, resulting in rising air levels of trichloramine (0.66 
mg/m3) (118). 
11.1.3 Food industry workers 
King et al. investigated eye and respiratory symptoms among workers in a US 
poultry processing facility and administered a screening questionnaire to 109 
employees. Answers from 68 employees at the evisceration department (39 men, 
29 women) and 41 workers in the dark meat department (18 men, 23 women) were 
available for analysis. The evisceration workers were chosen because of the 
extensive use of super-chlorinated water in their department, in contrast to the dark 
meat workers (reference group). Work-related nose irritation, such as sneezing (OR 
4.9, 95% CI 1.8–14) (but not itchy, running or stuffy nose), burning or stinging (OR 
3.3, 95% CI 1.3–9.2) or watery eyes (OR 7.0, 95% CI 2.4–24) were significantly 
more common in evisceration workers than in dark meat workers; ORs adjusted for 
smoking status. The prevalence of work-related sore throat was also higher in 
evisceration workers, but did not reach statistical significance. A second survey was 
performed a year later comprising 18 evisceration workers and 16 dark meat 
workers. Measurements were performed by personal sampling. Levels of 
trichloramine were significantly higher in the evisceration area (GM 0.0051 mg/m3) 
than in the dark meat area (GM 0.0012 mg/m3). Soluble chlorine was also present 
in the indoor air of the premises; the concentration was significantly higher in the 
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evisceration area (GM 0.0635 mg/m3) than in the dark meat area (GM 0.0094 
mg/m3). Thus, soluble chlorine predominated in the indoor air. Exposure levels of 
trichloramine were significantly higher for employees reporting burning and 
stinging eyes (12/34, 35%) compared to those who did not report such symptoms. 
Further, exposure levels of soluble chlorine were higher for subjects reporting 
burning or stinging eyes (10/32, 31%), itchy or stuffy nose (9/32, 28%), frequent 
sneezing (5/32, 16%) and cough (8/32, 25%), compared to those who did not report 
such symptoms. Aerosolisation of the chlorinated water resulting in high air levels 
of soluble chlorine makes it difficult to separate effects from exposure to 
trichloramine from those of soluble chlorine (76). 
Massin et al. recruited 175 cleaning and disinfecting workers from the food 
industry (149 men, 26 women) and 70 non-exposed workers (52 men, 18 women). 
Irritant symptoms were evaluated by questionnaire. The personal inhalation 
exposure was given as the sum of trichloramine and soluble chlorine (range of AMs 
0.33–0.49 mg/m3). In addition, glutaraldehyde and formaldehyde was used as 
disinfection agents, but air levels were not reported. A total exposure index 
including all irritants was calculated for each worker. Three subgroups were 
constituted; a non-exposed group and two groups with lower and higher exposure 
index. The prevalence of irritant symptoms was higher among subjects with highest 
exposure index than in non-exposed; irritation in eyes (48% vs 5.7%), nose (39% 
vs 1.4%), sore throat (27% vs 2.9%) and dry cough (27% vs 1.4%). Significant 
concentration-response relationships between irritant eye, nose and throat 
symptoms and exposure to irritants were found. In addition, the workers were 
divided in three subgroups taking exposure duration into account; non-exposed 
group, exposure duration ≤ 6 years and exposure duration > 6 years. The prevalence 
rates for the groups with exposure duration > 6 years and < 6 years were 51% and 
30% (eye irritation), 41% and 20% (nose irritation), 34% and 15% (sore throat) and 
27% and 16% (dry cough), respectively. Significant concentration-response 
relationships between all symptoms and number of working years were found (85). 
11.1.4 Conclusion 
In summary, inorganic chloramines are strong mucous membrane irritants, and 
several cross-sectional studies have shown higher prevalences of self-reported 
ocular and/or upper airway irritation among workers occupationally exposed to 
inorganic chloramines and competitive swimmers compared to an unexposed 
reference group (25, 27, 36, 73, 76, 78, 82, 85, 101). Food industry workers (76, 
85) and competitive swimmers (78) are to a higher degree co-exposed to soluble 
chlorine from aerosols or the chlorinated water itself than swimming pool workers. 
Studies on these categories are therefore of limited value in the risk assessment of 
irritant effects of airborne trichloramine. 
Several studies have demonstrated significantly more ocular and upper airway 
irritation in pool workers than in referents (25, 27, 36, 73, 82) and exposure-
response relationships have been shown in a few studies (36, 84, 101). Stationary 
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sampling was used in most of these studies. The temporal link between exposure 
and symptoms was sometimes weak. 
Despite the amount of human irritation data on trichloramine, it is difficult to 
draw a firm conclusion regarding a no observed adverse effect concentration 
(NOAEC). In the study by Parrat et al., irritation symptoms were more frequent in 
pool workers exposed to 0.30–0.52 mg/m3 (AM 0.36 mg/m3) than in referents (101). 
The study suggests a lowest observed adverse effect concentration (LOAEC) for 
irritation around 0.4 mg/m3. This value is supported by several other studies on pool 
workers which show irritation at approximately 0.5 mg/m3 (36, 64, 84). 
Duration of exposure was taken into account in some studies, and an association 
between the prevalence of irritation in upper airways or eyes and cumulative 
trichloramine exposure was observed (73, 84, 101). The cumulative exposures were 
calculated in different ways and are difficult to interpret in terms of exposure 
concentration. These data are therefore not suited for identifying NOAECs and 
LOAECs. 
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11.2 Effects of single and short-term exposure 
11.2.1 Accidental exposure 
Mixing solutions of ammonia and sodium hypochlorite results in acrid chloramine 
fumes (49). Gapany-Gapanavicius et al. reported the case of a healthy 27-year-old 
woman who mixed ammonia and sodium hypochlorite in a small and poorly 
ventilated bathroom. The vapours from the mixture caused burning sensations  
in the eyes and throat, dyspnoea, coughing, nausea and vomiting. Pneumonitis 
developed, but pulmonary function had returned to normal after 9 days (44). 
A healthy 53-year-old woman was cleaning a walk-in-freezer using a mixture of 
ammonia and sodium hypochlorite which caused formation and release of inorganic 
chloramines into the air. The door was closed and there was no air exchange in the 
freezer. After approximately 30 min she noted shortness of breath. Over the next  
3 hours she had increased tightness of the throat and lost her voice. The symptoms 
worsened. Emergency tracheostomy was performed. Radiologic evidence of 
pneumonitis developed over the next 4 hours and she received supportive care. The 
tracheal tube was removed within 5 days and she was fully recovered within 7 days 
(127). 
As the vapours in these 2 cases probably contained also ammonia, which may 
produce similar health effects as inorganic chloramines, the responsible agent 
cannot be identified. 
Bowen et al. investigated outbreaks of acute ocular and respiratory symptoms 
associated with indoor swimming pool exposure among patrons of two hotels. In 
one of the hotels, the ventilation system malfunctioned during the outbreak. Out of 
77 registered guests who stayed at the first hotel within 2 days of onset of outbreak, 
47 (67%) were interviewed by telephone with a standardised questionnaire con-
taining questions about exposure to the swimming pool area, general and respiratory 
and ocular symptoms. Among the 31 guests who visited the indoor pool area, 22 
(71%) developed acute ocular symptoms such as burning and watery eyes, and  
15 (48%) reported acute respiratory symptoms such as cough and sore throat. At  
the second hotel, 30 out of 77 registered guests and 59 companions completed  
the questionnaire. Among those 69 exposed to the indoor pool area, 41 (59%) 
developed acute ocular symptoms, and 28 (41%) acute respiratory symptoms. In 
total, all cases with ocular symptoms and 42/43 with respiratory symptoms had 
visited the pool area. Symptoms occurred within minutes of exposure to the indoor 
pool area and lasted up to 14 days, 4 persons sought medical care. Children were 
predominantly affected, but there was no association with gender. Environmental 
health investigations were performed. Appropriate water and air samples were not 
available for laboratory analysis. According to the authors, chloramines likely 
contributed to the illness; symptoms were consistent with trichloramine exposure 
and were sometimes severe (17). 
Sanderson et al. investigated outbreaks of work-related acute eye and upper 
respiratory irritation and other symptoms such as nausea and headache in 6 poultry 
processing plants. A questionnaire was administered to all 170 workers at one of 
these plants. Over 80% of the inspectors, evisceration/reprocessing and clean-up 
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crew reported eye and nasal irritation, but only about one-third of the packers. 
Potential causes of the outbreaks were explored; air samples were collected at all 6 
plants for chlorine gas and at 4 plants for ammonia, but concentrations of these 
gases were low. No measurements of airborne trichloramine were performed, 
but the outbreaks all had temporal association with problems or changes in the 
plant’s water chlorination and super-chlorination processes. The complaints were 
eliminated after technical changes, such as construction of a new water supply 
system and ventilation changes, suggesting a causal relationship between the 
reported complaints and exposure to trichloramine (113). 
11.2.2 Effects on lung function and pneumoproteins 
Studies investigating effects on lung function and pneumoproteins among workers 
and swimmers exposed to inorganic chloramines (effects predominantly evaluated 
against measurements of trichloramine levels) are described below and summarised 
in Table 8.  
11.2.2.1 Swimming pool workers and swimmers 
Löfstedt et al. measured lung function and FENO before and after work in 52  
pool workers and 50 office workers (for details, see Section 11.1.1). The average 
airborne trichloramine concentrations measured by stationary and personal 
sampling were 0.18 and 0.071 mg/m3, respectively. No changes in lung function 
were found over the work shift and there was no difference between the groups. 
Regarding FENO, there was a significant difference between the groups in that 
FENO decreased (as expected) over the work shift among referents but increased 
in pool workers, suggesting an inflammatory effect on the airways. The increase 
was more pronounced in non-smoking pool workers (82). 
A similar study by the same research group included 23 pool workers and 50 
office workers (for details, see Section 11.1.1). The average airborne trichloramine 
concentrations measured by stationary and personal sampling were 0.023 mg/m3 
and 0.019 mg/m3, respectively. No changes in lung function were found over the 
work shift and there was no difference between the groups. Mean FENO values 
differed between groups before shift (18 ppb vs 16.1 ppb in referents) and decreased 
over work shift in both groups (17.9 ppb vs 14.3 ppb), but significantly more in 
referents than in pool workers. Personal trichloramine concentrations were not 
associated with lung function or FENO (137). 
Nordberg et al. investigated lung function [forced expiratory volume in the first 
second (FEV1) and FEV% (FEV1/forced vital capacity × 100) as well as biomarkers 
of pulmonary epithelial integrity (CC16 and SP-D) in volunteers before and after 
exposure to indoor pool air. Two groups of volunteers were studied; 37 previously 
non-exposed healthy persons (20 men and 17 women, mean age 24.5 years) and 14 
pool workers (5 men and 9 women, mean age 39.9 years) who performed bicycle 
exercise for 2 hours in an indoor pool environment. Trichloramine in air was 
measured by personal sampling during pool exposures. All participants were also 
exposed to filtered air in a separate exposure chamber, which was used as control 
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condition. In previously non-exposed volunteers, marginal but statistically 
significant decreases in both FEV1 and FEV% (P = 0.01 and 0.05, respectively) were 
found after exposure to pool air (0.23 mg/m3 of trichloramine). The individual 
differences in changes between exposure conditions in FEV1 and FEV% were 
significant with P-values of 0.01 and 0.004, respectively. In pool workers, a 
statistically significant decrease (marginal effect) was found, but only in FEV% 
(P = 0.003) after exposure to pool air (0.15 mg/m3 of trichloramine). The individual 
differences in changes between exposure conditions in FEV1 and FEV% were, 
however, non-significant. There were no statistically significant exposure-related 
changes in serum concentrations of CC16 and SP-D after exposure to pool air for 2 
hours. According to the authors, the lack of exposure-related changes in biomarker 
levels could be explained by the relatively short exposure duration and the low 
exposure level of trichloramine (98). 
Bernard et al. investigated short-term effects of trichloramine on the pulmonary 
epithelium of pool attendees. Three lung-specific proteins, the alveolar SP-A and 
SP-B and the bronchiolar CC16, were measured in serum of 16 children (mean age 
9.6 years) and 13 adults (mean age 36.9 years), before and after attending an indoor 
swimming pool for 2 hours. Children could have free activities while the adults 
were asked to stay at the poolside for 1 hour and then could swim freely. Stationary 
sampling of trichloramine in air was performed and the mean concentration was 
0.49 mg/m3. There was a significant increase in serum levels of SP-A and SP-B, 
and the SP-B/CC16 ratio in both children and adults; in adults already after 1 hour 
without swimming. CC16 levels decreased significantly after 1 hour and reversed 
towards normal 1 hour later in adults, but did not show any distinct pattern in 
children (11). 
Carbonelle et al. investigated the effect of trichloramine on the pulmonary 
epithelium of pool attendees. Three lung-specific proteins (SP-A, SP-B and CC16) 
were measured in serum of 29 recreational swimmers, among them 16 children aged 
5–14 years (10 girls, 6 boys) and 13 adults aged 26–49 years (7 women, 6 men) 
before and after attending a chlorinated pool with a mean airborne trichloramine 
concentration of 0.49 mg/m3. These pneumoproteins were also measured in 14 
trained swimmers aged 18–23 years (6 women, 8 men) before, immediately after, 
and 11 hours after performing an intensive 45-min standardised swimming session 
in a chlorinated pool with a mean airborne trichloramine concentration of 0.36 
mg/m3, and in a non-chlorinated pool sanitised by the copper/silver method. 
Pulmonary function was evaluated by spirometry at the same time as the blood 
sampling was done, both in recreational and trained swimmers. Stationary sampling 
of trichloramine in air was performed at the poolside 20 cm above the pool’s water 
surface to assess exposure during swimming. Serum levels of SP-A and SP-B were 
significantly increased in a time-dependent manner in recreational and trained 
swimmers attending the chlorinated pool, but were unaffected by strenuous exercise 
in the non-chlorinated pool. No significant decrements in lung function were found. 
Serum CC16 levels increased immediately after strenuous exercise in trained 
swimmers, both in the non-chlorinated and chlorinated pools, but were not 
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increased in recreational swimmers. According to the authors, the latter finding is 
probably due to mechanical stress on the epithelial barrier caused by over-inflation 
and/or hyperventilation during intense exercise (21). 
In a similar study, Carbonelle et al. investigated possible effects on the pulmonary 
epithelium and lung function in adults exposed to lower airborne concentrations of 
trichloramine. Serum levels of SP-A, SP-B, CC16 and Krebs von den Lungen-6 
protein (KL-6) were measured in 11 healthy volunteers (7 women, 4 men) before 
and after performing an intensive 45-min standardised swimming session in  
a non-chlorinated pool. After 1 week, the subjects performed a similar swimming 
session in a chlorinated pool. All tests were repeated 3 hours after exercise had 
ceased in both conditions. Measurements of airborne trichloramine were performed 
by stationary sampling on the poolside 20 cm above the pool’s water surface and 
ranged from 0.16 to 0.28 mg/m3. Lung function was evaluated by spirometry and 
possible airway inflammation was assessed using measurements of FENO. Serum 
levels of the pneumoproteins were unaffected after exercise in the chlorinated pool, 
and no decrements in lung function were found. FENO increased by 34% after 
exercise in the non-chlorinated pool but remained unchanged in the chlorinated 
pool. The authors concluded that exercise performed in a pool having an indoor air 
trichloramine concentration < 0.3 mg/m3, did not induce any short-term changes in 
lung function or epithelial permeability (20). 
Font-Ribera et al. measured lung function, biomarkers of airway inflammation 
(FENO, 8 cytokines and vascular endothelial growth factor) and oxidative stress  
(8-isoprostane) in exhaled breath condensate in 48 healthy adult non-smokers, 
before and after swimming for 40 min in a chlorinated indoor swimming pool. In 
addition, serum levels of the pneumoproteins SP-D and CC16, CC16 genotype, 
energy expenditure during swimming, and atopy were determined. Air measure-
ments of trichloramine were done for a comparison with swimming pools in other 
countries but were not used for personal exposure estimates; the mean air 
concentration was 0.29 mg/m3. Most participants were women (65%), the mean age 
was 30 years, and 30% had a positive Phadiatop test (allergy screening test). 
Trihalomethanes in exhaled breath was measured as a marker of individual 
exposure to disinfection by-products. There was a slight increase in serum CC16 
levels (3.3%) after swimming. According to the authors, both exercise and different 
markers of disinfection by-products exposure, such as change in trihalomethanes 
concentration in exhaled breath after swimming, explained this association. No 
significant changes in lung function tests or markers of airway inflammation or 
oxidative stress were found (38). 
Llana-Belloch et al. evaluated the effects on markers of lung epithelium 
permeability and oxidative stress in 20 healthy volunteers (all men, mean age 
22 years) before and after swimming for 40 min in three chlorinated indoor pools 
with different characteristics. Blood samples were collected and analysed for 
pneumoproteins SP-A, SP-B, markers of oxidative stress (plasma malondialdehyde 
and protein carbonyls, GSH and oxidised GSH) and lactate before and after 
exercise. Total air chlorine concentrations were measured in all swimming pools 
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and were 0.1–1.0 mg/m3. The authors suggested that trichloramine was the major 
part of total chlorine in the air samples but the concentration of trichloramine in air 
was not reported. No increase in blood lactate was found after the swimming 
session, confirming that the exercise was performed at a moderate level. 
Concentrations of chlorine in water and air were not associated with changes in 
markers of lung epithelium integrity and oxidative damage. The authors concluded 
that short-term moderate exercise and exposure to chlorinated disinfection by-
products will not affect markers of lung epithelial damage and oxidative stress (80). 
11.2.2.2 Food industry workers 
King et al. investigated respiratory symptoms in 34 poultry processing workers (for 
details, see Section 11.1.3). The workers were evaluated with spirometry before and 
after shift, and 3/34 subjects had significant cross-shift declines in FEV1 (> 10%). 
The airborne trichloramine exposure (personal sampling) of these subjects were 
significantly higher (GM 0.022 mg/m3) compared to those without significant 
cross-shift declines in FEV1 (GM 0.0021 mg/m3). The GM concentration of soluble 
chlorine in air was also higher in those with significant cross-shift declines in FEV1, 
however, not significantly (0.071 mg/m3 vs 0.022 mg/m3). Concurrent exposure to 
trichloramine and soluble chlorine, the latter due to aerosolisation of the chlorinated 
water, makes it difficult to identify the responsible agent (76). 
11.2.2.3 Conclusion 
Short-term changes in pneumoproteins have been shown at mean airborne trichlor-
amine concentrations ≥ 0.29 mg/m3 (11, 21, 38) but not at lower exposure levels 
(20, 98). Marginal effects on lung function were demonstrated in one study with 
personal trichloramine exposure levels of 0.15 mg/m3 and 0.23 mg/m3 (98). In 
contrast, no effects on lung function were demonstrated in studies with exposure 
levels of 0.023 mg/m3 (137), 0.18 mg/m3 (personal exposure 0.071 mg/m3) (82), 
0.16–0.28 mg/m3 (20), 0.29 mg/m3 (38), and 0.36 and 0.49 mg/m3 (21). FENO has 
been measured in some studies as a possible marker of airway inflammation, with 
mostly negative results. However, Löfstedt et al. found an increase in FENO over 
work shift in pool workers exposed to 0.18 mg/m3 of trichloramine (82).  
11.2.3 Other effects 
Wones et al. investigated whether a 4-week consumption of 1.5 l/day of distilled 
water containing monochloramine under controlled conditions would alter para-
meters of lipid or thyroid metabolism in healthy men. The 48 subjects drank 
distilled water during a 4-week dietary stabilisation period. Following this period 
they were divided into three dose groups (16/group). One group drank 1.5 l of 
distilled water, the second group drank 1.5 l distilled water containing 2 mg/l of 
monochloramine (0.043 mg/kg bw/day assuming a body weight of 70 kg) and the 
third group drank 1.5 l distilled water with a concentration of 15 mg/l of mono-
chloramine (0.32 mg/kg bw/day) each day during 4 consecutive weeks. The study 
diet was designed individually to be isocaloric. Blood was collected at the 
beginning of the study, during 4 consecutive days at the end of the stabilisation 
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period and at the end of the monochloramine exposure. Total cholesterol, 
triglycerides, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein 
(LDL) cholesterol (calculated), apolipoproteins A1, A2 and B, thyroxine (T4), 
triiodothyronine (T3), T3 resin uptake and thyroid stimulating hormone (TSH) were 
analysed. The consumption of water containing 2 mg/l of monochloramine did not 
affect the parameters studied, whereas 15 mg/l was associated with an increase in 
the plasma level of apolipoprotein B (142). The authors did not discuss a possible 
toxic effect as a consequence of this finding. 
Monochloramine was given in drinking water to 10 healthy male volunteers 
every 3rd day at totally 6 occasions at concentrations increasing from 0.01 mg/l at 
day 1 to 2.4 mg/l at day 16. The 10 control subjects received untreated water. At 
each occasion the subjects drank two 500-ml portions, the second one administered 
4 hours after the first. Assuming a body weight of 70 kg, the highest dose 
corresponds to 0.034 mg/kg bw/day. In a second experiment, healthy male 
volunteers (10/group) were administered 0 or 5 mg/l monochloramine in a volume 
of 500 ml of water daily for 12 weeks (corresponding to 0.036 mg/kg bw/day). An 
extensive battery of measures including serum chemistry, blood count, urine 
analysis and physical examination were conducted before, during and following the 
experiments. The authors concluded that no definitive finding of detrimental 
physiological impact was identified in any of the experiments (81).  
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11.3 Effects of long-term exposure 
11.3.1 Asthma-related symptoms 
Asthma is characterised by reversible obstruction in the airways, airway hyper-
responsiveness and chronic airway inflammation. Common symptoms are shortness 
of breath, wheezing, chest tightness and coughing (46).  
Spirometry is a standard test for measuring pulmonary function, and to diagnose 
asthma. Bronchial challenge test is used to detect airway hyperreactivity. The subject 
inhales nebulised methacholine or histamine to provoke bronchoconstriction and 
the degree of narrowing is quantified by spirometry. Chronic airway inflammation 
is associated with higher levels of nitric oxide and measurements of FENO can help 
to identify different asthma phenotypes and improving management of asthma 
(107).  
Several studies have investigated chronic respiratory symptoms, indicating 
asthma, among workers with occupational exposure to inorganic chloramines in 
indoor swimming pool facilities, in cleaning and disinfection in the food industry 
and among swimmers, as described below and summarised in Table 9. In most 
studies questionnaires were used for assessment of chronic respiratory symptoms, 
and in several studies objective clinical tests were also used. Effects were pre-
dominantly evaluated against measurements of trichloramine levels. 
11.3.1.1 Swimming pool workers  
Chu et al. investigated the prevalence of asthma-related symptoms among 61 pool 
workers in 10 indoor swimming pools in Taiwan of which 6 had spa pools located 
in the same buildings. The reference group consisted of 43 management employees 
(for details, see Section 11.1.1). The overall average air concentration of trichlor-
amine was 0.035 (0.017–0.15) mg/m3 in the swimming pools and 0.059 ± 0.042 
(SD) mg/m3 in the spa pools. Corresponding soluble chlorine concentrations were 
0.072 (0.005–0.21) mg/m3 and 0.085 ± 0.056 mg/m3. Symptoms were considered 
work-related if present during or after a work shift. Exposed workers had 
significantly more phlegm (OR 4.2, 95% CI 1.2–15) than non-exposed subjects, but 
there were no significant differences for asthma-related symptoms (OR, 95% CI) 
such as shortness of breath (0.5, 0.1–2.5), cough (1.3, 0.5–3.5), chest tightness (2.3, 
0.7–7.6) and wheezing (0.3, 0.03–4) (25).  
Dang et al. investigated work-related respiratory symptoms among 143 exposed 
and unexposed pool workers at an indoor waterpark and performed measurements 
of airborne trichloramine during two high-occupancy days and one low-occupancy 
day (for details, see Section 11.1.1). Lifeguards (n = 69; 37 men) reported signi-
ficantly more work-related respiratory symptoms (PR, 95% CI) such as coughing 
(10.2, 4.3–24), wheezing (9.7, 2.4–40), shortness of breath (6.7, 2.5–18) and chest 
tightness (6.7, 2.1–21) (adjusted for smoking habits and asthma) compared to 
unexposed employees working outside the pool area (n = 74; 24 men). All 6 
lifeguards with existing asthma in the exposed group reported worsening of asthma 
symptoms at work, but none of the 7 employees with asthma in the unexposed group 
(27). 
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Fantuzzi et al. investigated the prevalence of asthma-related respiratory symptoms 
in 81 lifeguards and swimming instructors (for details, see Section 11.1.1).  
The average air concentration of trichloramine was 0.65 mg/m3. No significant 
association between reported asthma symptoms and airborne trichloramine levels 
was shown, but the number of subjects with asthma was low (36). 
In the study by Fornander et al., possible airway inflammation was evaluated in 
39 pool workers by measuring FENO (for details, see Section 11.1). The average 
level of trichloramine was 0.20 mg/m3. In most pool workers, FENO was within the 
normal range (mean value 15 ± 13 ppb). Prevalence of airway irritation was not 
associated with FENO or air trichloramine levels (42). 
Jacobs et al. investigated the prevalence of asthma-related symptoms, physician-
diagnosed asthma and use of asthma medication in 342 exposed pool workers  
(for details, see Section 11.1.1). Measurements of airborne trichloramine were 
performed in 6 different swimming facilities and the overall mean was 0.56 mg/m3. 
Pool workers reported significantly more asthma-related symptoms (OR, 95% CI) 
such as phlegm (1.8, 1.3–2.4) and chest tightness (1.4, > 1.0–1.8) during the last 12 
months, physician-diagnosed asthma (2.1, 1.5–3.0), asthma attacks (2.6, 1.5–4.6) 
and use of asthma medication (3.6, 2.4–5.3) compared to a randomly selected 
reference group from the general population (n = 2 711) (73). 
Massin et al. used spirometry and methacholine bronchial challenge test to assess 
pulmonary function and airway hyperresponsiveness in 334 lifeguards recruited 
from 46 public swimming pools and 17 adventure swimming pools in France (for 
details, see Section 11.1.1). The average concentrations of trichloramine were 0.24 
mg/m3 in the public swimming pools and 0.67 mg/m3 in the adventure swimming 
pools. In general, the prevalence of chronic respiratory symptoms was low, and no 
association was found with current or cumulative trichloramine exposure. Measured 
values of pulmonary function exceeded the predicted values for all variables in both 
men and women. The prevalence of positive methacholine bronchial challenge test 
was twice as common in women as in men. No association was found between 
trichloramine exposure and airway hyperresponsiveness (84). 
Thickett et al. reported 3 pool workers with suspected work-related asthma 
following exposure to trichloramine, 2 of which had previous asthma and allergy. 
The investigation included spirometry, peak expiratory flow (PEF) measurements 
and bronchial challenge tests to methacholine, as well as trichloramine measure-
ments. Two pool workers had PEF measurements showing significant work-related 
changes, as well as a positive specific challenge test (immediate asthmatic 
reactions) to trichloramine at 0.5 mg/m3. The third pool worker had a positive work-
place challenge test, i.e. spirometry (FEV1) was first performed at baseline, and then 
after three 10-min exposures at the poolside. Measurements of trichloramine in the 
indoor swimming pool showed air levels of 0.1–0.57 mg/m3. The authors concluded 
that trichloramine might be a cause of occupational asthma (129). 
In the study by Demange et al., 39 lifeguards were given a health questionnaire, 
and spirometry, measurement of FENO and a methacholine bronchial challenge  
test were performed (for details, see Section 11.1.1). Overall, pulmonary function 
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values exceeded the predicted ones for FEV1, both among men and women. The 
prevalence of positive methacholine bronchial challenge test among lifeguards was 
relatively high (38%), but there was no reference group for comparison. The median 
FENO was higher among those with positive methacholine bronchial challenge test 
(18.9 ppb) compared to the rest (12.5 ppb), but the values were within the upper 
reference range (30). Measurements of airborne trichloramine were not performed. 
Nordberg et al. investigated the prevalence of self-reported asthma in a cohort of 
1 102 pool workers by questionnaire (for details, see Section 11.1.1). Exposure was 
classified in 3 different categories based on the average time during a workday each 
participant spent in the pool area. Exposure category 0 was given to those who did 
not spend any time in the pool area, category 1 did occasionally spend some time 
and category 2 spent most of the workday in the pool area. “Self-reported asthma” 
was defined as having a positive answer to the following question: “Do you suffer 
from asthma or have you suffered from asthma?”. In a nested case-control study 
within the cohort, 44 cases of self-reported asthma that occurred after beginning as 
pool worker were compared with 128 age- and sex-matched controls without 
asthma. Subjects who spent most of the workday in the pool area (category 2) 
reported asthma more (non-significantly) often, after correction for heredity 
(OR 2.3, 95% CI 0.8–6.7). There was a tendency to a reduced risk of developing 
asthma in relation to the number of years of work in swimming pool environments 
among individuals who had worked more than 1 year, however not significant 
(P = 0.07), indicating a possible healthy worker effect (98). Measurements of 
airborne trichloramine were not performed. 
Rosenman et al. investigated the occurrence of swimming pool workers with 
confirmed work-related asthma using data from the state surveillance systems in 
California, Michigan and New Jersey. In total, 44 confirmed cases of work-related 
asthma were identified; 17 cases 1994–2011 in California, 15 cases 1991–2012 in 
Michigan and 12 cases 1990–2011 in New Jersey. A majority (52%) of the cases 
were new onset; 32% secondary to an acute exposure incident and 20% to repeated 
exposure. Maintenance workers (35%) and lifeguards (32%) were the most 
common occupations. The authors concluded that the pool environment either 
might be a trigger of pre-existing asthma or associated with new onset of work-
related asthma (112). Airborne concentrations of trichloramine were not reported. 
11.3.1.2 Food industry workers 
King et al. investigated asthma symptoms related to work in 109 poultry processing 
workers, of which 68 (39 men, 29 women) worked in the evisceration department 
and 41 (18 men, 23 women) in the dark meat department (for details, see Section 
11.1.3). Evisceration workers reported more work-related wheezing (OR 5.9, 95% 
CI 1.4–40) and coughing (OR 6.2, 95% CI 2.1–21) than dark meat workers, ORs 
adjusted for smoking status. The prevalence of work-related asthma symptoms was 
also higher among evisceration workers, but did not reach statistical significance. 
A second survey was performed a year later comprising 34 workers (18 evisceration 
workers and 16 dark meat workers). Personal airborne levels of trichloramine were 
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significantly higher in the evisceration area (GM 0.0051 mg/m3) than in the dark 
meat area (GM 0.0012 mg/m3). However, workers (both groups) reporting current 
asthma symptoms (wheezing or two of the following symptoms: chest tightness, 
shortness of breath and cough) did not have significantly higher exposure levels of 
trichloramine than those without symptoms. Instead, workers reporting current 
asthma symptoms had higher exposure to soluble chlorine than those without such 
symptoms (GMs 0.048 mg/m3 vs 0.019 mg/m3), but the relationship was no longer 
significant after adjustment for smoking (76). 
Massin and coworkers administered a symptom questionnaire to 175 cleaning 
and disinfecting workers in the food industry (149 men, 26 women) and 70 non-
exposed workers (52 men, 18 women) (for details, see Section 11.1.3). Lung 
function and bronchial responsiveness were evaluated by spirometry and an 
abbreviated version of the methacholine bronchial challenge test. The sum of 
airborne soluble chlorine and trichloramine was measured by personal samplers for 
each step in the production process. Glutaraldehyde and formaldehyde was also 
used as disinfection agents, but air levels were not reported. A total exposure index 
for all irritants was calculated for each exposed worker. Three subgroups were 
constituted; a non-exposed group and two groups with lower and higher exposure. 
The workers were also divided in three subgroups with respect to cumulative 
exposure, taking number of working years into account. Overall, the prevalence of 
chronic respiratory symptoms was rather low and no relation to exposure levels or 
exposure duration was found. Baseline levels of pulmonary function were normal 
and not related to exposure. No associations between bronchial responsiveness and 
exposure levels or exposure duration were found (85). 
11.3.1.3 Competitive swimmers 
Exercise may increase ventilation up to 200 l/min in endurance athletes such as 
swimmers, and exercise alone increases bronchial responsiveness to methacholine 
in patients with asthma. Competitive swimmers, with up to 30 hours per week of 
training, inhale large amounts of air that floats above the water surface. In addition, 
they may microaspirate water in the airways. A high prevalence of asthma and use 
of asthma medication has been reported among competitive athletes participating 
in the Summer Olympic Games and particularly among endurance athletes, such as 
cycling, rowing and swimming (54).  
Goodman and Hays found a higher prevalence of asthma among competitive 
swimmers compared to other competitive athletes (OR 2.6, 95% CI 1.9–3.5) in a 
meta-analysis including 6 studies (48). Mountjoy et al. reported a significantly 
higher prevalence of airway hyperresponsiveness/asthma in competitive swimmers 
compared to other aquatic disciplines (90).  
Other studies have shown higher prevalences of asthma symptoms in competitive 
swimmers than in the general population (106, 111). However, the direction of the 
association is not clear and both exposure to chemicals and preference to swimming 
among asthmatics may be responsible for the association. 
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Helenius et al. investigated respiratory symptoms, bronchial responsiveness 
and signs of airway inflammation in 29 professional swimmers (12 men and 17 
women, mean age 19 years) from the Finnish national team and 19 healthy control 
subjects (14 men and 5 women, mean age 24.4 years). Respiratory symptoms were 
evaluated via questionnaire, lung function was assessed using spirometry, and 
bronchial responsiveness by a histamine challenge test. Induced sputum samples 
were also collected and a skin prick test was performed. Of the swimmers, 8 (28%), 
including 4 of 6 with asthma previously diagnosed by a physician, had a history of 
exercise-induced bronchial symptoms. Spirometry values were within normal limits 
for all the swimmers. Fourteen (48%) of the swimmers and three (16%) of the 
controls showed increased bronchial responsiveness. Fifteen (52%) of the 
swimmers and seven (39%) of the control subjects had positive skin prick tests. 
Sputum from swimmers had significantly higher differential cell counts of 
eosinophils (mean 2.7% vs 0.2%) and neutrophils (54.7% vs 29.9%) than sputum 
from control subjects (P < 0.01). Eosinophilia (sputum differential eosinophil count 
> 4%) was observed in 6 (21%) of the swimmers and in none of the controls
(P < 0.05). The 8 swimmers with a history of exercise induced bronchial symptoms
had significantly higher sputum eosinophil differential cell counts than symptom-
free swimmers (P < 0.01). No association was found between the sputum eosinophil
counts and increased bronchial responsiveness. Atopic and non-atopic swimmers
had similar amounts of sputum eosinophils and neutrophils. The authors concluded
that long-term and repeated exposure to chlorine compounds in swimming pools
during training and competition may contribute to the increased occurrence of
bronchial hyperresponsiveness and airway inflammation in swimmers (56).
Exposure data were not reported.
In another study, Helenius et al. followed 42 professional swimmers, most of 
them from the Finnish national team, for 5 years. All swimmers were evaluated with 
spirometry, histamine challenge test, skin prick test and questionnaire at baseline 
and at follow-up. Sputum samples were collected from 29 swimmers at both 
occasions. Sixteen (38%) swimmers were still active competitive swimmers at 
follow-up while 26 (62%) had stopped competing. Bronchial responsiveness was 
increased in 7 (44%) of the 16 active swimmers at baseline and in 8 (50%) of the 
active swimmers at follow-up, but only in 8/26 (31%) of the past swimmers at 
baseline and 3/26 (12%) at follow-up. The difference in change in bronchial 
hyperresponsiveness between groups was significant (P = 0.023). There was also a 
significant difference in the change in current asthma between the groups; it 
occurred in 31% of active swimmers at baseline and in 44% at follow-up, the 
corresponding numbers in past swimmers was 31% at baseline and 12% at follow-
up (P = 0.004). Mild eosinophilic airway inflammation was aggravated over time in 
active swimmers as reflected in the sputum eosinophil counts. The authors 
concluded that the athletes’ asthma is partly reversible and may develop during and 
decline after an active sports career (55). Exposure data were not reported. 
Lévesque et al. compared the prevalence of respiratory symptoms in 305 
competitive swimmers with that of 499 indoor soccer players in the Québec City 
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region of Canada via questionnaire, and evaluated the relationship between 
trichloramine concentrations and the athletes’ respiratory symptoms (for details, see 
Section 11.1.2). There were no differences between the groups regarding wheezing 
or previous or current asthma diagnosis. The competitive swimmers reported 
significantly more symptoms (OR, 95% CI) from the lower airways (1.5, 1.0–2.2), 
such as cough (1.2, 1.1–2.7) (ORs adjusted for gender, age and number of training 
sessions per week). In a second part of the study, respiratory symptoms were 
assessed during five training sessions in 72 competitive swimmers and 73 soccer 
players. The mean concentration of trichloramine in air was 0.34 mg/m3. The 
swimmers experienced significantly more symptoms from lower airways (adjusted 
OR 3.5, 95% CI 2.0–6.0). The swimmers were divided in two groups based on the 
median exposure level (0.37 mg/m3). Swimmers with high exposure did not have 
more symptoms from lower airways than those with lower exposure (78). 
Pedersen et al. investigated airway responsiveness and airway inflammation 
among 33 adolescent competitive swimmers (15 girls, 18 boys; mean age 14 years) 
and in two control groups consisting of 35 unselected adolescents (19 girls, 16 boys; 
mean age 14 years) and 32 asthmatics (13 girls, 19 boys; mean age 14 years). The 
swimmers and controls were evaluated via questionnaire, spirometry, methacholine 
challenge test, FENO and induced sputum. No differences in FENO, cellular sputum 
composition or prevalence of airway hyperresponsiveness were found between the 
groups, and the swimmers did not differ in the prevalence of respiratory symptoms 
from the unselected adolescents. The authors concluded that adolescent competitive 
swimmers that had been involved in competitive swimming for only a few years 
had no significant signs of airway damage (102).  
Seys et al. evaluated members of a swimming club who had complained of 
respiratory symptoms associated with attending a municipal indoor swimming pool 
in Belgium (for details, see Section 11.1.2). Competitive swimmers and coaches 
were invited to a medical evaluation, and of them, 22 adolescent swimmers and 6 
adult coaches were investigated by clinical interview and spirometry, measurement 
of FENO and a methacholine bronchial challenge test. Repeated measurements of 
airborne trichloramine by stationary sampling showed levels of 0.20–1.30 mg/m3. 
Common reported symptoms from lower airways were cough (57%) and dyspnoea 
(46%). Mean FEV1 % predicted was 109.1%. Mean FENO level was 19.7 ppb; the 
cut-off value of 25 ppb was exceeded in 3 subjects. Airway hyperreactivity was 
detected in 22/28 swimmers (85%). After removal of a glue containing polyamines, 
used to repair a pipework, the concentration of trichloramine in air decreased to 
below 0.5 mg/m3. At follow-up 1 year later including 13/28 subjects from the first 
evaluation, the hyperreactivity was less pronounced in 6/12 subjects, more 
pronounced in 5/12 subjects and was unchanged in 1 subject. However, the air 
levels of trichloramine had presently risen due to reduced intake of outside air 
because of low outside temperature (118). 
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11.3.1.4 Children/adolescents 
In general, children’s exposure to indoor swimming pool air during leisure time and 
school time is limited compared to that of pool workers and competitive swimmers. 
Studies conducted in Belgium have demonstrated an increased risk of asthma 
symptoms among children with atopy associated with cumulative indoor swimming 
pool attendance (9, 11, 15). 
Bernard et al. investigated prevalence of asthma in relation to pool attendance 
among 1 881 children aged 7–14 years in Belgium by retrospectively analysing data 
from an earlier asthma survey conducted 1996–1999. Data on health status, 
respiratory symptoms and environmental and lifestyle variables were obtained  
via questionnaire, completed by their parents. Asthma was defined as a positive 
exercise induced bronchoconstriction (EIB) test, i.e. a reduction in PEF of ≥ 10% 
at 5 or 10 min after exercise. In addition, children with medication for asthma were 
included (total asthma). School directors gave information on pool attendance. 
Cumulative pool attendance was estimated by multiplying the time spent in pool 
water by the weekly frequency of attendance, and the number of years attending the 
school pool. The prevalence of respiratory symptoms, i.e. wheezing, was not 
associated with positive EIB test or total asthma. Positive EIB test and total asthma 
prevalence were significantly associated with cumulative attendance. The 
associations remained significant after adjustment for the height of the pool hall, 
pets and passive smoking, and were strongest among the youngest children 
(P < 0.001) (11). Measurements of airborne trichloramine were not performed. 
The authors also studied effects on the lung epithelium in relation to pool 
attendance. Lung-specific proteins (SP-A, SP-B and CC16) and immunoglobulin E 
(IgE) were measured in serum of 226 children (116 boys and 110 girls), mean age 
10 years. Children with asthma were not included. The school directors provided 
information on pool attendance; measurements of airborne trichloramine were  
not performed. A significant dose-effect association between cumulative pool 
attendance and proteins SP-A and SP-B was demonstrated (11). 
Bernard et al. also investigated respiratory symptoms among 341 children aged 
10–13 years who all visited the same indoor swimming pool facility in Belgium. 
The concentrations of trichloramine in air were 0.25–0.54 mg/m3. The parents 
completed a questionnaire concerning their children’s health status, respiratory 
symptoms and current and previous swimming pool attendance. Total and allergen-
specific IgE were measured in serum, and an EIB test was performed. The test was 
defined as positive if a reduction of 20% or more in FEV1 was seen after exercise. 
All children performed a FENO test and it was considered elevated if nitric oxide 
was > 30 ppb. Asthma was defined as having a positive EIB test or a physician-
diagnosed asthma (total asthma). Cumulative pool attendance was associated with 
elevated FENO (OR 1.3, 95% CI 1.1–1.4) and total asthma but only in children with 
IgE > 100 kIU/l (OR 1.8, 95% CI 1.1–2.7). There was a dose-response effect and 
the strongest effect was found with pool attendance before the age of 6–7 years (9). 
In a later study, Bernard et al. examined 847 school children, aged 13–18 years 
who had attended outdoor or indoor chlorinated pools, 114 of them had mainly 
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attended a copper-silver pool (referents). Data on pool attendance and the child’s 
health status were collected via parental questionnaire. The students were inter-
viewed about respiratory symptoms, and total and allergen-specific IgE were 
measured in serum, and an EIB test was performed. The test was defined as positive 
if a reduction of ≥ 10% in FEV1 after exercise was found. Ever asthma was defined 
as asthma diagnosed at any time by a physician, and current asthma was defined as 
physician-diagnosed asthma presently treated with medication and/or a positive 
EIB test. The concentration of trichloramine in air was in the range 0.3–0.5 mg/m3 
in the indoor swimming pools the children attended. In those with a cumulative pool 
attendance > 1 000 hours, ORs (95% CIs) for ever and current asthma was 3.7 (1.4–
9.9) and 8.1 (1.7–37), respectively, compared to referents. Atopic children (i.e. 
those with total IgE > 30 kIU/l) had a significantly higher risk for asthma symptoms 
and for ever or current asthma related to total numbers of hours spent in chlorinated 
pools; among those with cumulative pool attendance > 1 000 hours, the ORs (95% 
CI) for ever and current asthma were 7.8 (2.1–29) and 15 (1.8–120), respectively, 
compared to atopics with cumulative pool attendance < 100 hours (15). 
The information on the exposure assessments of trichloramine in these three 
Belgian studies (9, 11, 15) is very sparse regarding sampling time, where measure-
ments were performed and number of samples. This makes it difficult to relate the 
exposure of trichloramine to the effects reported. 
Studies in other European countries such as Spain (39, 40), the United Kingdom 
(41) and the Netherlands (72) found no association between cumulative swimming 
pool attendance and respiratory symptoms among children. These studies were 
population-based and had larger sample sizes. 
In the Spanish study, Font-Ribera et al. investigated the prevalence of asthma in 
children related to early pool attendance. A questionnaire was sent to the parents of 
3 223 children aged 9–12 years. Data was collected concerning the children’s pool 
attendance and respiratory symptoms the last 12 months. The children attended 
different swimming pools; most of them were chlorinated (median air trichloramine 
concentration 0.16 mg/m3). Swimming pool attendance during the last 12 months 
was associated with a slightly lower prevalence (OR, 95% CI) of current asthma 
(0.5, 0.2–0.8) compared to those children who never attended pools. A similar (non-
significant) finding was shown for ever asthma (0.7, 0.4–1.1) (39). 
A prospective longitudinal study was performed in a population-based British 
cohort comprising 5 738 children (50.7% boys) followed by questionnaires up to 
10 years of age. Data on swimming were collected at 0.5–6.7 years of age, and data 
on respiratory symptoms, allergies, asthma and asthma medication at 7 and 10 
years. Spirometry and a skin prick test were performed at 7–8 years. No increased 
risk of asthma or any respiratory symptoms associated to swimming pool 
attendance was found either in all or in atopic children. Children with high 
cumulative swimming pool attendance from birth to 7 years had an OR (95% CI) 
of 0.9 (0.6–1.4) and 0.5 (0.3–0.9), for ever and current asthma, respectively, at 7 
years, and a 0.2 (95% CI 0.02–0.4) standard deviation increase in midexpiratory 
flow, compared to those with low cumulative exposure. Children with asthma and 
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high cumulative swimming pool attendance had lower prevalence of current asthma 
at 10 years (OR 0.3, 95% CI 0.14–0.8) than those with low cumulative swimming 
pool attendance. The authors concluded that swimming was associated with 
increased lung function and a lower prevalence of asthma symptoms, especially 
among children with pre-existing respiratory conditions (41). Air levels of 
trichloramine were not reported. 
Font-Ribera et al. performed a cross-sectional survey among 2 758 children aged 
6–12 years in Spain. Data on previous and current swimming pool attendance, 
health status and respiratory symptoms the last 12 months was collected via parental 
questionnaire. Current regular swimming in indoor pools was not associated with 
symptoms in the last 12 months. Regular indoor pool attendance before 2 years of 
age was not associated with ever had or having asthma or wheezing (40). Air levels 
of trichloramine were not reported. 
The study by Jacobs et al. included 2 359 Dutch children aged 6–13 years, of 
which 419 children were tested for allergen sensitisation and CC16 levels in serum. 
The parents were given a questionnaire concerning swimming pool attendance, 
upper and lower respiratory symptoms, allergy and eczema. Measurements of 
airborne trichloramine were performed by stationary sampling in 9 swimming pool 
facilities visited on a regular basis by 77% of the study population. The average 
concentration of airborne trichloramine was 0.21 mg/m3. CC16 levels were 
associated with sensitisation to house dust mites and common allergens but not with 
respiratory symptoms. Reported swimming pool attendance and trichloramine 
exposure were not associated with asthma, wheezing or CC16 levels (72). 
Bernard et al. measured CC16, SP-D, total and allergen-specific IgE in 835 
school children (470 girls, 365 boys; mean age 15.4 years). Data on pool attendance, 
general and respiratory health were collected via parental questionnaire. The 
CC16/SP-D ratio was calculated and was believed to integrate changes in 
permeability (SP-D) and secretory function (CC16) of the airway epithelium. 
Children with the highest pool attendance (total or before the age of 7 years) had 
significantly lower serum levels of CC16 and CC16/SP-D ratios than other children. 
CC16 levels were not associated with any sensitisation (pollen, house mite or pets) 
or prevalence of asthma, hay fever and rhinitis. Among boys, a low CC16/SP-D 
ratio was associated with a higher prevalence of house dust mite sensitisation, of 
allergic rhinitis in those sensitised to house dust mite and of asthma in those 
sensitised to any aeroallergen (OR 3.4, 95% CI 1.2–11), house dust mite (OR 5.2, 
95% CI 1.4–24) or pollen (OR 5.8, 95% CI 1.5–27). Among girls, a low CC16/SP-
D ratio was associated with pet sensitisation and with hay fever in those sensitised 
to pollen, but not with asthma (14). Air levels of trichloramine were not reported. 
In a recent study, Andersson et al. investigated the prevalence of physician-
diagnosed asthma and respiratory symptoms among 1 866 Swedish school children 
aged 11–12 years (boys 51%) by questionnaire. Of them, 1 652 also participated  
in skin prick testing. Current swimming pool attendance was reported as ≥ 1/week 
or < 1/week in the last 12 months. The prevalence of current asthma was 8.9%  
(boys 10%, girls 7.9%). Stratified analyses for allergic sensitisation adjusted for 
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gender, parental smoking, parental asthma and damp housing showed statistically 
significant associations (OR, 95% CI) between physician-diagnosed asthma (1.9, 
1.1–3.3) and current asthma (1.9, 1.1–3.3) and pool attendance among atopic 
children (5). Air levels of trichloramine were not reported. 
11.3.1.5 Conclusion 
Exposure to trichloramine in the workplace air may aggravate asthma symptoms  
in individuals with existing asthma (27, 129). Some studies have shown higher 
prevalences of self-reported asthma-related symptoms (27, 73), physician-
diagnosed asthma, asthma attacks and use of asthma medication (73) in exposed 
workers compared to an unexposed reference group. The overall mean concentration 
of airborne trichloramine in the study by Jacobs et al. was 0.56 (0.13–1.34) mg/m3 
(73). No significant associations between self-reported asthma-related symptoms 
and trichloramine exposure were found in other studies (42, 76, 85), even at higher 
mean exposure levels (36).  
Young competitive swimmers reported significantly more symptoms from lower 
airways in general and during training sessions (trichloramine air levels: 0.26–0.41 
mg/m3) than referents, but there was no association between trichloramine levels 
and symptoms (78). 
A high prevalence of airway hyperreactivity has been found in pool workers (30) 
as well as in competitive swimmers (56, 118). There are, however, indications that 
the increased hyperreactivity is partially reversible when exposure cease or decrease 
(55, 118). There were no associations between exposure to trichloramine and 
objective clinical tests of airway hyperreactivity (84) and airway inflammation (42). 
A high prevalence of work-related asthma among lifeguards (112) as well as in 
competitive swimmers (48, 90) has been reported, and two studies indicated that 
occupational exposure to trichloramine may contribute to development of asthma 
in individuals without previous respiratory diseases (98, 129). Some cross-sectional 
studies indicate an association between cumulative attendance in chlorinated pools 
and an increased risk of asthma among atopic school children (5, 9, 11, 15). These 
findings are, however, contradicted by results from other large population-based 
studies in children (39-41, 72).  
11.3.2 Other effects 
In a study by Zierler et al., the cancer mortality in 43 communities in Massachusetts 
using either chlorine or monochloramine for disinfection of drinking water was 
investigated. Residents exposed to chloraminated water were used as controls 
assuming less exposure to chlorination-by-products (trihalomethanes). In general, 
cancer mortality was not associated with type of disinfectant used, except a slight 
association for chlorine use and bladder cancer. A small increase in mortality from 
influenza and pneumonia was noted in chloraminated communities (144). In a later 
case-control study, the relationship between residence in communities using 
chlorine for disinfection and mortality in bladder cancer remained (145). Again, 
exposure to chloraminated drinking water was used as control, and the results from 
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these studies can not be used to evaluate adverse health effects from exposure to 
inorganic chloramines. 
11.4 Genotoxic effects 
No data were located. 
11.5 Carcinogenic effects 
No data were located. 
11.6 Reproductive and developmental effects 
No data were located. 
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ke
rs
 
(g
en
de
r 
no
t g
iv
en
) 
N
o 
re
fe
re
nt
s 
0.
20
 A
M
 
0.
04
–0
.3
6 
Q
ue
st
io
nn
ai
re
; 
FE
N
O
 
FE
N
O
 w
as
 w
ith
in
 th
e 
no
rm
al
 r
an
ge
 (
m
ea
n 
15
 ±
 1
3 
pp
b)
  
in
 p
oo
l w
or
ke
rs
. P
re
va
le
nc
e 
of
 a
ir
w
ay
 ir
ri
ta
tio
n 
w
as
 n
ot
 
as
so
ci
at
ed
 w
ith
 F
E
N
O
 o
r 
ex
po
su
re
 le
ve
ls
. 
(4
2)
 
C
ro
ss
-s
ec
tio
na
l, 
Fr
an
ce
 
33
4 
lif
eg
ua
rd
s 
(2
56
 m
en
, 7
8 
w
om
en
) 
N
o 
re
fe
re
nt
s 
Sw
im
m
in
g 
po
ol
s:
 
0.
24
 A
M
 
L
ei
su
re
 s
w
im
m
in
g 
po
ol
s:
 
0.
67
 A
M
  
Q
ue
st
io
nn
ai
re
; 
Sp
ir
om
et
ry
; 
M
et
ha
ch
ol
in
e 
br
on
ch
ia
l 
ch
al
le
ng
e 
te
st
 
N
o 
as
so
ci
at
io
ns
 b
et
w
ee
n 
ex
po
su
re
 le
ve
ls
 a
nd
 a
ir
w
ay
 
hy
pe
rr
es
po
ns
iv
en
es
s.
 
(8
4)
 
C
ro
ss
-s
ec
tio
na
l, 
U
ni
te
d 
St
at
es
 
69
 li
fe
gu
ar
ds
 
(3
7 
m
en
, 3
2 
w
om
en
) 
74
 h
ot
el
 e
m
pl
oy
ee
s 
(2
4 
m
en
, 5
0 
w
om
en
) 
0.
44
 A
M
  
(h
ig
h-
oc
cu
pa
nc
y 
da
y)
 
Q
ue
st
io
nn
ai
re
 
L
if
eg
ua
rd
s 
re
po
rt
ed
 m
or
e 
w
or
k-
re
la
te
d 
re
sp
ir
at
or
y 
sy
m
pt
om
s 
(P
R
, 9
5%
 C
I)
 s
uc
h 
as
 c
ou
gh
in
g 
(1
0,
 4
.3
–2
4)
, 
w
he
ez
in
g 
(9
.7
, 2
.4
–4
0)
, s
ho
rt
ne
ss
 o
f 
br
ea
th
 (
6.
7,
 2
.5
–1
8)
 
an
d 
ch
es
t t
ig
ht
ne
ss
 (
6.
7,
 2
.1
–2
1)
 (
ad
ju
st
ed
 f
or
 s
m
ok
in
g 
ha
bi
ts
 a
nd
 a
st
hm
a)
 c
om
pa
re
d 
to
 u
ne
xp
os
ed
 e
m
pl
oy
ee
s.
  
A
ll 
6 
lif
eg
ua
rd
s 
w
ith
 a
st
hm
a 
re
po
rt
ed
 w
or
se
ni
ng
 o
f 
as
th
m
a 
sy
m
pt
om
s 
at
 w
or
k,
 b
ut
 n
on
e 
of
 th
e 
7 
co
nt
ro
ls
 w
ith
 a
st
hm
a.
  
(2
7)
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am
pl
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ot
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ta
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ot
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e)
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St
ud
y 
de
si
gn
/ 
co
un
tr
y 
St
ud
y 
gr
ou
p 
E
xp
os
ur
e 
le
ve
l, 
m
g/
m
3  
M
et
ho
d 
E
ff
ec
ts
 
R
ef
er
en
ce
 
C
as
e 
re
po
rt
, 
U
ni
te
d 
K
in
gd
om
 
2 
lif
eg
ua
rd
s 
(1
 m
an
, 1
 w
om
an
) 
an
d 
 
1 
sw
im
m
in
g 
in
st
ru
ct
or
 
(w
om
an
) 
N
o 
re
fe
re
nt
s 
0.
1–
0.
57
  
Sp
ir
om
et
ry
 (
PE
F)
; 
Pr
ov
oc
at
io
n 
te
st
s 
2 
po
ol
 w
or
ke
rs
 h
ad
 P
E
F 
m
ea
su
re
m
en
ts
 s
ho
w
in
g 
si
gn
if
ic
an
t 
w
or
k-
re
la
te
d 
ch
an
ge
s 
as
 w
el
l a
s 
a 
po
si
tiv
e 
sp
ec
if
ic
 
ch
al
le
ng
e 
te
st
 to
 tr
ic
hl
or
am
in
e 
at
 0
.5
 m
g/
m
3 .
 T
he
 3
rd
 p
oo
l 
w
or
ke
r 
ha
d 
a 
po
si
tiv
e 
w
or
kp
la
ce
 c
ha
lle
ng
e 
te
st
. 
(1
29
) 
C
ro
ss
-s
ec
tio
na
l, 
N
et
he
rl
an
ds
 
34
2 
ex
po
se
d 
po
ol
 w
or
ke
rs
 
(1
27
 m
en
, 2
15
 w
om
en
) 
2 
71
1 
su
bj
ec
ts
 r
an
do
m
ly
 
se
le
ct
ed
 f
ro
m
 th
e 
ge
ne
ra
l 
D
ut
ch
 p
op
ul
at
io
n 
0.
56
 A
M
 
0.
66
 A
M
 (
es
tim
at
ed
  
lo
ng
-t
er
m
 e
xp
os
ur
e)
  
Q
ue
st
io
nn
ai
re
 
Po
ol
 w
or
ke
rs
 r
ep
or
te
d 
m
or
e 
as
th
m
a-
re
la
te
d 
sy
m
pt
om
s 
(O
R
, 9
5%
 C
I)
 s
uc
h 
as
 p
hl
eg
m
 (
1.
8,
 1
.3
–2
.4
) 
an
d 
ch
es
t 
tig
ht
ne
ss
 (
1.
4,
 >
 1
.0
–1
.8
) 
du
ri
ng
 th
e 
la
st
 1
2 
m
o,
 p
hy
si
ci
an
-
di
ag
no
se
d 
as
th
m
a 
(2
.1
, 1
.5
–3
.0
),
 a
st
hm
a 
at
ta
ck
s 
(2
.6
,  
1.
5–
4.
6)
 a
nd
 u
se
 o
f 
as
th
m
a 
m
ed
ic
at
io
n 
(3
.6
, 2
.4
–5
.3
) 
th
an
 
re
fe
re
nt
s.
 
(7
3)
 
C
ro
ss
-s
ec
tio
na
l, 
It
al
y 
81
 li
fe
gu
ar
ds
 a
nd
 
sw
im
m
in
g 
in
st
ru
ct
or
s 
(4
0 
m
en
, 4
1 
w
om
en
) 
47
 o
th
er
 e
m
pl
oy
ee
s 
(2
1 
m
en
, 2
6 
w
om
en
) 
0.
65
 A
M
 
Q
ue
st
io
nn
ai
re
 
N
o 
si
gn
if
ic
an
t a
ss
oc
ia
tio
n 
be
tw
ee
n 
re
po
rt
ed
 a
st
hm
a 
sy
m
pt
om
s 
an
d 
ai
rb
or
ne
 tr
ic
hl
or
am
in
e 
le
ve
ls
. T
he
 n
um
be
r 
of
 s
ub
je
ct
s 
w
ith
 a
st
hm
a 
w
as
 lo
w
. 
(3
6)
 
C
ro
ss
-s
ec
tio
na
l, 
Fr
an
ce
 
39
 li
fe
gu
ar
ds
  
(2
9 
m
en
, 1
0 
w
om
en
) 
N
o 
re
fe
re
nt
s 
– 
Q
ue
st
io
nn
ai
re
; 
Sp
ir
om
et
ry
; 
M
et
ha
ch
ol
in
e 
br
on
ch
ia
l 
ch
al
le
ng
e 
te
st
; 
FE
N
O
 
Pu
lm
on
ar
y 
fu
nc
tio
n 
va
lu
es
 e
xc
ee
de
d 
th
e 
pr
ed
ic
te
d 
on
es
  
fo
r 
FE
V
1.
 T
he
 p
re
va
le
nc
e 
of
 p
os
iti
ve
 c
ha
lle
ng
e 
te
st
 a
m
on
g 
lif
eg
ua
rd
s 
w
as
 r
el
at
iv
el
y 
hi
gh
 (
38
.5
%
).
  
T
he
 m
ed
ia
n 
FE
N
O
 w
as
 h
ig
he
r 
am
on
g 
th
os
e 
w
ith
 p
os
iti
ve
 
ch
al
le
ng
e 
te
st
 (
18
.9
 p
pb
) 
co
m
pa
re
d 
to
 th
e 
ot
he
rs
 (
12
.5
 
pp
b)
; v
al
ue
s 
w
er
e 
w
ith
in
 th
e 
up
pe
r 
re
fe
re
nc
e 
ra
ng
e.
  
(3
0)
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 s
ta
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is
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St
ud
y 
de
si
gn
/ 
co
un
tr
y 
St
ud
y 
gr
ou
p 
E
xp
os
ur
e 
le
ve
l, 
m
g/
m
3  
M
et
ho
d 
E
ff
ec
ts
 
R
ef
er
en
ce
 
N
es
te
d 
ca
se
-
co
nt
ro
l, 
Sw
ed
en
  
   C
ro
ss
-s
ec
tio
na
l, 
Sw
ed
en
 
44
 c
as
es
 o
f 
se
lf
-r
ep
or
te
d 
as
th
m
a 
th
at
 o
cc
ur
re
d 
af
te
r 
th
ey
 b
eg
an
 w
or
ki
ng
 a
s 
a 
po
ol
 w
or
ke
r  
12
8 
ag
e-
 a
nd
 s
ex
-m
at
ch
ed
 
co
nt
ro
ls
 w
ith
ou
t a
st
hm
a 
1  
10
2 
po
ol
 w
or
ke
rs
  
(5
13
 m
en
, 5
89
 w
om
en
) 
 
– 
Q
ue
st
io
nn
ai
re
 
In
cr
ea
se
d 
pr
ev
al
en
ce
 o
f 
as
th
m
a 
(O
R
 2
.3
, 9
5%
 C
I 
0.
8–
6.
7)
 
(a
ft
er
 c
or
re
ct
io
n 
fo
r 
he
re
di
ty
) 
am
on
g 
po
ol
 w
or
ke
rs
 in
 th
e 
hi
gh
es
t e
xp
os
ur
e 
ca
te
go
ry
 (
2)
 c
om
pa
re
d 
to
 c
at
eg
or
ie
s 
0 
an
d 
1  
(n
o 
an
d 
lo
w
 e
xp
os
ur
e)
 (
no
n-
si
gn
if
ic
an
t)
. 
A
ss
oc
ia
tio
n 
be
tw
ee
n 
nu
m
be
rs
 o
f 
ho
ur
s,
 d
ur
in
g 
an
 a
ve
ra
ge
 
da
y,
 s
pe
nt
 in
 th
e 
sw
im
m
in
g 
po
ol
 e
nv
ir
on
m
en
t a
nd
 th
e 
pe
rc
en
ta
ge
 o
f 
w
or
ke
rs
 r
ep
or
tin
g 
w
or
k -
re
la
te
d 
sy
m
pt
om
s 
su
ch
 a
s 
dy
sp
no
ea
 a
nd
 c
ou
gh
in
g 
( P
 <
 0
.0
1)
. 
(9
8)
 
Fo
od
 in
du
st
ry
 w
or
ke
rs
 
C
ro
ss
-s
ec
tio
na
l, 
 
U
ni
te
d 
St
at
es
 
Po
ul
tr
y 
pr
oc
es
si
ng
 
w
or
ke
rs
 
1s
t  s
ur
ve
y:
  
68
 e
vi
sc
er
at
io
n 
w
or
ke
rs
  
(1
8 
m
en
, 2
9 
w
om
en
) 
R
ef
er
en
ts
: 
41
 d
ar
k 
m
ea
t w
or
ke
rs
 
(1
8 
m
en
, 2
3 
w
om
en
)  
2n
d  s
ur
ve
y:
  
18
 e
vi
sc
er
at
io
n 
w
or
ke
rs
 
16
 d
ar
k 
m
ea
t w
or
ke
rs
 
1s
t  s
ur
ve
y:
  
N
o 
da
ta
 
    2n
d  s
ur
ve
y:
 
Pe
rs
on
al
 s
am
pl
in
g 
G
M
: 
0.
00
5 
ev
is
ce
ra
tio
n 
0.
00
12
 d
ar
k 
m
ea
t 
So
lu
bl
e 
ch
lo
ri
ne
 G
M
: 
0.
06
3 
ev
is
ce
ra
tio
n 
0.
00
9 
da
rk
 m
ea
t 
Q
ue
st
io
nn
ai
re
; 
S p
ir
om
et
ry
 
1s
t  s
ur
ve
y:
 E
vi
sc
er
at
io
n 
w
or
ke
rs
 r
ep
or
te
d 
m
or
e 
(O
R
, 9
5%
 
C
I )
 w
or
k-
re
la
te
d 
w
he
ez
in
g 
(5
.9
, 1
.4
–4
0)
 a
nd
 c
ou
gh
in
g 
(6
.2
, 2
.1
–2
1)
 th
an
 d
ar
k 
m
ea
t w
or
ke
rs
, O
R
s 
ad
ju
st
ed
 f
or
 
sm
ok
in
g 
st
at
us
. T
he
 p
re
va
le
nc
e 
of
 w
or
k-
re
la
te
d 
as
th
m
a 
sy
m
pt
om
s 
w
as
 a
ls
o 
hi
gh
er
 in
 e
vi
sc
er
at
io
n 
w
or
ke
rs
 (
no
n-
si
gn
if
ic
an
t)
. 
2n
d  s
ur
ve
y:
 W
or
ke
rs
 (
bo
th
 g
ro
up
s)
 r
ep
or
tin
g 
cu
rr
en
t 
as
th
m
a 
sy
m
pt
om
s 
di
d 
no
t h
av
e 
hi
gh
er
 e
xp
os
ur
e 
to
 
tr
ic
hl
or
am
in
e 
th
an
 th
os
e 
w
ith
ou
t s
ym
pt
om
s.
 N
o 
as
so
ci
at
io
n 
be
tw
ee
n 
ex
po
su
re
 to
 tr
ic
hl
or
am
in
e 
an
d 
 
as
th
m
a 
sy
m
pt
om
s 
(a
dj
us
te
d 
fo
r 
sm
ok
in
g 
ha
bi
ts
) 
w
as
 
fo
un
d.
 I
ns
te
ad
, a
n 
as
so
ci
at
io
n 
be
tw
ee
n 
so
lu
bl
e 
ch
lo
ri
ne
 
an
d 
cu
rr
en
t a
st
hm
a 
sy
m
pt
om
s  
w
as
 r
ep
or
te
d.
 
(7
6)
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if
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ot
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he
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e)
.  
St
ud
y 
de
si
gn
/ 
co
un
tr
y 
St
ud
y 
gr
ou
p 
E
xp
os
ur
e 
le
ve
l, 
m
g/
m
3  
M
et
ho
d 
E
ff
ec
ts
 
R
ef
er
en
ce
 
C
ro
ss
-s
ec
tio
na
l, 
Fr
an
ce
 
17
5 
w
or
ke
rs
 in
 th
e 
fo
od
 
in
du
st
ry
  
(1
49
 m
en
, 2
6 
w
om
en
) 
70
 n
on
-e
xp
os
ed
 w
or
ke
rs
 
(5
2 
m
en
, 1
8 
w
om
en
) 
Pe
rs
on
al
 s
am
pl
in
g:
 
0.
33
–0
.4
9 
A
M
s 
 
(s
um
 o
f 
so
lu
bl
e 
ch
lo
ri
ne
 
an
d 
tr
ic
hl
or
am
in
e)
 a  
C
o-
ex
po
su
re
 to
 
gl
ut
ar
al
de
hy
de
 a
nd
 
fo
rm
al
de
hy
de
 
Q
ue
st
io
nn
ai
re
; 
Sp
ir
om
et
ry
; 
M
et
ha
ch
ol
in
e 
br
on
ch
ia
l 
ch
al
le
ng
e 
te
st
 
O
ve
ra
ll,
 th
e 
pr
ev
al
en
ce
 o
f 
ch
ro
ni
c 
re
sp
ir
at
or
y 
sy
m
pt
om
s 
w
as
 r
at
he
r 
lo
w
 a
nd
 n
o 
re
la
tio
n 
to
 e
xp
os
ur
e 
le
ve
ls
 o
r 
ex
po
su
re
 d
ur
at
io
n 
(y
ea
rs
) 
w
as
 f
ou
nd
. B
as
el
in
e 
le
ve
ls
 o
f 
pu
lm
on
ar
y 
fu
nc
tio
n 
w
er
e 
no
rm
al
 a
nd
 n
ot
 r
el
at
ed
 to
 to
ta
l 
ex
po
su
re
. N
o 
as
so
ci
at
io
n 
be
tw
ee
n 
br
on
ch
ia
l r
es
po
ns
iv
e-
ne
ss
 a
nd
 e
xp
os
ur
e 
ex
pr
es
se
d 
as
 to
ta
l e
xp
os
ur
e 
in
de
x 
an
d 
ex
po
su
re
 d
ur
at
io
n,
 r
es
pe
ct
iv
el
y,
 w
as
 f
ou
nd
. 
(8
5)
 
C
om
pe
tit
iv
e 
sw
im
m
er
s 
C
ro
ss
-s
ec
tio
na
l, 
C
an
ad
a 
Pa
rt 
1:
  
30
5 
co
m
pe
tit
iv
e 
sw
im
m
er
s 
(1
01
 b
oy
s,
 2
04
 g
ir
ls
) 
49
9 
in
do
or
 s
oc
ce
r 
pl
ay
er
s 
(2
97
 b
oy
s,
 2
02
 g
ir
ls
) 
Pa
rt 
2:
  
72
 c
om
pe
tit
iv
e 
sw
im
m
er
s 
73
 in
do
or
 s
oc
ce
r 
pl
ay
er
s 
Pa
rt 
1:
 
N
o 
da
ta
 
Pa
r t 
2:
 
0.
34
 A
M
 
0.
37
 m
ed
ia
n 
 
0.
26
–0
.4
1 
Q
ue
st
io
nn
ai
re
 
(r
es
pi
ra
to
ry
 
sy
m
pt
om
s)
 
Q
u e
st
io
nn
ai
re
 
(r
es
pi
ra
to
ry
 
sy
m
pt
om
s 
du
ri
ng
 
tr
ai
ni
ng
 s
es
si
on
s)
 
Pa
rt 
1:
 S
w
im
m
er
s 
re
po
rt
ed
 m
or
e 
sy
m
pt
om
s 
(O
R
, 9
5%
 
C
I)
fr
om
 lo
w
er
 a
ir
w
ay
s 
(1
.5
, 1
.0
–2
.2
) 
su
ch
 a
s 
co
ug
h 
(1
.2
,
1.
1 –
2.
7)
 th
an
 s
oc
ce
r 
pl
ay
er
s 
(O
R
s 
ad
ju
st
ed
 f
or
 s
ex
, a
ge
an
d 
nu
m
be
r 
of
 tr
ai
ni
ng
 s
es
si
on
s 
pe
r 
w
ee
k)
.
Pa
r t 
2:
 S
w
im
m
er
s 
re
po
rt
ed
 m
or
e 
sy
m
pt
om
s 
fr
om
 lo
w
er
 
ai
rw
ay
s 
(O
R
 3
.5
, 9
5%
 C
I 
2.
0–
6.
0)
 th
an
 s
oc
ce
r 
pl
ay
er
s.
 
Sw
im
m
er
s 
ex
po
se
d 
to
 tr
ic
hl
or
am
in
e 
le
ve
ls
 >
 0
.3
7 
m
g/
m
3  
di
d 
no
t r
ep
or
t m
or
e 
sy
m
pt
om
s 
fr
om
 lo
w
er
 a
ir
w
ay
s 
th
an
 
sw
im
m
er
s 
ex
po
se
d 
to
 <
 0
.3
7 
m
g/
m
3 .
  
(7
8)
 
C
ro
ss
-s
ec
tio
na
l, 
B
el
gi
um
 
22
 c
om
pe
tit
iv
e 
sw
im
m
er
s 
(1
0 
bo
ys
, 1
2 
gi
rl
s)
 a
nd
  
10
 c
oa
ch
es
  
(3
 m
en
, 3
 w
om
en
) 
N
o 
re
fe
re
nt
s 
0.
20
–1
.3
0 
C
lin
ic
al
 in
te
rv
ie
w
; 
Sp
ir
om
et
ry
; 
M
et
ha
ch
ol
in
e 
br
on
ch
ia
l 
ch
al
le
ng
e 
te
st
; 
FE
N
O
 
C
om
m
on
 s
ym
pt
om
s 
fr
om
 lo
w
er
 a
ir
w
ay
s 
w
er
e 
co
ug
h 
(5
7%
) 
an
d 
dy
sp
no
ea
 (
46
%
).
 M
ea
n 
FE
V
1%
 p
re
di
ct
ed
 w
as
 
10
9%
. M
ea
n 
FE
N
O
 le
ve
l w
as
 1
9.
7 
pp
b;
 th
e 
cu
t o
ff
 v
al
ue
 
of
 2
5 
pp
b 
w
as
 e
xc
ee
de
d 
in
 3
 s
ub
je
ct
s.
 A
ir
w
ay
 h
yp
er
-
re
ac
tiv
ity
 w
as
 d
et
ec
te
d 
in
 2
2/
28
 s
w
im
m
er
s 
(8
5%
).
 
(1
18
)
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T
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 9
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te
d 
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m
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om
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ct
s 
in
 h
um
an
s 
ex
po
se
d 
to
 a
ir
bo
rn
e 
tr
ic
hl
or
am
in
e 
(e
xp
os
ur
e 
le
ve
ls
 r
ef
er
 to
 s
ta
tio
na
ry
 s
am
pl
in
g 
if
 n
ot
 s
ta
te
d 
ot
he
rw
is
e)
.  
St
ud
y 
de
si
gn
/ 
co
un
tr
y 
St
ud
y 
gr
ou
p 
E
xp
os
ur
e 
le
ve
l, 
m
g/
m
3  
M
et
ho
d 
E
ff
ec
ts
 
R
ef
er
en
ce
 
C
ro
ss
-s
ec
tio
na
l, 
Fi
nl
an
d 
29
 c
om
pe
tit
iv
e 
sw
im
m
er
s 
(1
2 
m
en
, 1
7 
w
om
en
) 
19
 h
ea
lth
y 
no
n-
ex
po
se
d 
su
bj
ec
ts
 
–
Q
ue
st
io
nn
ai
re
;
Sp
ir
om
et
ry
;
H
is
ta
m
in
e
br
on
ch
ia
l
ch
al
le
ng
e 
te
st
;
In
du
ce
d 
sp
ut
um
 
te
st
Sp
iro
m
et
ry
: V
al
ue
s 
w
er
e 
w
ith
in
 n
or
m
al
 li
m
its
 f
or
 a
ll 
sw
im
m
er
s.
 1
4 
(4
8%
) 
of
 th
e 
sw
im
m
er
s 
an
d 
3 
(1
6%
) 
of
 th
e 
co
nt
ro
ls
 s
ho
w
ed
 in
cr
ea
se
d 
br
on
ch
ia
l r
es
po
ns
iv
en
es
s.
  
Sp
ut
um
 d
iff
er
en
tia
l c
el
l c
ou
nt
s:
 S
w
im
m
er
s 
ha
d 
hi
gh
er
 
ce
ll 
co
un
ts
 o
f 
eo
si
no
ph
ils
 (
m
ea
n 
2.
7%
 v
s 
0.
2%
) a
nd
 
ne
ut
ro
ph
ils
 (
55
%
 v
s 
30
%
) 
th
an
 c
on
tr
ol
s 
(P
 <
 0
.0
1)
. 
E
os
in
op
hi
lia
 (
eo
si
no
ph
il 
co
un
t o
f 
>
 4
%
) 
w
as
 o
bs
er
ve
d 
in
 
6 
(2
1%
) 
sw
im
m
er
s 
an
d 
in
 n
on
e 
of
 th
e 
co
nt
ro
ls
 (
P 
< 
0.
05
). 
T
he
 8
 s
w
im
m
er
s 
w
ith
 a
 h
is
to
ry
 o
f 
ex
er
ci
se
 in
du
ce
d 
br
on
ch
ia
l s
ym
pt
om
s 
ha
d 
hi
gh
er
 e
os
in
op
hi
l c
el
l c
ou
nt
s 
th
an
 s
ym
pt
om
-f
re
e 
sw
im
m
er
s 
(P
 <
 0
.0
1)
. N
o 
as
so
ci
at
io
n 
w
as
 f
ou
nd
 b
et
w
ee
n 
eo
si
no
ph
il 
co
un
ts
 a
nd
 in
cr
ea
se
d 
br
on
ch
ia
l r
es
po
ns
iv
en
es
s.
  
(5
6)
 
Fo
llo
w
-u
p,
 
Fi
nl
an
d 
42
 c
om
pe
tit
iv
e 
sw
im
m
er
s 
(1
6 
ac
tiv
e 
an
d 
26
 p
as
t 
sw
im
m
er
s)
 
N
o 
re
fe
re
nt
s 
–
Q
ue
st
io
nn
ai
re
;
Sp
ir
om
et
ry
;
H
is
ta
m
in
e
br
on
ch
ia
l
ch
al
le
ng
e 
te
st
;
S k
in
 p
ri
ck
 te
st
;
In
du
ce
d 
sp
ut
um
 
te
st
B
ro
nc
hi
al
 r
es
po
ns
iv
en
es
s 
w
as
 in
cr
ea
se
d 
in
 7
 (
44
%
) 
an
d 
 
8 
(5
0%
) 
of
 th
e 
ac
tiv
e 
sw
im
m
er
s 
at
 b
as
el
in
e 
an
d 
at
 f
ol
lo
w
-
up
, b
ut
 o
nl
y 
in
 8
 (
31
%
) 
of
 th
e 
pa
st
 s
w
im
m
er
s 
at
 b
as
el
in
e 
an
d 
3 
(1
2%
) 
at
 f
ol
lo
w
-u
p.
 T
he
 d
if
fe
re
nc
e 
in
 c
ha
ng
e 
in
 
br
on
ch
ia
l h
yp
er
re
sp
on
si
ve
ne
ss
 b
et
w
ee
n 
gr
ou
ps
 w
as
 
si
gn
if
ic
an
t (
P 
= 
0.
02
3)
. T
he
re
 w
as
 a
 s
ig
ni
fi
ca
nt
 d
if
fe
re
nc
e 
in
 th
e 
ch
an
ge
 in
 c
ur
re
nt
 a
st
hm
a 
be
tw
ee
n 
th
e 
gr
ou
ps
; i
t 
oc
cu
rr
ed
 in
 3
1%
 o
f 
ac
tiv
e 
sw
im
m
er
s 
at
 b
as
el
in
e 
an
d 
 
in
 4
4%
 a
t f
ol
lo
w
-u
p,
 c
or
re
sp
on
di
ng
 n
um
be
rs
 in
 p
as
t 
sw
im
m
er
s 
w
er
e 
31
%
 a
t b
as
el
in
e 
an
d 
12
%
 a
t f
ol
lo
w
-u
p 
(P
 =
 0
.0
04
).
 M
ild
 e
os
in
op
hi
lic
 a
ir
w
ay
 in
fl
am
m
at
io
n 
w
as
 
ag
gr
av
at
ed
 o
ve
r 
tim
e 
in
 a
ct
iv
e 
sw
im
m
er
s 
as
 r
ef
le
ct
ed
 in
 
th
e 
sp
ut
um
 e
os
in
op
hi
l c
ou
nt
s.
  
(5
5)
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hl
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 r
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am
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ot
 s
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St
ud
y 
de
si
gn
/ 
co
un
tr
y 
St
ud
y 
gr
ou
p 
E
xp
os
ur
e 
le
ve
l, 
m
g/
m
3  
M
et
ho
d 
E
ff
ec
ts
 
R
ef
er
en
ce
 
C
ro
ss
-s
ec
tio
na
l, 
Fi
nl
an
d 
33
 c
om
pe
tit
iv
e 
sw
im
m
er
s 
(1
5 
gi
rl
s,
 1
8 
bo
ys
;  
m
ea
n 
ag
e 
14
.3
 y
) 
2 
co
nt
ro
l g
ro
up
s:
 
35
 u
ns
el
ec
te
d 
ad
ol
es
ce
nt
s 
(1
9 
gi
rl
s,
 1
6 
bo
ys
;  
m
ea
n 
ag
e 
14
.4
 y
) 
32
 a
st
hm
at
ic
s 
 
(1
3 
gi
rl
s,
 1
9 
bo
ys
;  
m
ea
n 
ag
e 
14
.1
 y
) 
–
Q
ue
st
io
nn
ai
re
;
Sp
ir
om
et
ry
; H
is
ta
m
in
e
b r
on
ch
ia
l c
ha
lle
ng
e 
te
st
;
FE
N
O
; I
nd
uc
ed
 s
pu
tu
m
 
te
st
N
o 
di
ff
er
en
ce
s 
in
 F
E
N
O
, c
el
lu
la
r 
sp
ut
um
 c
om
po
si
tio
n 
or
 
pr
ev
al
en
ce
 o
f 
ai
rw
ay
 h
yp
er
re
sp
on
si
ve
ne
ss
 b
et
w
ee
n 
th
e 
gr
ou
ps
. T
he
 s
w
im
m
er
s 
di
d 
no
t d
if
fe
r 
in
 th
e 
pr
ev
al
en
ce
 o
f 
re
sp
ir
at
or
y 
sy
m
pt
om
s 
co
m
pa
re
d 
to
 th
e 
un
se
le
ct
ed
 
ad
ol
es
ce
nt
s.
  
(1
02
) 
C
hi
ld
re
n/
ad
ol
es
ce
nt
s 
C
ro
ss
-s
ec
tio
na
l, 
Sp
ai
n 
3 
22
3 
ch
ild
re
n 
ag
ed
 9
–1
2 
y 
N
o 
re
fe
re
nt
s 
0.
16
 A
M
 
Pa
re
nt
al
 q
ue
st
io
nn
ai
re
 
(r
es
pi
ra
to
ry
 s
ym
pt
om
s 
la
st
 1
2 
m
o)
 
Sw
im
m
in
g 
po
ol
 a
tte
nd
an
ce
 d
ur
in
g 
th
e 
la
st
 1
2 
m
o 
w
as
 
as
so
ci
at
ed
 w
ith
 a
 s
lig
ht
ly
 lo
w
er
 p
re
va
le
nc
e 
of
 c
ur
re
nt
 
as
th
m
a 
(O
R
 0
.5
, 9
5%
 C
I 
0.
2–
0.
8)
 c
om
pa
re
d 
to
 c
hi
ld
re
n 
w
ho
 n
ev
er
 a
tte
nd
ed
 p
oo
ls
; a
 s
im
ila
r 
(n
on
-s
ig
ni
fi
ca
nt
) 
fi
nd
in
g 
w
as
 s
ho
w
n 
fo
r 
ev
er
 a
st
hm
a 
(O
R
 0
.7
, 9
5%
 C
I 
0.
4–
1.
1)
. 
(3
9)
 
C
ro
ss
-s
ec
tio
na
l, 
N
et
he
rl
an
ds
 
2 
36
9 
ch
ild
re
n 
ag
ed
 6
–1
3 
y 
N
o 
re
fe
re
nt
s 
0.
21
 A
M
 
Pa
re
nt
al
 q
ue
st
io
nn
ai
re
 
(r
es
pi
ra
to
ry
 s
ym
pt
om
s,
 
al
le
rg
y 
an
d 
po
ol
 
at
te
nd
an
ce
);
 C
C
16
 in
 
se
ru
m
; A
er
oa
lle
rg
en
-
sp
ec
if
ic
 I
gE
 
C
C
16
 le
ve
ls
 w
er
e 
as
so
ci
at
ed
 w
ith
 s
en
si
tis
at
io
n 
to
 h
ou
se
 
du
st
 m
ite
s 
an
d 
co
m
m
on
 a
lle
rg
en
s 
bu
t n
ot
 w
ith
 r
es
pi
ra
to
ry
 
sy
m
pt
om
s.
 R
ep
or
te
d 
sw
im
m
in
g 
po
ol
 a
tte
nd
an
ce
 a
nd
 
tr
ic
hl
or
am
in
e 
ex
po
su
re
 w
er
e 
no
t a
ss
oc
ia
te
d 
w
ith
 a
st
hm
a,
 
w
he
ez
in
g 
or
 C
C
16
 le
ve
ls
. 
(7
2)
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 r
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pl
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ot
 s
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rw
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St
ud
y 
de
si
gn
/ 
co
un
tr
y 
St
ud
y 
gr
ou
p 
E
xp
os
ur
e 
le
ve
l, 
m
g/
m
3  
M
et
ho
d 
E
ff
ec
ts
 
R
ef
er
en
ce
 
C
ro
ss
-s
ec
tio
na
l, 
B
el
gi
um
 
34
1 
ch
ild
re
n 
ag
ed
 1
0–
13
 y
 
N
o 
re
fe
re
nt
s 
0.
25
–0
.5
4 
Pa
re
nt
al
 q
ue
st
io
nn
ai
re
 
(r
es
pi
ra
to
ry
 s
ym
pt
om
s 
an
d 
po
ol
 a
tte
nd
an
ce
);
  
E
IB
 te
st
; F
E
N
O
; C
C
16
  
in
 s
er
um
; T
ot
al
 a
nd
 
al
le
rg
en
-s
pe
ci
fi
c 
Ig
E
 
C
um
ul
at
iv
e 
po
ol
 a
tte
nd
an
ce
 w
as
 a
ss
oc
ia
te
d 
w
ith
 
el
ev
at
ed
 F
E
N
O
 (
O
R
 1
.3
, 9
5%
 C
I 
1.
1–
1.
4)
 a
nd
 to
ta
l 
as
th
m
a 
bu
t o
nl
y 
in
 c
hi
ld
re
n 
w
ith
 I
gE
 >
 1
00
 k
IU
/l 
(O
R
 
1.
8,
 9
5%
 C
I 
1.
1–
2.
7)
. T
he
re
 w
as
 a
n 
ex
po
su
re
-r
es
po
ns
e 
ef
fe
ct
 a
nd
 th
e 
st
ro
ng
es
t e
ff
ec
t w
as
 f
ou
nd
 w
ith
 p
oo
l 
at
te
nd
an
ce
 b
ef
or
e 
th
e 
ag
e 
of
 6
–7
 y
. 
(9
) 
C
ro
ss
-s
ec
tio
na
l, 
B
el
gi
um
 
84
7 
sc
ho
ol
 c
hi
ld
re
n 
ag
ed
 1
3–
18
 y
, o
f 
w
hi
ch
: 
73
3 
ex
po
se
d 
 
(a
tte
nd
in
g 
ou
td
oo
r 
or
 
in
do
or
 c
hl
or
in
at
ed
 p
oo
ls
, 
11
4 
no
n-
ex
po
se
d 
 
(m
ai
nl
y 
at
te
nd
in
g 
co
pp
er
-s
ilv
er
 p
oo
ls
) 
0.
30
–0
.5
0 
Pa
re
nt
al
 q
ue
st
io
nn
ai
re
 
(r
es
pi
ra
to
ry
 s
ym
pt
om
s 
an
d 
po
ol
 a
tte
nd
an
ce
);
  
E
IB
 te
st
; T
ot
al
 a
nd
 
al
le
rg
en
-s
pe
ci
fi
c 
Ig
E
 
In
 c
hi
ld
re
n 
w
ith
 a
 c
um
ul
at
iv
e 
po
ol
 a
tte
nd
an
ce
 >
 1
 0
00
 h
, 
O
R
 (
95
%
 C
I)
 f
or
 e
ve
r 
as
th
m
a 
w
as
 3
.7
 (
1.
4–
9.
9)
 a
nd
  
fo
r 
cu
rr
en
t a
st
hm
a 
8.
1 
(1
.7
–3
7)
 c
om
pa
re
d 
to
 r
ef
er
en
ts
. 
A
to
pi
c 
ch
ild
re
n 
ha
d 
hi
gh
er
 r
is
k 
fo
r 
as
th
m
a 
sy
m
pt
om
s,
 
an
d 
fo
r 
ev
er
 o
r 
cu
rr
en
t a
st
hm
a 
re
la
te
d 
to
 to
ta
l n
um
be
rs
 
of
 h
ou
rs
 s
pe
nt
 in
 c
hl
or
in
at
ed
 p
oo
ls
; a
m
on
g 
at
op
ic
s 
w
ith
 
cu
m
ul
at
iv
e 
po
ol
 a
tte
nd
an
ce
 >
 1
 0
00
 h
, O
R
s 
(9
5%
 C
Is
) 
fo
r 
ev
er
 a
nd
 c
ur
re
nt
 a
st
hm
a 
w
er
e 
7.
8 
(7
.8
–2
9)
 a
nd
 1
5 
(1
.8
–1
20
),
 r
es
pe
ct
iv
el
y,
 c
om
pa
re
d 
to
 th
os
e 
w
ith
 
cu
m
ul
at
iv
e 
po
ol
 a
tte
nd
an
ce
 <
 1
00
 h
. 
(1
5)
 
C
ro
ss
-s
ec
tio
na
l, 
Sw
ed
en
 
1 
86
6 
sc
ho
ol
 c
hi
ld
re
n 
 
ag
ed
 1
1–
12
 y
 (
bo
ys
 5
1%
) 
N
o 
re
fe
re
nt
s 
–
Pa
re
nt
al
 q
ue
st
io
nn
ai
re
(r
es
pi
ra
to
ry
 s
ym
pt
om
s 
an
d 
po
ol
 a
tte
nd
an
ce
);
S k
in
 p
ri
ck
 te
st
; T
ot
al
 a
nd
al
le
rg
en
-s
pe
ci
fi
c 
Ig
E
C
ur
re
nt
 s
w
im
m
in
g 
po
ol
 a
tte
nd
an
ce
 w
as
 r
ep
or
te
d 
as
 
≥ 
1/
w
k 
or
 <
 1
/w
k 
in
 th
e 
la
st
 1
2 
m
o.
 T
he
 p
re
va
le
nc
e 
 
of
 c
ur
re
nt
 a
st
hm
a 
w
as
 8
.9
%
 (
bo
ys
 1
0%
, g
ir
ls
 7
.9
%
).
 
St
ra
tif
ie
d 
an
al
ys
es
 f
or
 a
lle
rg
ic
 s
en
si
tis
at
io
n 
ad
ju
st
ed
 f
or
 
ge
nd
er
, p
ar
en
ta
l s
m
ok
in
g,
 p
ar
en
ta
l a
st
hm
a 
an
d 
da
m
p 
ho
us
in
g 
sh
ow
ed
 a
 s
ig
ni
fi
ca
nt
 a
ss
oc
ia
tio
n 
(O
R
, 9
5%
 C
I)
 
fo
r 
ph
ys
ic
ia
n-
di
ag
no
se
d 
as
th
m
a 
(1
.9
, 1
.1
–3
.3
) 
an
d 
cu
rr
en
t a
st
hm
a 
(1
.9
, 1
.1
–3
.3
) 
an
d 
po
ol
 a
tte
nd
an
ce
 b
ut
 
on
ly
 a
m
on
g 
at
op
ic
 c
hi
ld
re
n.
 
(5
)
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(e
xp
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 r
ef
er
 to
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ta
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 s
am
pl
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g 
if
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ot
 s
ta
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rw
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e)
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St
ud
y 
de
si
gn
/ 
co
un
tr
y  
St
ud
y 
gr
ou
p 
E
xp
os
ur
e 
le
ve
l, 
m
g/
m
3  
M
et
ho
d 
E
ff
ec
ts
 
R
ef
er
en
ce
 
C
ro
ss
-s
ec
tio
na
l, 
B
el
gi
um
 
1 
88
1 
ch
ild
re
n 
 
ag
ed
 7
–1
4 
y 
N
o 
re
fe
re
nt
s 
– 
Pa
re
nt
al
 q
ue
st
io
nn
ai
re
 
(h
ea
lth
 s
ta
tu
s,
 r
es
pi
ra
to
ry
 
sy
m
pt
om
s)
; S
ch
oo
l 
di
re
ct
or
s 
re
po
rt
ed
 p
oo
l 
at
te
nd
an
ce
;  E
IB
 te
st
 
Pr
ev
al
en
ce
 o
f 
re
sp
ir
at
or
y 
sy
m
pt
om
s 
w
as
 n
ot
 a
ss
oc
ia
te
d 
w
ith
 p
os
iti
ve
 E
IB
 te
st
 o
r 
to
ta
l a
st
hm
a 
(p
os
iti
ve
 E
IB
 te
st
 
an
d/
or
 m
ed
ic
at
io
n 
fo
r 
as
th
m
a)
. P
os
iti
ve
 E
IB
 te
st
 a
nd
 
to
ta
l a
st
hm
a 
pr
ev
al
en
ce
 w
er
e 
si
gn
if
ic
an
tl
y 
as
so
ci
at
ed
 
w
ith
 c
um
ul
at
iv
e 
po
ol
 a
tte
nd
an
ce
. T
he
 a
ss
oc
ia
tio
ns
 
re
m
ai
ne
d 
si
gn
if
ic
an
t a
ft
er
 a
dj
us
tm
en
t f
or
 p
oo
l h
ei
gh
t, 
pe
ts
 a
nd
 p
as
si
ve
 s
m
ok
in
g,
 a
nd
 w
er
e 
st
ro
ng
es
t a
m
on
g 
th
e 
yo
un
ge
st
 c
hi
ld
re
n 
( P
 <
 0
.0
01
).
 
(1
1)
 
C
ro
ss
-s
ec
tio
na
l, 
B
el
gi
um
 
83
5 
sc
ho
ol
 c
hi
ld
re
n 
 
(4
70
 g
ir
ls
, 3
65
 b
oy
s;
  
m
ea
n 
ag
e 
15
.4
 y
)  
N
o 
re
fe
re
nt
s 
– 
Pa
re
nt
al
 q
ue
st
io
nn
ai
re
 
(h
ea
lth
 s
ta
tu
s,
 r
es
pi
ra
to
ry
 
sy
m
pt
om
s 
an
d 
po
ol
 
at
te
nd
an
ce
) ;
 C
C
16
 a
nd
 
SP
-D
 in
 s
er
um
; T
ot
al
 a
nd
 
al
le
rg
en
-s
pe
ci
fi
c 
Ig
E
 
C
hi
ld
re
n 
w
ith
 th
e 
hi
gh
es
t p
oo
l a
tte
nd
an
ce
 (
to
ta
l o
r 
be
fo
re
 
th
e 
ag
e 
of
 7
 y
) 
ha
d 
si
gn
if
ic
an
tly
 lo
w
er
 le
ve
ls
 o
f 
C
C
16
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12. Dose-effect and dose-response relationships
12.1 Monochloramine 
No inhalation data were located. 
12.1.1 Human studies 
Daily consumption of drinking water containing monochloramine corresponding to 
0.043 mg/kg bw/day (assuming a body weight of 70 kg) for 4 weeks did not alter 
parameters of lipid and thyroid metabolism in 16 healthy men, whereas 0.32 mg/kg 
bw/day was associated with an increase in the plasma level of apolipoprotein B 
(142). 
No effects were shown in 10 healthy male volunteers administered monochlor-
amine in water daily for 12 weeks (corresponding to 0.036 mg/kg bw/day assuming 
a body weight of 70 kg) or every 3rd day for 13 days at increasing concentrations 
corresponding to ≤ 0.034 mg/kg bw/day as evaluated by an extensive battery of 
measures including serum chemistry, blood count, urine analysis and physical 
examination (81). 
No relevant studies on long-term exposure were located. 
12.1.2 Animal studies 
Animal studies on monochloramine are summarised in Table 4 (Chapter 10). Clear 
conjunctival irritation was observed in rabbits after 1 hour of exposure to a solution 
containing monochloramine (corresponding to 4 mg/l Cl2). Monochloramine was 
considerably more irritating than free chlorine (33). 
Transiently increased GSH levels in rats were reported after single oral gavage 
doses of 0.19–0.75 mg/kg bw of monochloramine (2). 
Some short-term drinking water studies have been performed. After 9-week 
exposures of rats to 0.8–3.4 mg/kg bw/day of monochloramine, some alterations 
in immune function were observed (35). In mice, administration for 28 days at 
dose levels of 0.38–38 mg/kg bw/day resulted in some minimal immunological 
effects that were judged to be biologically insignificant. No effects were observed 
in haematological parameters, organ weights, body weight, body weight gain or 
water consumption (50). No effects on body weight gain or haematological 
parameters were observed in rats exposed 45 days at 1.2–12 mg/kg bw/day, except 
a decrease in methaemoglobin, opposite to what was expected (19). In mice, 
reduced body weight and slightly increased haematocrit were seen at doses ≥ 8.7 
mg/kg bw/day, whereas other haematological parameters (including GSH levels) 
were unaffected following administration during 30 days at doses of 0.44–35 mg/kg 
bw/day (89). Exposure of monkeys for 6 weeks (10 mg/kg bw/day) had no effect 
on haematological and clinicochemical parameters in blood, on serum thyroxine 
(T4) levels or body weight (8). 
Some long-term drinking water studies were located. Following administration 
of 0.05–5.2 mg/kg bw/day of monochloramine to male rats (4/group) for up to 12 
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months, an indication of increased DNA synthesis (thymidine incorporation) in 
kidney, spleen, liver and testes, and decreased blood GSH levels, were seen at all 
doses (2). 
Male and female rats and mice were administered monochloramine in drinking 
water (2.1–17.2 mg/kg bw/day) for up to 2 years. No carcinogenic effects were seen 
in mice and male rats. A marginal, dose-related increase in mononuclear cell 
leukaemia incidence among female rats was considered as equivocal evidence of 
carcinogenic activity (99). 
Reduced body weight gain and minor biochemical, haematological, immuno-
logical and histopathological changes were observed in rats exposed to 21.6 mg/kg 
bw/day of monochloramine for 13 weeks in drinking water. The effects were largely 
related to reduced water and food consumption (104). Similar effects were reported 
also in other long-term studies in rats and mice at daily doses of 5–17 mg/kg bw/day 
(2, 28, 29, 99). 
A few oral studies on reproductive or developmental toxicity were found.  
After administration of 1.6–8 mg/kg bw/day of monochloramine by oral gavage for 
5 consecutive days to mice, no sperm-head abnormalities were observed 1, 3 and 5 
weeks after the last dose (86). No histological changes or effects on reproductive 
organs were noted in male and female rats administered monochloramine (2.5–10 
mg/kg bw/day) by oral gavage for up to 73 days. Sperm quality and foetuses were 
unaffected (23). Neither were any effects on foetuses shown after exposure of 
Virgin rats to monochloramine via drinking water (0.09–9.3 mg/kg bw/day) 2.5 
months prior to and throughout gestation (1). 
12.2 Dichloramine 
In the only study located, male and female rats were administered dichloramine in 
drinking water (0.019–24 mg/kg bw/day) for 13 weeks. Minimal to mild histo-
logical effects in thyroid, kidneys or gastric cardia were observed from 0.19 mg/kg 
bw/day in males and from 2.5 mg/kg bw/day in females, respectively (Table 5, 
Chapter 10) (92). 
12.3 Trichloramine 
12.3.1 Human studies 
12.3.1.1 Ocular and airway irritation  
Several cross-sectional studies have shown higher prevalences of self-reported 
ocular and/or upper airway irritation among pool workers exposed to trichloramine 
compared to unexposed reference groups (Table 10). Pool workers are mainly 
exposed to trichloramine in air, whereas food industry workers and competitive 
swimmers to a higher degree are exposed also to soluble chlorine, in aerosols and/or 
the chlorinated water itself. Only swimming pool workers are therefore included in 
the following compilation of irritant effects of airborne trichloramine. 
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Chu et al. reported significantly more irritation (“during or after work shift”) in 
the throat (but not in the eyes and nose) in pool workers exposed to trichloramine 
concentrations of 0.017–0.15 mg/m3 (co-exposure to soluble chlorine) compared to 
unexposed referents, however, no concentration-response data were presented (25).  
Löfstedt et al. reported significantly more ocular and nasal symptoms during  
the last week in pool workers with stationary and personal measurements of 
trichloramine being in the range 0.001–0.64 mg/m3 and < 0.001–0.24 mg/m3 (AMs 
0.18 and 0.071 mg/m3), respectively, compared to referents, but there was a lack of 
concentration-response relationships among exposed (82). Also some other studies 
did not find any concentration-response relationships between airborne trichlor-
amine levels and self-reported irritation (42, 73). 
In contrast, concentration-response relationships were demonstrated in some 
studies. Significantly higher prevalences of irritative symptoms in eyes and nose 
were reported in pool workers in one study at 0.36 (0.30–0.52) mg/m3 of trichlor-
amine (101) and in three other studies with pool workers from around 0.5 mg/m3 
(36, 64, 84). In addition, significant concentration-response trends for eye, nose and 
throat irritation over the whole exposure range (4 sub-groups) were reported for 
lifeguards (84). 
An association between the prevalence of irritation in upper airways or eyes and 
cumulative trichloramine exposure was observed in some studies (73, 84, 101). 
However, the cumulative exposures were calculated in different ways and are 
difficult to interpret in terms of exposure concentration. NOAECs and LOAECs can 
therefore not be identified from the cumulative exposure data. 
12.3.1.2 Effects on pneumoproteins and lung function  
Respiratory effects after short-term exposure are summarised in Table 11. Effects 
on pneumoproteins were shown at trichloramine concentrations ≥ 0.29 mg/m3 (11, 
21, 38) but not at lower exposure levels (20, 98).  
Marginal but significant effects on lung function were demonstrated in one study 
with trichloramine concentrations of 0.15 and 0.23 mg/m3 (personal exposure) (98). 
In contrast, no effects on lung function were demonstrated in studies with exposure 
levels of 0.023 mg/m3 (137), 0.18 mg/m3 (personal exposure 0.071 mg/m3) (82), 
0.16–0.28 mg/m3 (20), 0.29 mg/m3 (38) and 0.36 and 0.49 mg/m3 (21). 
An increase in FENO over work shift was observed in pool workers exposed to 
0.18 mg/m3 of trichloramine, suggesting an inflammatory effect on the airways 
(82). 
12.3.1.3 Asthma  
Exposure to trichloramine in the workplace air may aggravate asthma symptoms  
in individuals with existing asthma (27, 129). The average concentration of 
trichloramine reported in the study by Dang et al. was 0.44 mg/m3 (27). In the case 
report by Thickett et al., 2 pool workers with occupational asthma had a positive 
specific challenge test to trichloramine at 0.5 mg/m3, and the 3rd pool worker had a 
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positive workplace challenge test to indoor pool air with trichloramine levels of 
0.1–0.57 mg/m3 (129). 
Some studies showed higher prevalences of self-reported asthma-related 
symptoms in exposed pool workers and competitive swimmers compared to 
unexposed referents (27, 73, 78). The overall mean concentration of trichloramine 
in the study by Jacobs et al. was 0.56 (0.13–1.34) mg/m3 (73); the air levels in the 
study by Lévesque et al. were 0.26–0.41 mg/m3 (78). A high prevalence of airway 
hyperreactivity has been found in pool workers (30), as well as in competitive 
swimmers (56, 118). No significant associations have been found between levels or 
duration of trichloramine exposure and self-reported asthma symptom, pulmonary 
function, airway hyperreactivity and airway inflammation.  
12.3.2 Animal studies 
Animal studies on trichloramine are summarised in Table 6 (Chapter 10). In female 
mice, lung epithelium hyperpermeability (expressed as changes in concentrations 
of albumin and total proteins in BALF, and of CC16 in BALF and serum) was 
observed after single inhalation exposures at 11.9 and 13.1 mg/m3 up to 8 hours. 
No effects were seen at 0.53–3.45 mg/m3 (21). 
An RD50 value of 12.5 mg/m3 in mice was reported following a 1-hour inhalation 
exposure to trichloramine (43). 
In rats, an LC50 value of 560 mg/m3 following 1 hour of exposure was deter-
mined. The cause of death was lung oedema (7). 
In the only long-term study located, male and female rats were administered 
trichloramine in drinking water (0.020–13 mg/kg bw/day) for 13 weeks. Minimal 
to mild histological effects in thyroid and kidneys were observed at doses > 0.23 
mg/kg bw/day in males and > 0.29 mg/kg bw/day in females, respectively. 
Increased hepatic enzyme activities were observed among females only (13 mg/kg 
bw day) (92). It is unclear how these effect levels were derived from the results 
presented in the paper.
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13. Previous evaluations by national and international bodies 
Some previous evaluations regarding inorganic chloramines have been performed 
with the main focus on monochloramine in drinking water. A few bodies have 
evaluated the health effects of trichloramine following inhalation exposure. 
13.1 Chloramines/monochloramine 
US Environmental Protection Agency (US EPA) 1994, Chloramines  
US EPA concluded that several short-term studies on monochloramine showed no 
observed adverse haematological effects in mice, rats and monkeys. EPA further 
concluded that studies regarding mutagenicity of chloramines were inconclusive 
and stated that equivocal evidence of carcinogenic activity was found in female  
rats because of a slightly increased incidence of mononuclear cell leukaemia. There 
was no evidence of carcinogenic activity in male rats, female or male mice. 
As regards human health, it was noted that no epidemiologic studies had been 
designed to address specifically the potential adverse health effects of exposure to 
chloramines. The EPA Carcinogenic Risk Assessment Verification Endeavour 
(CRAVE) Work group verified (12/02/92) a classification for monochloramine of 
group D, not classifiable as to human carcinogenicity, meaning that there is 
inadequate human and animal evidence of carcinogenicity (132).  
Government of Canada. Healthy Canadians 1996, Monochloramine 
Monochloramine was considered weekly mutagenic in vitro. No treatment-related 
developmental or reproductive effects had been observed in rats exposed to 
monochloramine in drinking water. Some possible immunological effects were 
noted, but the biological significance of these effects were considered not clear.  
An administered dose of 3.8 mg/kg bw had been reported to cause a reduction in 
spleen weight and augmented production of prostaglandin E2 in male rats. The 
available epidemiologic studies were regarded inadequate for the assessment of 
carcinogenicity of monochloramine in humans. There were some clinical evidence 
of neoplastic responses in rats and mice following chronic exposure to monochlor-
amine in drinking water. The evidence for the carcinogenicity of monochloramine 
was considered to be limited and the compound was classified as being possibly 
carcinogenic to humans (inadequate evidence in humans, some evidence in 
animals). 
A tolerable daily intake was estimated to 0.048 mg/kg bw per day and a maximum 
acceptable concentration (MAC) for monochloramine in drinking water of 1.8 mg/l 
was derived (53). 
International Agency for Research on Cancer (IARC) 2004, Chloramines 
No human carcinogenicity data specifically on chloramine were available to the 
Working Group. Chloraminated drinking-water (predominantly in the form of 
monochloramine) tested for carcinogenicity by oral administration in female and 
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male mice and rats did not demonstrate clear evidence of carcinogenic activity. 
Ingestion of monochloramine produced no clinical abnormalities in male volunteers 
at a concentration of 15 mg/l. No reproductive or developmental effects had been 
associated with monochloramine. Monochloramine induced single-strand breaks 
and loss of DNA-transforming activity and was a week mutagen in B. subtilis. It 
was not mutagenic to S. typhimurium. In vitro, monochloramine caused double-
strand breaks and chromatin condensation in rabbit gastric mucosal cells and human 
stomach cancer cells. In vivo, monochloramine did not induce micronuclei, chromo-
somal aberration, aneuploidy or sperm abnormality in mice, but induced the 
formation of micronuclei in erythrocytes of newt larvae.  
IARC concluded that there was inadequate evidence in humans for carcino-
genicity of chloramine and inadequate evidence in experimental animals for the 
carcinogenicity of monochloramine. The overall evaluation was that chloramine 
was not classifiable as to its carcinogenicity to humans (Group 3) (68). 
World Health Organization (WHO) 2011, Monochloramine 
WHO concluded that although monochloramine had been shown to be mutagenic 
in some in vitro studies, it had not been found to be genotoxic in vivo. 
A tolerable daily intake (TDI) of 94 μg/kg bw was calculated based on the highest 
dose administered to male rats in a 2-year drinking water study by NTP (99). An 
additional uncertainty factor for possible carcinogenicity was not applied because 
equivocal cancer effects reported in the NTP study in only one species and in only 
one sex were within the range observed in historical controls. No other increases in 
tumour incidence were observed (140). 
13.2 Trichloramine 
World Health Organization (WHO) 2006 
WHO based its recommendations on the study by Héry et al. (64) in which onset  
of irritative symptoms in the eyes and throat were reported at an air level of 0.5 
mg/m3 of trichloramine; at 0.7 mg/m3 all of the staff reported irritative symptoms. 
WHO thus recommended a maximum trichloramine level of 0.5 mg/m3 in indoor 
swimming pool air as a comfort value, in order to protect the visitors from possible 
health effects (139). 
German Working Group on Indoor Guide Values of the Federal Environment 
Agency and the States’ Health Authorities 2011 
In its risk assessment of trichloramine in the air of indoor swimming pools, the 
Working Group noted that few human and animal studies were available (no 
repeated exposure studies in animals). A valid lowest observed adverse effect  
level (LOAEL) could therefore not be derived from the current studies and no 
toxicologically based indoor air guide value established. Instead, the Swiss 
technical standard of 0.2 mg/m3 of trichloramine (122) was adopted to protect the 
public against irritation from air in indoor swimming pools. As toxicological and 
epidemiological support, it was referred to the absence of irritation in recreational 
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swimmers following a few hours of exposure to 0.5 mg/m3 of trichloramine (21), 
whereas irritation occurred in competitive swimmers and lifeguards after repeated 
exposure near 0.4 mg/m3 (preliminary data by Parrat et al. 2009) (143).  
Ministry of Social Affairs and Health, Finland 2012 
In the evaluation of data on trichloramine, respiratory irritation was identified as 
the critical effect for the setting of an OEL. It was recognised that such effects had 
been observed at exposure levels starting from 0.5 mg/m3 (64, 73). On the basis of 
these findings, an 8-hour OEL of 0.5 mg/m3 was set in 2012 (88). 
14. Evaluation of human health risks 
14.1 Assessment of health risks 
Inorganic chloramines are not commercially available, but monochloramine is 
produced in situ for disinfection or for use in chemical synthesis. Mono, di- and 
trichloramine are also formed when free chlorine reacts with nitrogen containing 
substances present in e.g. chlorinated water sources.  
Monochloramine and dichloramine are water-soluble but monochloramine is the 
principal chloramine in chlorine disinfected water. Trichloramine is immiscible 
with water and evaporates rapidly into the air and is the predominant inorganic 
chloramine in the indoor air of swimming pool facilities. In contrast, in the food 
processing industry, a significant amount of the inorganic chlorine species in the air 
is soluble. The primary occupational exposure route for the inorganic chloramines 
is inhalation. Drinking water studies are therefore considered to be of low relevance 
in the occupational setting. 
Air monitoring has mostly been performed as stationary sampling. The results 
may deviate from results obtained by personal sampling. Linear regression analyses 
based on data from parallel 8-hour samplings of trichloramine in pool air suggested 
a relation between personal and stationary sampling of approximately 1:2 (137, 
138). 
14.1.1 Monochloramine 
The data base is scarce and no inhalation data were located. 
No clinical effects were seen among male healthy volunteers ingesting mono-
chloramine in drinking water daily during 4 or 12 weeks in doses corresponding to 
0.043 mg/kg bw/day (142) or 0.034 mg/kg bw/day (81), respectively. 
Monochloramine was regarded considerably more eye irritating than free chlorine 
in a study on rabbits (33). Minor immunological and haematological effects after 
short-term oral exposure (0.8–38 mg/kg bw/day) were reported in some studies in 
rodents (19, 35, 50, 89). No haematological or clinicochemical effects were seen  
in monkeys after 6 weeks of oral exposure to 10 mg/kg bw/day (8). A transient 
increase in GSH production was observed in rats after single oral gavage doses of 
approximately 0.19–0.75 mg/kg bw (2). 
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In long-term drinking water studies, reduced body weight gain and minor 
biochemical, haematological, immunological and histopathological changes were 
observed in rats exposed to 21.6 mg/kg/day for 13 weeks. The effects were largely 
related to reduced water and food consumption (104). Similar effects were reported 
also in other long-term studies in rats and mice at daily doses of 5–17 mg/kg bw/day 
(2, 28, 29, 99). 
No carcinogenic effects were seen in mice or male rats administered monochlor-
amine in drinking water for up to 2 years. A marginal increase in mononuclear cell 
leukaemia incidence among female rats was considered as equivocal evidence of 
carcinogenic activity (99). Limited data indicate that monochloramine is weakly 
mutagenic in vitro but not genotoxic in vivo.  
No reproductive or developmental effects were shown in the few animal studies 
located. 
14.1.2 Dichloramine 
No human data were located. 
In the only animal study located, mild histopathological effects in kidneys, 
thyroid and gastric cardia were observed among male and female rats administered 
dichloramine in drinking water for 13 weeks (92). 
14.1.3 Trichloramine 
The animal database is meagre and comprise to our knowledge three single 
inhalation studies and a 13-week drinking water study. However, there were no 
indications of adverse systemic effects from trichloramine exposure, even after 
acute inhalation exposure at lethal concentrations. Human studies have mainly 
focused on ocular and airway irritation and pulmonary effects.  
14.1.3.1 Irritation  
Trichloramine is a strong sensory irritant and accidental high short-term airborne 
exposure may cause acute irritative symptoms in humans, mainly in the upper 
airways and eyes (17, 113). Several cross-sectional studies have shown higher 
prevalences of self-reported ocular and upper airway irritation among competitive 
swimmers and workers with occupational exposure to trichloramine compared  
to unexposed reference groups. In these studies, men and women as well as 
adolescents and children were included, but results regarding health effects were 
generally not presented separately for the different groups. Pool workers are mainly 
exposed to trichloramine in air, whereas food industry workers and competitive 
swimmers to a higher degree are exposed also to soluble chlorine, in aerosols and/or 
the chlorinated water itself. Only swimming pool workers are therefore included in 
the assessment of airborne trichloramine.  
Irritative symptoms in eyes and upper respiratory tract are evident at airborne 
trichloramine levels of 0.5 mg/m3 (36, 64, 84). In another study, irritation symptoms 
were more frequent among pool workers exposed to 0.36 (0.30–0.52) mg/m3 than 
among referents (101).  
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Irritation below 0.5 mg/m3 has been reported in some additional studies (25, 82). 
However, due to lack of exposure-response relationships, these studies were con-
sidered less suited to form the basis for a health-based OEL. Nevertheless, they 
provide additional support for irritation as the critical effect. 
It should be noted that the measurements were performed by stationary sampling 
in these studies.  
Duration of exposure seems to be of importance; an association between the 
prevalence of irritative symptoms in exposed pool workers and cumulative tri-
chloramine exposure has been shown (73, 84, 98, 101). However, the data are not 
presented in a way that allows the cumulative exposure estimates to be used as basis 
for a health-based OEL. 
The human irritation data are supported by animal data. Depressed breathing was 
shown in rats at a single exposure (60 min) to trichloramine at 4.5–25.0 mg/m3 
giving an estimated RD50 value of 12.5 mg/m3 (43). 
Overall, irritation is considered to be the critical effect of trichloramine. However, 
despite a large amount of human data it is difficult to draw a firm conclusion 
regarding a NOAEC. The study by Parrat et al. (101) suggests a LOAEC around 
0.36 mg/m3, rounded to 0.4 mg/m3.  
14.1.3.2 Pneumoproteins and lung function  
A marginal but significant decrement in lung function was demonstrated in one 
study after exposure to airborne trichloramine levels of 0.15 mg/m3 and 0.23 mg/m3 
(both personal sampling) (98). In contrast, no effects on lung function were 
demonstrated in other studies with average exposure levels of 0.02–0.49 mg/m3 
(stationary sampling) (20, 21, 38, 82, 137). Transient changes in serum pneumo-
proteins associated with changes in lung epithelium permeability were seen in some 
studies at airborne trichloramine concentrations ≥ 0.3 mg/m3 (11, 21, 38), whereas 
no such effects were observed in studies at lower mean exposure levels (20, 98).  
One animal study supports an effect on pneumoproteins. Mice inhalation exposed 
to 12 mg/m3 of trichloramine for 1–8 hours showed an increased bidirectional 
leakage of proteins across the pulmonary epithelium. These effects were not seen 
at 0.53–3.45 mg/m3 (21). 
The results on lung function are inconsistent and the interpretation and clinical 
relevance of changes in pneumoproteins is uncertain at present, therefore these 
studies cannot be used to derive a recommendation for a health-based OEL. 
14.1.3.3 Asthma 
Exposure to trichloramine in the workplace air may aggravate asthma symptoms in 
individuals with existing asthma (27, 129).  
Some studies showed higher prevalences of self-reported asthma-related symp-
toms in exposed pool workers (work-related) (27, 73) and competitive swimmers 
(during training) (78) compared to unexposed reference groups or other competitive 
athletes or athletes in other aquatic disciplines (48, 90). 
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A high prevalence of airway hyperreactivity has been found in pool workers (30) 
as well as in competitive swimmers (56, 118).  
Limited data indicate that occupational exposure to trichloramine may contribute 
to the development of asthma in individuals without previous respiratory diseases 
(98, 129). Some cross-sectional studies indicate an association between cumulative 
attendance in chlorinated pools and an increased risk of asthma among atopic school 
children (5, 9, 11, 15), but these findings are contradicted by results from other large 
population-based studies in children (39-41, 72).  
No significant associations have been found between levels or duration of tri-
chloramine exposure and self-reported asthma symptom, pulmonary function, 
airway hyperreactivity and airway inflammation (36, 42, 76, 78, 84, 85). 
In conclusion, the risk of developing asthma following long-term exposure to 
trichloramine cannot be evaluated at present. 
14.1.3.4 Other data  
Data on genotoxicity, carcinogenicity and reproductive and developmental toxicity 
are lacking.  
14.2 Groups at extra risk 
Inorganic chloramines are regarded as irritants. Asthmatics and atopic individuals 
who are hyperreactive to other respiratory irritants are expected to be more sensitive 
to these substances. 
14.3 Scientific basis for an occupational exposure limit  
There are insufficient toxicological data to recommend health-based OELs for 
monochloramine and dichloramine. 
The major effect after trichloramine inhalation is self-reported irritation of the 
eyes and upper respiratory tract. Irritation is considered to be the critical effect and 
has been reported in many studies on pool workers. Several of these studies reported 
irritation at approximately 0.5 mg/m3 of trichloramine (36, 64, 84). One study 
showed irritation at slightly lower trichloramine levels, 0.36 (0.30–0.52) mg/m3 
(101). Therefore, 0.4 mg/m3 is regarded as the LOAEC and is used to derive a 
recommended health-based OEL.  
Considering that there are no indications of adverse systemic effects from tri-
chloramine exposure, the sharpness of the concentration-effect curve for irritation 
and that a LOAEC is used as point of departure, an assessment factor of 2 is applied, 
to account for extrapolation from LOAEC to NOAEC (95). As the irritation data 
are collected from various field studies with occupationally exposed subjects, no 
assessment factor for interindividual variability is needed. The studies on pool 
workers reviewed in this document used stationary sampling to determine the 
trichloramine concentrations. Two studies with stationary and personal sampling 
carried out in parallel suggest that the stationary method may overestimate the true 
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personal exposure in swimming pool facilities (Section 14.1) (137, 138). This 
motivates an additional assessment factor of 2 when personal monitoring is applied.  
The resulting recommended health-based OEL is 0.1 mg/m3 (0.4/2/2) as an 
8-hour time-weighted average. This corresponds to 0.2 mg/m3 for stationary 
measurements in swimming pool facilities. 
No short-term exposure limit (STEL) is recommended as currently available 
analytical methods require longer sampling times. 
No measurement difficulties are foreseen at the recommended health-based OEL. 
15. Research needs 
Air sampling and analysis 
The air sampling method and the chemical analytical methods used today are 
relatively unspecific. Methods for analysis and identification of monochloramine, 
dichloramine or trichloramine in air samples should be developed. 
Today pumped sampling is used and the equipment is relatively heavy to wear; a 
diffusive sampler for the inorganic chloramines should be developed.  
Health effects 
Long-term animal studies are needed to establish a NOAEC for inhalation exposure.  
Data on human toxicokinetics and on mechanisms of toxicity are lacking. More 
studies regarding short-term effects of the inorganic chloramines in humans should 
be performed, preferably in an exposure chamber under controlled conditions to 
establish human NOAECs. For future occupational studies, exposure should be 
assessed by personal sampling in parallel to a standardised validated questionnaire 
regarding human health effects. In addition to studying self-reported symptoms for 
evaluation of health effects following exposure to inorganic chloramines, more 
studies should be performed using objective measurements including effect markers 
such as FENO, inflammatory markers or eye and nose irritation tests. Possible 
gender differences in exposure and health effects should be evaluated. Larger 
longitudinal studies with sufficient statistical power are needed to evaluate the 
possible risk of developing asthma following long-term exposure to the inorganic 
chloramines, especially in adolescents and children with atopy. Data are lacking 
regarding possible persistent health effects after cessation of exposure.  
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16. Summary 
Wastensson G, Eriksson K. The Nordic Expert Group for Criteria Documentation 
of Health Risks from Chemicals. 152. Inorganic chloramines. Arbete och Hälsa 
2019;53(2):1–110. 
 
Inorganic chloramines are not commercially available, but monochloramine is 
produced in situ for disinfection or for use in chemical synthesis. Inorganic 
chloramines are also formed when free chlorine reacts with nitrogen containing 
substances, e.g. ammonia and urea, present in chlorinated water sources. 
Occupational exposure may therefore occur in e.g. swimming pool facilities and the 
food processing industry. 
Monochloramine is soluble and stable in water and the dominating inorganic 
chloramine in chlorinated water sources. No clinical effects were seen in healthy 
volunteers given monochloramine in drinking water during 4 or 12 weeks in doses 
of 0.043 or 0.034 mg/kg bw/day, respectively. Limited data indicate that mono-
chloramine is weakly mutagenic in vitro but not genotoxic in vivo. One drinking 
water study indicated equivocal evidence of carcinogenicity in female rats but not 
in male rats and mice. No reproductive or developmental effects were shown in 
rodents in the few studies located. 
Dichloramine is soluble but unstable in water. In the only study located, mild 
histological effects in kidneys, thyroid and gastric cardia were observed in rats 
administered dichloramine in drinking water for 13 weeks. 
Trichloramine is immiscible with water and evaporates easily from water into 
air. Therefore, the primary exposure route of concern in the occupational setting is 
inhalation. Occupational exposure to trichloramine has been demonstrated in indoor 
swimming pool facilities and in the food processing industry where chlorinated 
water is used for disinfection. Exposure-response relationships between airborne 
levels and self-reported ocular and upper airway irritation have been shown in 
several studies. Exposure to trichloramine may aggravate asthma symptoms  
in individuals with existing asthma. The risk of developing asthma following  
long-term exposure to trichloramine cannot be evaluated at present. No data on 
genotoxic, carcinogenic, reproductive or developmental effects were located. 
Conclusions: The toxicological data for mono- and dichloramine are insufficient 
to recommend health-based occupational exposure limits (OELs). 
As regards trichloramine, the critical effect is judged to be irritation observed in 
several studies on pool workers, starting at approximately 0.4 mg/m3 (stationary 
sampling). Based on these data, a health-based OEL of 0.1 mg/m3 (8-hour time-
weighted average) is recommended. This corresponds to 0.2 mg/m3 for stationary 
measurements in swimming pool facilities. No short-term exposure limit (STEL) is 
recommended. 
 
Key words: asthma, dichloramine, health-based occupational exposure limit, 
irritation, monochloramine, review, risk assessment, toxicity, trichloramine.  
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17. Summary in Swedish 
Wastensson G, Eriksson K. The Nordic Expert Group for Criteria Documentation 
of Health Risks from Chemicals. 152. Inorganic chloramines. Arbete och Hälsa 
2019;53(2):1–110. 
 
Oorganiska kloraminer tillverkas inte kommersiellt men monokloramin produceras  
in situ för desinfektion eller för användning som synteskemikalie. Oorganiska 
kloraminer bildas även när fritt klor reagerar med kväveinnehållande föreningar, 
såsom urea och ammoniak, som finns i klorerat vatten. Yrkesmässig exponering 
förekommer därför tex. i badhus och i livsmedelsindustrin. 
Monokloramin är lösligt och stabilt i vatten och den dominerade oorganiska 
kloraminen i klorerat vatten. Inga kliniska effekter observerades bland friska 
individer som fick dricksvatten med 0,043 eller 0,034 mg monokloramin/kg kropps-
vikt under 4 eller 12 veckor. Ett begränsat antal studier antyder att monokloramin 
är svagt mutagent in vitro men inte genotoxiskt in vivo. En dricksvattenstudie 
antydde en carcinogen effekt på honråttor men inte på hanråttor och möss. Inga 
effekter på reproduktion hos gnagare eller deras avkomma sågs i de få studier som 
hittades.  
Dikloramin är lösligt men instabilt i vatten. Den enda studie som påträffades 
visade på milda vävnadsförändringar i njurarna, sköldkörteln och övre magmunnen 
hos råttor efter intag av dikloramin i dricksvatten under 13 veckor.  
Trikloramin är inte blandbart med vatten och avdunstar lätt från vatten. Den 
huvudsakliga exponeringsvägen i arbetsmiljön är därför via inandning. Yrkes-
mässig exponering för trikloramin har påvisats i badhus och i livsmedelsindustrin 
där klorerat vatten används för desinfektion. Ett samband mellan lufthalter och 
självrapporterad irritation i ögon och övre luftvägar har påvisats i ett flertal studier. 
Exponering för trikloramin kan förvärra astmasymtom bland personer med befintlig 
astma. Risken att utveckla astma efter långvarig exponering för trikloramin kan i 
dagsläget inte utvärderas. Inga uppgifter hittades om genotoxicitet, carcinogenicitet 
eller effekter på reproduktion eller avkomma.  
Slutsatser: Det går inte att rekommendera hälsobaserade gränsvärden för mono- 
och dikloramin på grund av otillräckligt vetenskapligt underlag. 
För trikloramin bedöms den kritiska effekten vara irritation vilket observerats i 
ett flertal studier på badhusanställda, från cirka 0,4 mg/m3 (stationär provtagning). 
Med detta som utgångspunkt rekommenderas ett hälsobaserat nivågränsvärde  
på 0,1 mg/m3 (tidsvägt medelvärde, 8 timmar). Detta motsvarar 0,2 mg/m3 vid 
stationär provtagning i badhusmiljö. Inget korttidsgränsvärde rekommenderas. 
 
 
 
 
Nyckelord: astma, dikloramin, hygieniskt gränsvärde, irritation, monokloramin, 
riskbedömning, toxicitet, trikloramin, översikt. 
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19. Data bases used in search of literature 
In the search for literature the following data bases were used: 
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Chemical Abstracts 
HSELINE 
Medline EBSCO 
Medline OVID 
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PubMed 
Toxline 
 
Last complete search was performed in February 2017. 
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Appendix 1. Exposure limits for trichloramine in air  
Country 8-hour TWA, mg/m3 Reference 
Occupational exposure limits   
Canada, Ontario – 1 
Denmark – 2 
European Union – 3 
Finland  0.5 4 
Germany, AGS, DFG – 5, 6 
Norway – 7 
Sweden – 8 
United Kingdom – 9 
United States, OSHA – 10 
Recommended values   
Canada, Workers Compensation Board  < 0.35 11 
France, ANSES/AFFSET  0.3 12 
Germany, Environment Agency   0.2 13 
Switzerland, SIA  0.2 14 
WHO  0.5 15 
AFFSET: Agence française de sécurité sanitaire de l’environnement et du travail (Agency for 
environmental and occupational health safety), AGS: Ausschuss für Gefahrstoffe (Committee 
for Hazardous Substances), ANSES: Agence nationale de sécurité sanitaire de l’alimentation, de 
l’environnement et du travail (Agency for food, environmental and occupational health safety), 
DFG: Deutsche Forschungsgemeinschaft (German Research Foundation), OSHA: Occupational 
Safety and Health Administration, SIA: Schweizerischer Ingenieur- und Architektenverein 
(Swiss Society of Engineers and Architects), TWA: time-weighted average, WHO: World Health 
Organization. 
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Appendix 2. Previous NEG criteria documents 
NEG documents published in the scientific serial Arbete och Hälsa (Work and Health). 
Substance/Agent Arbete och Hälsa issue 
Acetonitrile 1989:22, 1989:37* 
Acid aerosols, inorganic 1992:33, 1993:1* 
Acrylonitrile 1985:4 
Allyl alcohol 1986:8 
Aluminium and aluminium compounds 1992:45, 1993:1*, 2011;45(7)*D 
Ammonia 1986:31, 2005:13* 
Antimony 1998:11* 
Arsenic, inorganic 1981:22, 1991:9, 1991:50* 
Arsine 1986:41 
Asbestos 1982:29 
Benomyl 1984:28 
Benzene 1981:11 
1,2,3-Benzotriazole 2000:24*D 
Boric acid, Borax 1980:13 
1,3-Butadiene 1994:36*, 1994:42 
1-Butanol 1980:20 
γ-Butyrolactone 2004:7*D 
Cadmium 1981:29, 1992:26, 1993:1* 
7/8 Carbon chain aliphatic monoketones 1990:2*D 
Carbon monoxide 1980:8, 2012;46(7)* 
Carbon nanotubes 2013;47(5)* 
Ceramic Fibres, Refractory 1996:30*, 1998:20 
Chlorine, Chlorine dioxide 1980:6 
Chloromequat chloride 1984:36 
4-Chloro-2-methylphenoxy acetic acid 1981:14 
Chlorophenols 1984:46 
Chlorotrimethylsilane 2002:2 
Chromium 1979:33 
Cobalt 1982:16, 1994:39*, 1994:42 
Copper 1980:21 
Creosote 1988:13, 1988:33* 
Cyanoacrylates 1995:25*, 1995:27 
Cyclic acid anhydrides 2004:15*D 
Cyclohexanone, Cyclopentanone 1985:42 
n-Decane 1987:25, 1987:40* 
Deodorized kerosene 1985:24 
Diacetone alcohol 1989:4, 1989:37* 
Dichlorobenzenes 1998:4*, 1998:20 
Diesel engine exhaust 2016;49(6)*D 
Diesel exhaust 1993:34, 1993:35* 
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NEG documents published in the scientific serial Arbete och Hälsa (Work and Health). 
Substance/Agent Arbete och Hälsa issue 
Diethylamine 1994:23*, 1994:42 
2-Diethylaminoethanol 1994:25*N 
Diethylenetriamine 1994:23*, 1994:42 
Diisocyanates 1979:34, 1985:19 
Dimethylamine 1994:23*, 1994:42 
Dimethyldithiocarbamates 1990:26, 1991:2* 
Dimethylethylamine 1991:26, 1991:50* 
Dimethylformamide 1983:28 
Dimethylsulfoxide 1991:37, 1991:50* 
Dioxane 1982:6 
Endotoxins 2011;45(4)*D 
Enzymes, industrial 1994:28*, 1994:42 
Epichlorohydrin 1981:10 
Ethyl acetate 1990:35* 
Ethylbenzene 1986:19 
Ethylenediamine 1994:23*, 1994:42 
Ethylenebisdithiocarbamates and Ethylenethiourea 1993:24, 1993:35* 
Ethylene glycol 1980:14 
Ethylene glycol monoalkyl ethers 1985:34 
Ethylene oxide 1982:7 
Ethyl ether 1992:30* N 
2-Ethylhexanoic acid 1994:31*, 1994:42 
Flour dust 1996:27*, 1998:20 
Formaldehyde 1978:21, 1982:27, 2003:11*D 
Fungal spores 2006:21* 
Furfuryl alcohol 1984:24 
Gasoline 1984:7 
Glutaraldehyde 1997:20*D, 1998:20 
Glyoxal 1995:2*, 1995:27 
Halothane 1984:17 
n-Hexane 1980:19, 1986:20 
Hydrazine, Hydrazine salts 1985:6 
Hydrogen fluoride 1983:7 
Hydrogen sulphide 1982:31, 2001:14*D 
Hydroquinone 1989:15, 1989:37* 
Industrial enzymes 1994:28* 
Isoflurane, sevoflurane and desflurane 2009;43(9)* 
Isophorone 1991:14, 1991:50* 
Isopropanol 1980:18 
Lead, inorganic 1979:24, 1992:43, 1993:1* 
Limonene 1993:14, 1993:35* 
Lithium and lithium compounds 2002:16* 
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NEG documents published in the scientific serial Arbete och Hälsa (Work and Health). 
Substance/Agent Arbete och Hälsa issue 
Manganese 1982:10 
Mercury, inorganic 1985:20 
Methacrylates 1983:21 
Methanol 1984:41 
Methyl bromide 1987:18, 1987:40* 
Methyl chloride 1992:27*D 
Methyl chloroform 1981:12 
Methylcyclopentadienyl manganese tricarbonyl 1982:10 
Methylene chloride 1979:15, 1987:29, 1987:40* 
Methyl ethyl ketone 1983:25 
Methyl formate 1989:29, 1989:37* 
Methyl isobutyl ketone 1988:20, 1988:33* 
Methyl methacrylate 1991:36*D 
N-Methyl-2-pyrrolidone  1994:40*, 1994:42 
Methyl-tert-butyl ether 1994:22*D 
Microbial volatile organic compounds (MVOCs) 2006:13* 
Microorganisms 1991:44, 1991:50* 
Mineral fibers 1981:26 
Nickel 1981:28, 1995:26*, 1995:27 
Nitrilotriacetic acid 1989:16, 1989:37* 
Nitroalkanes 1988:29, 1988:33* 
Nitrogen oxides 1983:28 
N-Nitroso compounds 1990:33, 1991:2* 
Nitrous oxide 1982:20 
Occupational exposure to chemicals and hearing impairment 2010;44(4)* 
Occupational skin exposure to chemicals 2018;52(3)* 
Oil mist 1985:13 
Organic acid anhydrides 1990:48, 1991:2* 
Ozone 1986:28 
Paper dust 1989:30, 1989:37* 
Penicillins 2004:6* 
Permethrin 1982:22 
Petrol 1984:7 
Phenol 1984:33 
Phosphate triesters with flame retardant properties 2010;44(6)* 
Phthalate esters 1982:12 
Platinum 1997:14*D, 1998:20 
Polychlorinated biphenyls (PCBs) 2012;46(1)* 
Polyethylene,  1998:12* 
Polypropylene, Thermal degradation products in the 
processing of plastics 
1998:12* 
Polystyrene, Thermal degradation products in the processing 
of plastics 
1998:12* 
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NEG documents published in the scientific serial Arbete och Hälsa (Work and Health). 
Substance/Agent Arbete och Hälsa issue 
Polyvinylchloride, Thermal degradation products in the 
processing of plastics 
1998:12* 
Polytetrafluoroethylene, Thermal degradation products in 
the processing of plastics 
1998:12* 
Propene 1995:7*, 1995:27 
Propylene glycol 1983:27 
Propylene glycol ethers and their acetates 1990:32*N  
Propylene oxide 1985:23 
Refined petroleum solvents 1982:21 
Refractory Ceramic Fibres 1996:30* 
Selenium 1992:35, 1993:1* 
Silica, crystalline 1993:2, 1993:35* 
Silicon carbide 2018;52(1)*  
Styrene 1979:14, 1990:49*, 1991:2 
Sulphur dioxide 1984:18 
Sulphuric, hydrochloric, nitric and phosphoric acids 2009;43(7)* 
Synthetic pyretroids 1982:22 
Tetrachloroethane 1996:28*D 
Tetrachloroethylene 1979:25, 2003:14*D 
Thermal degradation products of plastics 1998:12* 
Thiurams 1990:26, 1991:2* 
Tin and inorganic tin compounds 2002:10*D 
Toluene 1979:5, 1989:3, 1989:37*, 2000:19* 
1,1,1-Trichloroethane 1981:12 
Trichloroethylene 1979:13, 1991:43, 1991:50* 
Triglycidyl isocyanurate 2001:18* 
n-Undecane 1987:25, 1987:40* 
Vanadium 1982:18 
Vinyl acetate 1988:26, 1988:33* 
Vinyl chloride 1986:17 
Welding gases and fumes 1990:28, 1991:2* 
White spirit 1986:1 
Wood dust 1987:36 
Xylene 1979:35 
Zinc 1981:13 
 * : in English, remaining documents are in a Scandinavian language.  
D: collaboration with the Dutch Expert Committee on Occupational Safety (DECOS).  
N: collaboration with the US National Institute for Occupational Safety and Health (NIOSH).  
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